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ABSTRACT OF DISSERTATION 
 
 
GROUP 13 CHELATES IN PHOSPHATE DEALKYLATION 
 
 
 A series of mononuclear boron halides of the type LBX2 (LH = N-phenyl-3,5-di-t-
butylsalicylaldimine, X = Cl (2), Br (3)) and LBX ( LH2 = N-(2-hydroxyphenyl)-3,5-di-t-
butylsalicylaldimine, X = Cl (7), Br (8); LH2 = N-(2-hydroxyethyl)-3,5-di-t-
butylsalicylaldimine, X = Cl (9), Br (10); LH2= N-(3-hydroxypropyl)-3,5-di-t-
butylsalicylaldimine, X = Cl (11), Br (12)) were synthesized from their borate precursors 
LB(OMe)2 (1) (LH = N-phenyl-3,5-di-t-butylsalicylaldimine ) and LB(OMe) (LH2 = N-
(2-hydroxyphenyl)-3,5-di-t-butylsalicylaldimine (4), N-(2-hydroxyethyl)-3,5-di-t-
butylsalicylaldimine (5), N-(3-hydroxypropyl)-3,5-di-t-butylsalicylaldimine (6)). The 
borate precursors, 1, 4 - 6, in turn, were prepared by refluxing the corresponding ligands 
LH or LH2 with excess B(OMe)3. The boron halide compounds were air- and moisture-
sensitive and compound 7 on hydrolysis gave the oxo-bridged compound 13 that 
contained two seven-membered boron heterocycles. The boron halide compounds 
dealkylated trimethyl phosphate in stoichiometric reactions to produce methyl halide and 
unidentified phosphate materials. Compounds 8 and 12 were found to be the most 
effective dealkylating agents. Compound 8 on reaction with t-butyl diphenyl phosphinate 
produced a unique boron phosphinate compound LB(O)OPPh2 (14) containing a terminal 
phosphinate group. Compounds 1-14 were characterized by 1H, 13C, 11B, 31P NMR, IR, 
MS, EA and MP. Compounds 5, 6, 11, 12 and 13 were also characterized by single-
crystal X-ray diffraction. 
 The alkane elimination reaction between Salen(tBu)H2 ligands and diethylaluminum 
bromide was used to prepare the four Salen aluminum bromide compounds, 
salen(tBu)AlBr (15) (salen = N,N'-ethylenebis(3,5-di-tert-butylsalicylideneimine)), 
salpen(tBu)AlBr (16) (salpen = N,N'-propylenebis(3,5-di-tert-butylsalicylideneimine)), 
salben(tBu)AlBr (17) (salben = N,N'-butylenebis(3,5-di-tert-butylsalicylideneimine)) and 
salophen(tBu)AlBr (18) (salophen = N,N'-o-phenylenenebis(3,5-di-tert-
 
butylsalicylideneimine)). The compounds contained five-coordinate aluminum either in a 
distorted square planar or a trigonal bipyramidal environment. The bromide group in 
these compounds could be displaced by triphenylphosphine oxide or triphenyl phosphate 
to produce the six-coordinate cationic aluminum compounds [salen(tBu)Al(Ph3PO)2]Br 
(19), [salpen(tBu)Al(Ph3PO)2]Br (20), [salophen(tBu)Al(Ph3PO)2]Br (21) and 
[salophen(tBu)Al{(PhO)3PO}2]Br (22). All the compounds were characterized by 1H, 
13C, 27Al and 31P NMR, IR, mass spectrometry and melting point. Furthermore, 
compounds 15, 16, 17, 18, 20, 21 and 22 were structurally characterized by single-crystal 
X-ray diffraction. Compounds 15, 17 and 18 dealkylated a series of organophosphates in 
stoichiometric reaction by breaking the ester C─O bond. Also, they promoted the 
dealkylation reaction between trimethyl phosphate and added boron tribromide. 
Stoichiometric reaction of compound 15 with trimethyl phosphate produced the 
aluminophosphinate compound salen(tBu)AlOP(O)Ph2 (23). Compound 16 on reaction 
with tributyl phosphate produced the aluminophosphate compound 
[salpen(tBu)AlO]2[(BuO)2PO]2 (24). Compounds 23 and 24 were characterized by single-
crystal X-ray diffraction and spectroscopically. 
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Chapter 1 
 
Introduction and Background 
1.1. Group 13 chelates 
 Since the first use of AlCl3 in what later became known as the Friedel-Craft reaction in 
1877, 1 Group 13 Lewis acids have been widely used for catalytic and synthetic 
applications. This was advanced significantly by Ziegler in 1955 by the discovery that 
organoaluminum reagents polymerized olefins. 2 Extensive research in this area during 
the past few decades has lead to the discovery of group 13 compounds with interesting 
structures and a wide range of coordination environments for the metal. 3 Chelated group 
13 compounds are becoming increasingly popular with the use of ligands with tailor-
made structures. Many of these chelate compounds have far superior air and moisture 
stability compared to traditional unchelated group 13 Lewis acids. These compounds are 
finding applications in fields which have normally been dominated by transition metal 
compounds. Examples include important areas, such as asymmetric catalysis and oxirane 
polymerizations. 
 The chelate effect 4, 5 refers to the increased stability of a complex formed from 
multidentate ligands compared to a similar complex containing monodentate ligands. 
Thus a complex containing a chelate ring has a higher formation constant compared to a 
similar one containing no chelate ring. One common example is: 
Ni2+ (aq) + 6NH3 (aq) = [Ni(NH3)6]2+ (aq)      logβ = 8.61 
Ni2+ (aq) + 3en (aq) = [Nien3]2+ (aq)                logβ = 18.28 
 2
There are two concepts that have been invoked to explain the higher stability of chelate 
complexes compared to complexes with individual ligands. According to one concept, 
which is based on thermodynamic considerations, the increased stability is due to the 
increased entropy resulting from the net increase of the number of unbound molecules 
released when the chelate is formed. According to the other concept, which is based on 
geometrical consideration, the stability is due to the increased proximity of the other 
ligand atom(s) of the chelate once the first metal ligand bond is formed. This second 
concept implies that when one end of a multidentate ligand binds to a metal ion, the other 
ends stay in close proximity to the ion creating a high local concentration of the ligand 
atoms while a monodentate ligand can diffuse away from the metal ion. The first example 
of a group 13 chelate is probably tris(acetylacetonate) aluminum, first reported in 1887. 6 
In this compound aluminum has an octahedral geometry. Group 13 elements form a 
variety of stable chelates particularly with combinations of nitrogen and oxygen ligands. 
Of particular stability is the complex of EDTA with aluminum (stability constant = 16.3). 
In solution EDTA displaces aqua or hydroxo ligands from [Al(H2O)x(OH)y]n+. 
1.2 Schiff base ligands 
 Schiff base 7 ligands were first synthesized in 1864 and contain the azomethine group 
(-RC=N-). They are formed by the condensation of an amine with an aldehyde (Figure 
1.1). However, the first Schiff base-metal complex, bis(salicylaldimino)Cu(II), 8 was 
isolated in 1840 from the combination of cupric acetate, salicylaldehyde, and aqueous 
ammonia. Schiff base ligands have played a very important role in transition metal 9 and 
main group 10-15 coordination chemistry. They are easy to prepare and are of great 
synthetic flexibility and structural variability. This provides the ability to control the 
 3
coordination environment of the coordinated metal center. Condensation between 
aldehydes and amines can be effected in different conditions and in different solvents. 
The presence of a dehydrating agent, usually MgSO4, favors the formation of Schiff 
bases. They are generally purified by recrystallization since chromatography using silica 
gel can cause decomposition of the product. They can be characterized by conventional 
organic techniques. The presence of the C=N group gives a strong IR absorption in the 
region between 1680 and 1603 cm-1. The UV spectra are characterized by bands in the 
range 235-272 nm for the unconjugated C=N chromophore. However, conjugation with 
alkenic or aryl groups causes a change in the spectrum. The presence of keto-amine 
tautomerism can be observed by NMR. 
 Schiff base ligands usually contain both N and O as the donor atoms. The most widely 
studied types of these ligands are derivatives of salicylaldimines (Figure 1.2(a)). The 
most popular of these are the Salen class of ligands (Figure 1.2(b)) which are formed 
from the condensation of two moles of salicylaldehyde with one mole of a diamine. 
These are tetradentate, potentially dianionic ligands with two coordinate-covalent and 
two covalent sites. They are similar to porphyrin ligands but are less expensive and easier 
to synthesize. Also the open front of the Salen compounds can be utilized in catalytic 
reactions. These ligands provide a wide range of options in terms of varying the steric 
and electronic properties around the metal center. For example, a variety of organic 
groups can be incorporated into the ligand backbone. Moreover, their solubility can be 
varied by incorporating appropriate substituent groups on the phenyl rings. Salen(tBu) 
ligands are more appealing compared to unsubstituted Salen(H2) ligands because of their 
 4
better solubility in organic solvents and hence better scope of characterizing their 
solution-state properties.  
 Salen ligands have been used to prepare both mono- and binuclear compounds.10 
Besides tetradentate Salen ligands containing two N and two O as donor atoms (N2O2), 
Schiff base ligands having denticities of two, three and higher are also common. Some of 
the examples include N-phenylsalicylideneimine (NO), N-phenylsalicylidene-o-
aminophenol (NO2) and Phensal(tBu)H3 (N2O)(where Phensal(tBu)H = salicylidene(1-
iminophenylene-2-amine) ligands.  
 Group 13 elements, specially boron and aluminum, are known to form various 
mononuclear (1:1 ligand to metal) and binuclear (1:2 ligand to metal) chelate complexes 
with many Schiff base ligands, especially Salen type ligands. In most cases the bonding 
occurs through the oxygen or nitrogen atoms of the chelating ligands. This may be 
ascribed to high B-O (809 kJmol-1), B-N (390 kJmol-1), Al-O (511 kJmol-1) and Al-N 
(298 kJmol-1) bond energies. 16 
 While aluminum and gallium form both mono- and binuclear chelates of the type 
LMX and L(MX2)2 (M=Al or Ga; X= alkyl, alkoxide, aryloxide, siloxide group), 
respectively, depending on ligand to metal stoichiometry used, boron mainly forms 
binuclear chelates of the type L(MX2)2 or L(MXX')2 (M=Al or Ga; X,X'= alkyl, alkoxide, 
aryloxide, siloxide group) even with excess ligand. This is because of the tendency of 
boron to adopt a four-coordinate tetrahedral geometry which is not possible with 
mononuclear compounds with Salen ligands. In addition to neutral compounds, cationic 
five- and six-coordinate aluminum 17-22 and four coordinate boron 23 compounds of Schiff 
base ligands have been synthesized recently. 
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1.3. Group 13 complexes for Lewis acid catalysis 
 The Lewis acidic property of group 13 compounds stems from the electron deficiency 
around the metal center. This is dependent upon the extent of the interaction of the 
available p orbital of the metal with unshared or π-electrons of the ligand system. From 
an electronegativity consideration only, the Lewis acidity of group 13 compounds should 
decrease along the series B>Al>Ga>In>Tl. However other factors such as size of the 
metal, interaction of the metal p orbital with the unshared electrons of the ligand already 
present and steric factors could alter the trend. One advantage of group 13 chelated 
complexes over simple group 13 compounds like BCl3 or AlCl3 is the ability to tune their 
structure by varying the coordinated ligands, and, thus, prepare designer Lewis Acids. 
Moreover, the ligand does not participate in the reaction. Both neutral and cationic group 
13 chelate complexes find various applications as Lewis acids. These include Aldol 
transfer reaction, 24 Tishchenko reactions 24 Diels-Alder reactions 25-30, oligomerization of 
oxiranes 17, 18, 23 and lactides, 31, 32 and dealkylation of organophosphate esters. 33-35 
1.4. Organophosphate compounds 
 The esters of orthophosphoric acid can be classified into phosphate monoesters, 
diesters and triesters (Fig. 1.3). Mono- and di-esters have ionizable hydrogen atoms that 
can be replaced by cations. Triesters are covalent compounds and they do not exist 
naturally; they must be synthesized. Phosphate esters contain one or more P-O-C linkages 
where the P-O (~359 KJ mol-1) and C-O (~355 KJ mol-1) bonds are of comparable 
energy. 36 
 Organophosphate esters are a commercially important class of compounds finding 
applications in various areas. 37, 38 For example, tri-n-butyl phosphate is used for the 
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selective extraction of metals, particularly uranium compounds, and as a hydraulic fluid 
in aircraft. Tris(2-ethylhexyl) phosphate is used as a plasticizer in polymers and is a 
flame retardant. Triaryl phosphates are used as additives for gasoline, plasticizers, 
lubricants, coolants, hydraulic fluids, and flame retardants. Various organophosphate 
compounds are used in pesticides. The first laboratory synthesis of an organophosphate 
ester was reported in 1820 from the reaction of phosphoric acid and ethanol 39 However, 
the first large-scale use of organophosphate esters was developed during the 1930s for 
potential use in nerve gas agents. 37 
 The phosphate ester bond is very important in living systems. It appears in many 
biological molecules 40 such as DNA and RNA, and ATP (Fig. 1.4). Also, many 
coenzymes are esters of phosphoric acid. It participates in storage and transfer of genetic 
information, carries chemical energy and regulates the activity of enzymes and signaling 
molecules in the cell.  
1.5. Organophosphate toxicity 
 Organophosphate esters are active components of chemical warfare agents and 
pesticides. They can enter the body by inhalation, through skin or orally. They function 
by irreversibly blocking the serine hydroxy group in the enzyme acetylcholinesterase by 
phosphorylation (Figure 1.5). 41-43 Acetylcholinesterase is responsible for the hydrolysis 
of the neurotransmitter acetylcholine (Figure 1.5). Loss of the activity of this enzyme 
causes buildup of acetylcholine in the synapse and as a result the neural signal to the 
muscle is not terminated. This overstimulation leads to muscular paralysis and death. 
This occurs in seconds to minutes after the exposure and is the basis of the extreme 
neurotoxicity of nerve gas agents and pesticides. 
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Common antidotes for nerve gases are pyridine aldoxime (e.g., Pralidoxime), Atropine 
and Valium (Figure 1.6). Aldoxime reacts with inhibited acetyl cholinesterase and 
regenerates the active enzyme from the phosphorylated form. Atropine acts as an 
antagonist for the acetylcholine receptor in the synapse. It binds to the receptor and thus 
prevents transmission of the signal created by the binding of acetylcholine to the synapse. 
It thus gives protection from the build up of excess acetylcholine that results from the 
inhibition of acetylcholinesterase by the nerve agent. Anticonvulsants such as Valium 
protect against convulsions and the resulting brain damage. 
 Today, organophosphate pesticides are the most widely used type of pesticides and 
have replaced organochlorine pesticides, which are more persistent in the environment. 
Despite their potential environmental problems the use of organophosphate pesticides has 
been increasing and is predicted to increase in the future because of the lack of suitable 
substitutes. 44 Decontamination of nerve gases is required in battlefields, laboratories, 
storage and destruction sites. Long-lived pesticides pose a threat when they spread 
beyond their intended application. Examples of some nerve gas agents and pesticides are 
shown in Figure 1.7. All of these compounds possess a P-O-C linkage in their structure. 
The cleavage of the P-O-C bond has been targeted as a means of deactivating these toxic 
agents. 45, 46 This is convenient due to the nucleophilicity of the phosphorus and polar 
nature of the P─O and the C─O bonds. 
 Nerve gases can be destroyed by bleach, through oxidation to less toxic inorganic 
phosphates, and alkali, through hydrolysis of the P-O or P-S bonds. 45, 46 One 
disadvantage of using bleach is that a large excess is required. Also the active chlorine 
content of bleach solutions decreases with time. Moreover, bleach is indiscriminately 
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corrosive to any surface or compound it comes into contact with. Base hydrolysis also 
has some limitations such as the requirement of large quantities to maintain a high pH 
level. Also VX has low solubility in alkaline solution and reacts with base very slowly. 
Catalytic hydrolyses involving metal ions (e.g., Cu2+, Ag+, Hg2+) 45, 47-49 and enzymes 
(e.g., organophosphorus acid anhydrases) 45, 50-54 have been proposed but they also have 
their limitations. For example, Cu(II) has limited capability for hydrolysis of VX whereas 
Ag+ is too expensive and Hg2+ is too toxic to be used as a decontamination agent. The 
enzyme organophosphorus hydrolase (OPH) is highly efficient for the hydrolysis of 
organophosphorus pesticides (kcat is up to 3800 s-1) but has much lower efficiency for the 
hydrolysis of VX (kcat = 0.3 s-1). 55 
 1.6. Phosphate ester cleavage in biology  
 In biology, the hydrolytic cleavage of phosphate esters is catalyzed by a number of 
enzymes. These reactions have been the subject of much attention 56-60 and can be divided 
into two types: associative and dissociative (Figure 1.8). A dissociative path proceeds 
through a hydrated metaphosphate ion PO3-, and an associative path goes through a five-
coordinate phosphorus intermediate. Inversion of configuration around the phosphorus 
atom generally takes place in the associative mechanism. 
 Currently, it is thought that in solution the hydrolysis of di- and triesters follows a 
more associative-like pathway whereas that of monoesters proceeds through a 
dissociative mechanism. 61-63 This has been proposed to explain the higher reactivity of 
monoesters compared to di- and triesters. However, this is being debated. The enzymes 
catalyzing the hydrolytic cleavage contain metal ions and use the functional group of the 
amino acids and/or the Lewis acidity of the metal ions. A number of recent reviews have 
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been published on this subject. 64, 65 These enzymes can be divided into three classes 
depending on the phosphate containing substrate. These are, phosphate monoesterase, 
diesterase and triesterase. Important monoesterase enzymes are glucose-6-phosphatase, 
alkaline phosphatase, and purple acid phosphatase. Phosphate diesterases are exemplified 
by P1 nuclease, phospholipase C and 3'-5' exonuclease from the Klenow fragment of 
DNA polymerase I. 66 Examples of phosphotriesterases are parathion hydrolase and 
DFPase. 
1.6.1. Alkaline phosphatase 
 Alkaline phosphatase (AP) 64, 65, 67-70 is probably the most widely studied enzyme of 
the metallohydrolases. It shows low substrate specificity and optimal activity in alkaline 
conditions (pH 7.5) and is found in prokaryotes and eukaryotes. The most extensively 
studied of these enzymes is that from E. coli. This is a homodimeric protein (94kDa) that 
contains two Zn2+ ions and one Mg2+ ion in each active site. The hydrolysis proceeds 
through a phosphorylated intermediate formed by the nucleophilic attack of Ser-102 on 
the phosphate monoester. This intermediate is subsequently attacked by an adjacent Zn-
OH group (Figure 1.9). 71 A retention of configuration at the phosphorus center is 
observed which implies a dissociative mechanism. The two Zn2+ ions are important for 
the activity of AP, but the Mg2+ ion plays only an ancillary role. One or two of the Zn2+ 
ions can be substituted by Mg2+, Mn2+ or Co2+  but this results in a considerable reduction 
in activity. 70 This is probably related to either intrinsic chemical properties of the metal 
ions, slight change induced in the conformation of protein side chain at the active center 
or change in interaction between the Ser-102 residue and the metal. 72, 73 
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1.6.2. Purple acid phosphatase 
 Purple acid phosphatases (PAPs) 74-77are a group of phosphomonoesterases that 
catalyze phosphate ester hydrolysis under acidic conditions (pH optima at 4.9 - 6.0), 
resist inhibition by tartrate and exhibit a characteristic intense purple color. They contain 
two irons or one iron and another dipositive cation (Fig.1.10). Most of the enzymes 
having the FeIII-FeII couple are isolated from bovine spleen 78 or porcine uterine fluid. 79 
PAPs isolated from kidney beans 80 generally contain one iron and one zinc or 
manganese. 
1.6.3. P1 nuclease 
 P1 nuclease 81 is a phosphodiesterase that preferentially cleaves the bond between the 
3'-hydroxy and 5'-phosphate group of single stranded RNA and DNA. It requires the 
presence of three zinc ions 82 per molecule and the hydrolysis causes inversion of 
configuration at phosphorus . 83 
1.6.4. Phospholipase C 
 Phospholipase C (PLC) enzymes catalyze the hydrolysis of various phospholipids, for 
example, phosphatidylinositol and phosphatidylcholine. The PLC 84, 85 from soil 
bacterium B. Cereus contain two tightly bound Zn(II) ions (Zn1 and Zn2) per molecule, 
whereas a third more weakly bound zinc(II) ion (Zn3) was revealed in its X-ray crystal 
structure. 86 All of the zinc ions are in trigonal-bipyramidal coordination environments. 
Zn1 and Zn2 are 3.3 Å apart and bridged by Asp122 and a water. Zn3 has a lower site 
occupancy and is located 6.0 and 4.7 Å from the other two zinc ions. Other metal ions 
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like cobalt, magnesium and manganese can replace zinc in some PLC enzymes, however, 
this results in reduced activity and altered substrate specificity. 87-89 
1.6.5. Phosphate triesterase 
 Phosphate triesterases (PTEs) 90 catalyze the hydrolysis of organophosphate triesters. 
The triesters do not occur in nature but they are released into nature by the use of 
pesticides and insecticides. The best characterized phosphotriesterase is the enzyme from 
soil bacteria Pseudomonas diminuta which is a monomeric metalloprotein that 
hydrolyzes P-O, P-F, P-CN, and P-S bonds between the phosphorus and the leaving 
group. 91-93 The native enzyme contains two Zn2+ ions in the active site but they can be 
substituted with Cd2+, Co2+, Ni2+, or Mn2+ without affecting catalytic activity. 94 
1.7. Phosphate ester cleavage using models of biological catalysts 
 To elucidate the role of the metal ions in the hydrolysis of phosphate esters 
extensive studies have been conducted during the last several years. 66, 95, 96 Besides 
kinetic and structural studies of the original enzymes, several well-defined model 
compounds have been developed to understand the process of the cleavage. Besides 
understanding the mechanism of phosphate ester cleavage, studies of metal containing 
model compounds are also relevant to the synthesis of artificial metallohydrolases. These 
model compounds use d- and f-block metals such as cobalt, 97, 98 zinc, 99-103 copper, 104-106 
and lanthanides. 107-115 The systems include mono-, bi- (Fig. 1.11) and trinuclear metal 
compounds. Binuclear compounds have been found to be much more active than the 
mononuclear counterparts. For example, the hydrolysis rate of bis(p-nitrophenyl) 
phosphate (BNP) increases almost ten-fold for the binuclear [Zn2L1(OH)2]+ (L1= 
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[30]aneN6O4] complex with respect to the mononuclear L2-Zn-OH+ (L2=[15]aneN3O2). 
116 This was determined by comparing the second order rate constants kBNP for the mono- 
and binuclear species. kBNP was determined from the slope of the plot of hydrolysis rate 
vs. BNP- concentration. The rate of hydrolysis was monitored by visible spectroscopy. 
The higher reactivity with binuclear systems is attributed to the double Lewis acidic 
activation from the coordination of two phosphoryl oxygen atoms with two metal centers 
as shown for a peroxide bridged lanthanide binuclear complex in Figure 1.12. 
1.8. Phosphate ester cleavage with various agents 
1.8.1. Phosphate ester cleavage with metal halides and thiophenoxides 
 Alkali metal iodides have been studied for catalytic dealkylation of phosphates and 
phosphinates. 117 The order of effectiveness was found to be Li+ > Na+ > K+. The reaction 
is thought to proceed through a SN2 transition state (associative) (Fig.1.13). Fluoride salts 
MF (M= Na, K, Cs, Me4N) catalyze the hydrolysis of phosphate esters. 118 The cleavage 
of phosphate esters with fluoride ion is fully regiospecific and involves exclusively 
homolytic P-OAr bond cleavage. It does not have any effect on the P-OMe bond in 
trimethyl phosphate. However, the catalytic effect is much weaker when the metal ion is 
Li+. The cleavage is thought to proceed through the initial formation of a 
phosphorofluoridate, which then undergoes further hydrolysis (Figure 1.14). 
Thiophenoxide salts, PhS-M+ (M+ = Me4N+, K+, Na+, Li+) in methanol can dealkylate 
phosphate esters (Figure 1.15). 119 The reaction was thought to proceed through a solvent- 
separated ion pair. Trimethyl phosphate can be dealkylated in a stepwise manner with 
phenylthiotrimethylsilane, PhSSiMe3  in the presence of catalytic PhS  (Figure 1.16). 120 
This works for other phosphate triesters of the type (RO)3PO, ROP(O)(Me)2, 
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PhOP(O)(OR)2 and (PhO)2P(O)OR (R=Me, Et, n-Pr and Ph). The ease of cleavage is in 
the order of Me, Et, n-Pr. However, no cleavage occurs with phenyl. 
1.8.2. Dealkylation with organosilicon compounds 
 Bromo- and chloro- trialkysilanes react with alkyl phosphates or phosphonates to give 
the corresponding alkylsilyl esters. 121-123 Use of bromotrimethylsilane was found to be  
superior to the chloro compounds. Chlorotrimethylsilane in conjunction with a metal 
halide in acetonitrile has been used to dealkylate dialkyl vinyl phosphate (Figure 1.17). 
Iodotrimethylsilane is more reactive to phosphate and phosphonate esters and transforms 
them to the corresponding trimethylsilyl ester and alkyl iodide rapidly and quantitatively 
at room temperature (Figure 1.18). 124 However, the reaction is not catalytic. 
1.8.3. Phosphate cleavage with hypervalent iodine compounds 
 o-Iodosyl- and o-iodoylcarboxylate derivatives have been widely studied for the 
degradation of organophosphate substrates. 125 They have been found to be rapid catalysts 
for the hydrolysis of p-nitrophenyl diphenyl phosphate (PNDPP) (with a second order 
rate constant as high as 10-4 M-1.s-1) and fluorophosphonate nerve gas agents in presence 
of micellar reagents. In the catalytic cycle, IBA (IBA = o-iodosylbenzoate) is thought to 
function in a two-step sequence in which the first step involves the attack of the 
nucleophilic I-O  moiety on the phosphoryl group forming a phosphorylated 
intermediate (Figure 1.19). 
1.8.4. Dealkylation with quaternary ammonium salts and micelles 
 Quaternary pyridinium aldoximes e.g., 1-methyl-2-hydroxyiminomethylpyridinium 
iodide, can catalytically cleave 4-nitrophenyl diphenyl phosphate (PNDPP) in neutral or 
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slightly basic aqueous solution (Figure 1.20). 126 This reaction becomes considerably 
faster in comicelles with the inert cationic tenside, cetyltrimethylammonium bromide 
(CTAB). Cationic surfactants, 127-129 micellar, 130-132 metallomicellar 105, 133 and reverse 
micellar 128 systems have been widely studied to catalyze the cleavage of P-O bond. 
1.8.5. Phosphate ester cleavage using polymers and nanoparticles 
 Metalated hybrid polymers, e.g., CPPPL-Zn (Figure 1.21) have been found to 
catalytically cleave 2-(hydroxypropyl)-p-nitrophenyl phosphate (HPNP). 134 Zn(II)-based 
functional gold nanoparticles formed by self-assembly of triazacyclononane-
functionalized thiols on the surface of gold nanoparticles have been reported to be very 
effective catalyst for the cleavage of HPNP. 135 Initial research indicates that during the 
catalytic process there is cooperativity between Zn(II) ions bound to the functionalized 
gold nanoparticles. These catalyst have also been found to be fairly active in the cleavage 
of the phosphate bond in RNA dinucleotides. 
1.9. Phosphate ester cleavage with group 13 chelates 
1.9.1. Phosphate ester cleavage using chelated boron compounds 
 One advantage of chelated boron complexes over simple boron Lewis acidic 
compounds like BCl3 is the ability to tune their structure by varying constituents in the 
ligand environment. Chelated mononuclear (1:1 ligand to metal) boron compounds have 
been known for a long time. Some of the recent examples of these include β-diketonates, 
136 β-diketiminate, 137 substituted anthracene, 138 polysaccharides, 139 L-cysteine, 140 
nitroles, 141, 142 tropolonates 143 and salilcylaldimines. 23 Recently, binuclear (1:2 ligand to 
metal) boron compounds 33-35, 144-150 have attracted attention due to their potential use as 
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two-point Lewis acids. Most of these binuclear compounds are derived from Salen 
ligands. 
1.9.1.1. Binuclear boron alkoxides and borosiloxides 
 Binuclear boron alkoxides 146 can be prepared by the alcohol elimination reaction 
between Salen ligands and corresponding alkyl borates (Figure 1.22(a)). The resulting 
compounds show interesting extended structures due to intra- and intermolecular 
hydrogen bonding of the alkoxide oxygens with the imine protons. The compounds form 
readily even in the presence of excess ligand. This is in contrast to aluminum that forms 
both mono- and binuclear compounds depending on the metal to ligand ratio. This is due 
to the smaller size of boron and its preference for a four-coordinate tetrahedral geometry. 
Similar binuclear boron compounds can be prepared by the condensation of boronic acids 
with the Salen ligands. 150 They can further be derivatized to bimetallic boron siloxides 
(Figure 1.22 (b)). 148 
1.9.1.2. Binuclear boron halides 
 Although the bimetallic boron alkoxides and siloxides are interesting from a 
fundamental standpoint, they are not ideal for use as precursors to two-point Lewis acids. 
For example, the bimetallic borate compounds do not dealkylate trimethyl phosphate. 35 
This is probably due to the high strength of the B─O bond (~ 809 kJ mol-1). 16 One step 
towards this goal was the synthesis of binuclear boron bromides and chlorides of the type 
L[BX2]233-35 opening the possibility of creating cations through salt elimination reactions. 
Binuclear boron chlorides can be prepared in almost quantitative yield by combining the 
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corresponding Salen(tBu)[B(OMe2)2] reagents with BCl3 in stoichiometric ratio at room 
temperature (Figure 1.23). Similarly, binuclear boron bromides can be 
prepared using BBr3 instead of BCl3. However, one difference in the synthesis of boron 
chlorides is that the reaction for chloride remains unaffected with addition of excess BCl3 
whereas for bromides with addition of excess BBr3, one B-Br bond is cleaved to produce 
an additional product L[BBr2(BBr)+]BBr4-. 35 This was the first indication of the lability 
of B-Br bonds in these compounds. It was further evident by the formation of a cation 
upon the addition of THF. 35 In these compounds the boron atoms are in a distorted 
tetrahedral geometry and trans to one another. 
In addition to binuclear boron tetrahalides of the type L[BX2]2, Salen aryl boron 
bromide compounds L[B(p-tolyl)Br]2 33 can be prepared from Salen (tBu)[(p-
tolyl)B(OMe)]2 and BBr3 (Figure 1.24).  
1.9.1.3. Phosphate dealkylation with binuclear boron halide chelates 
 The binuclear boron halide chelate compounds can dealkylate a wide range of 
phosphates at ambient temperature (Tables 1.1 and 1.2). 33-35  For example, 
salpen(tBu)[BBr2]2 dealkylates (MeO)3P(O) by 89% and (nBuO)3P(O) by 99% in only 30 
minutes in stoichiometric reactions. 33 This is significant considering the fact that BCl3 or 
BBr3 alone is not very effective for phosphate dealkylation. In the dealkylation reaction 
MeCl or MeBr is produced along with a yet unidentified phosphate material. The reaction 
can be monitored by comparing the 1H NMR peak integration of methyl halide to that of 
the original phosphate.  
 The active species in this type of reaction is thought to be a cation formed through the 
heterolytic cleavage of a B-X bond. The cation then coordinates to the phosphate, thereby 
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activating the ester carbon (Figure 1.25). This is supported by the formation of this type 
of cation by the simple addition of a Lewis base to L[BX2]2 35 When THF was added to a 
solution of salpen(tBu)[BBr2]2 in CDCl3 in a NMR tube the 11B NMR shifted downfield 
by 4.85 ppm, indicating the displacement of Br - by THF and formation of a cation.  
 The coordination of the P=O bond to the boron atom makes the P-O-R bonds 
susceptible to nucleophilic attack by the halide anion (Figure 1.26). A similar type of 
activation of an alkyl group is found during the dealkylation of phosphoramidates in 
strongly acidic medium 151 and also during the dealkylation of phosphonates with boron 
tribromide 152 All of the alkoxy bonds are cleaved in the process to produce three moles 
of RX and an as yet uncharacterized boron phosphate material. The process could be 
made catalytic in the Salen boron bromide compounds by conducting the reaction in the 
presence of excess BBr3. 33, 35 In general, bromide compounds were found to be more 
active compared to chloride analogues, which is in accordance with the weaker B-Br 
bond strength (396 kJ. mol -1) in comparison to B-Cl (511 kJ. mol -1). None of the chelate 
compounds could dealkylate (ArO)3P(O). However, this could be anticipated by the fact 
that phenylthiotrimethyl silane (PhSSiMe3) also cannot dealkylate arylphosphates. 120 
Also, the aryl C-O bond strength is higher compared to alkyl C-O (e.g., D(CH3O―Ph) = 
424 kJ. mol-1, D(CH3O―CH3) = 349 kJ. mol-1). 153 
 It was also observed that Salen compounds with longer backbones (the connection 
between the two nitrogens) were more efficient than those with shorter backbones 
probably due to unfavorable interaction between two boron centers. Thus salpen[BBr2]2, 
having a propylene backbone, and salben[BBr2]2, having a butylene backbone, were more 
efficient than salen[BBr2]2 having an ethylene backbone. Also, the dealkylation activity 
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of the Salen boron bromide compounds decreased with the branched phosphates such as 
(PhO)2((2-Et)hexylO)P(O). It was also found that one mononuclear boron chelate 
complex, LBX2 (L= tBu Sal(tBu), X= Br) could dealkylate trimethyl phosphate at 92% 
conversion. 33 Thus, it seems that the presence of two boron centers may not be necessary 
for the dealkylation to occur. If this is the case then this will be in contrast with biological 
phosphate ester cleavage by enzymes and many binuclear d-block and lanthanide 
compounds where the presence of two metal centers increases the phosphate cleavage 
rate. Also, with these compounds, the cleavage involves the direct attack of a nucleophile 
(water or hydroxide) on the phosphorus atom which is not the case with the boron 
chelates where the attack occurs at the ester carbon of the phosphate. 
1.9.2. Phosphate ester cleavage with aluminum compounds 
 Aluminum hydroxyphosphate sulfate has been reported to catalyze the hydrolysis of 
the P-O bonds in phosphate esters. 154, 155 Allyl phosphates can be heterolytically cleaved 
by various organoaluminum reagents of the type R3Al (R = Me, Et and i-Bu) and R2AlX 
(R = Me, X = S-tBu, SPh, NHPh, OPh) through a cross-coupling reaction in a 
stereospecific manner at low temperature (Figure 1.27(a)). 156 More selective production 
of the cyclized product is obtained by the use of dimeric aluminum reagents of the type 
R2AlXAlR2 (X = S, PhN, and O) in which the reaction is thought to proceed through the 
formation of a chelated anionic complex with the phosphate residue (Figure 1.27(b)). 
 Phosphoric acid triesters with Me, Et, n-Bu and SiMe3 groups react with aluminum 
and gallium amides, [M(NMe2)3]2 (M = Al, Ga) to form amorphous metal phosphate 
(MPO4) solid state materials in aprotic solvents (Figure 1.28). 157 AlCl3 also reacts 
similarly. Trimethyl phosphate was found to be more reactive than the other phosphates. 
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Gallium amides were less reactive than aluminum amides. Unlike alkyl and silyl 
phosphates, triphenyl phosphate undergoes a ligand scrambling reaction. The driving 
force in these reactions is the bond energy difference between Al-O and Al-N (585 kJ 
mol-1 vs. 280 kJ mol-1). For alkyl and silyl substituents the C-O bond of the phosphate is 
preferentially cleaved whereas for phenyl esters the P-O bond instead of the C-O bond is 
formed. This is responsible for the prevention of formation of the aluminophosphate. 
Trialkyl phosphates P(O)(OR)3 (R = Me, Et, Ph, SiMe3) react with AlMe3, AlEt3 and 
GaMe3 to form the adducts Me3AlOP(OR)3 (R = Me, Et, Ph, SiMe3), Et3AlOP(OR)3 (R 
= SiMe3), and Me3GaOP(OR)3 (R = Me, Si Me3) (Figure 1.29). 158 The trimethylsilyl 
ester adducts further undergo thermally induced dealkylsilylation to form cyclic alumino 
and gallophosphate dimers, [R'2M(µ2-O)2P(SiMe3)2]2 (R'2M = Me2Al, Et2Al and Me2Ga). 
The phosphate adducts could also undergo reaction with Me2NH to form 
aluminophosphate (Figure 1.30).  
 Alumazene [2,6-(i-Pr)2C6H3NAlMe]3 has been reported to undergo dealkylsilylation 
reaction with the tris(trimethylsilyl) ester of phosphoric acid to form a heteroadamantane 
molecule (MeAl)[2,6-(i-Pr)2C6H3N]3{Al[OP(OSiMe3)3]}2(O3POSiMe3) 159 In this 
reaction the phosphate ester is first thought to form an adduct with the aluminum. From 
this adduct the formation of a bicyclic intermediate with a bridging O2P(OSiMe3)2 takes 
place through dealkylsilylation (Figure 1.31). This bicyclic intermediate then undergoes a 
second dealkylsilylation to give the final adamantane-like product. 
1.10. Goals of this research 
 The effectiveness of binuclear boron Schiff base halide compounds, Salen(tBu)[BBr2]2 
for dealkylation of organophosphate esters opened up a means of using a mild, soft route 
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for dealkylation of organophosphates. This finding was significant in the wake of recent 
concern for organophosphate nerve agent and pesticide destruction and 
decontamination.160-162 For understanding the full utility and scope of this finding it is 
necessary to expand this study to other comparable systems. One preliminary step would 
be to investigate monononuclear boron Schiff base compounds. Mononuclear cationic 
boron complexes with N-salicylidene-o-aminophenol have been found to catalyze the 
polymerization of oxiranes, 23 but so far mononuclear boron chelates have not been 
examined in detail for the dealkylation of phosphates. Previous work indicates that 
stoichiometric combinations of LBX2 (L= tBu Sal(tBu), X= Br) and trimethyl phosphate 
leads to phosphate cleavage.33 A detailed study of a series of mononuclear boron 
complexes for phosphate dealkylation would determine if the presence of two boron 
centers in the same compound is necessary for the dealkylation.  
 The high activity of boron halide Schiff base chelate complexes towards phosphate 
dealkylation demands a similar study with aluminum chelates since aluminum centers in 
these compounds may also act as Lewis acids and thus facilitate the initial coordination 
of the Lewis basic oxygen of phosphate esters. Both neutral and cationic Schiff base 
complexes of aluminum have been found to catalyze the polymerization of oxiranes, a 
reaction that has been attributed to the Lewis acidic property of the aluminum. 17, 18 Lewis 
 acids such as AlCl3 157 can dealkylate phosphates but only with long reaction times (2 
days) and under reflux in THF. Compounds with Al-Br bonds, such as Salen(tBu)AlBr, 
are expected to be more active compared to the chloride analogues due to the weaker 
bond strength. Synthesizing Salen(tBu)AlBr compounds and exploring their phosphate 
dealkylation activity will be an important goal of this research. 
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  Thus this research will focus on synthesis and characterization of new mononuclear 
boron and aluminum halide compounds and examination of their phosphate dealkylation 
activity. This study could help identify optimized systems for understanding the 
phosphate dealkylation pathway and also for practical applications like organophosphate 
nerve agent and pesticide decontamination.  
 Chapter 2 will describe the synthesis and characterization of a series of mononuclear 
boron Schiff base halides based on various N-salicylidineimine Schiff base ligands. The 
application of these compounds for phosphate dealkylation will be examined in Chapter 
3. Chapter 4 will discuss a series of five-coordinate aluminum bromide compounds based 
on Salen ligands and the cationinc compounds derived from them. The dealkylation of 
organophosphates with the Salen aluminum bromide compounds will be studied in 
Chapter 5. The directions this research may lead in continued research efforts will be 
described in Chapter 6. 
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Table 1.1. % Dealkylation of various phosphates with Salen boron halide compounds, 
L[BX2]2 (L = Salen(tBu) ligands)  
 
 
 
 
 
L Salen(tBu) Salpen(tBu) Salben Salhen
Carbons in backbone of the ligand 2 3 4 6 
X Cl Br Cl Br Cl Br Cl Br
Phosphate         
(MeO)3P(O) 14 76 20 89 11 90 7 81
(nBuO)3P(O)  42  99  77  69
(nPentO)3P(O)    98     
(MeO)2P(O)H    85     
(MeO)2P(O)Me  61  98  87  47
(iPrO)2P(O)H    63     
(PhO)2((2-Et)HexO)P(O)  48  71  64  88
(Me3SiO)3P(O)  88  98  90  79
(PhO)3P(O)  0  0  0  0 
NOTE: Reaction time: 30 minutes. 
SOURCE: Adapted from References 33 and 34.  
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Table 1.2. % Dealkylation of various phosphates with Salen phenyl boron bromide 
compounds, L[(ptolyl)BBr]2 (L = Salen(tBu) ligands) 
 
 
 
 
 
L Salen(tBu) Salpen(tBu) Salben(tBu) Salhen(tBu) 
Carbons in 
backbone 
2 3 4 6 
Phosphate     
(MeO)3P(O) 45 52 92 80 
(EtO)3P(O) 40 50 71 56 
(nBuO)3P(O) 31 58 70 47 
(MeO)2P(O)H 59 67 50 50 
(MeO)2P(O)Me 47 50 50 50 
(iPrO)2P(O)H  42 32 37 26 
(PhO)2((2-
Et)HexO)P(O) 
12 46 52 42 
(Me3SiO)3P(O) 43 48 69 89 
(PhO)3P(O) 0 0 0 0 
 
NOTE: Reaction time: 30 minutes. 
SOURCE: Adapted from Reference 33. 
 24
 
 
 
 
C
O
R H
+ R'NH2 C
N
R'
R H
+     H2O
 
 
 
 
 
Figure 1.1. Formation of a Schiff base. 
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Figure 1.2. (a) N-phenylsalicylaldimine and (b) Salen ligands. 
(a) 
 26
 
 
 
 
 
 
P O
HO
OR
HO (a)
P O
HO
RO
RO (b)
P O
RO
RO
RO (c)  
 
 
 
 
 
 
 
Figure 1.3. Phosphate esters: (a) monoester, (b) diester and (c) triester. 
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Figure 1.4. Phosphate ester bonds in ATP. 
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Figure 1.5. (a) Mode of action of the enzyme acetyl cholinesterase (b) Deactivation of 
acetylcholinesterase by nerve gas agent sarin. 
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Figure 1.6. Some antidotes for nerve gas exposure. 
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Figure 1.7. Structures of some organophosphate nerve gases and pesticides: (a) Sarin 
Gas, (b) VX gas, (c) Chloropyrifos, (d) Paraoxon and (e) Parathion. 
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Figure 1.8. Associative vs. dissociative mechanism for phosphate hydrolysis. 
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Figure 1.9. Proposed mechanism for phosphate ester cleavage by the active site of 
enzyme Alkaline Phosphatase (redrawn from reference [71]). 
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Figure 1.10. Binding mode and attack of FeIII bound nucleophile for proposed 
mechanism of phosphate ester hydrolysis by PAP 163-166(redrawn from reference 64). 
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Figure 1.11. Examples of binuclear zinc (a) and lanthanide (b) model compounds. 
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Figure 1.12. Proposed mechanism for phosphate ester cleavage by a peroxide bridged 
binuclear lanthanide compound. 114, 115 
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Figure 1.13. Proposed model for phosphate ester cleavage with metal iodide. 
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Figure 1.14. Cleavage of phosphate ester with fluoride ion. 
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Figure 1.15. (a) Phosphate ester cleavage with thiophenoxide salts and (b) proposed 
transition state. 
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Figure 1.16. Phosphate ester cleavage with phenylthiotrimethylsilane (PhSTMS). 
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Figure 1.17. Dealkylation of phosphate ester with chlorotrimethylsilane and metal halide. 
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Figure 1.18. Dealkylation with iodotrimethylsilane. 
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Figure 1.19. Cleavage of phosphate ester with o-iodosylbenzoate (IBA). 
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Figure 1.20. (a) Quaternary pyridinium aldoxime (b) Phosphate ester cleavage with 
aldoxime. 
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Figure 1.21. Metallated polymer CPPL-Zn. 
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Figure 1.22. Synthesis of binuclear boron alkoxides (a) and siloxides (b). 
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Figure 1.23. Synthesis of binuclear boron halides. 
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Figure 1.24. Synthesis of Salen[B(ptolyl)Br]2. 
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Figure 1.25. Formation of phosphate-coordinated boron cation. 
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Figure 1.26. Attack of P-O-R bond by halide. 
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Figure 1.27. (a) Cleavage of allyl phosphate with organoaluminum reagents. (b) 
Intermediate for the reaction of dimeric aluminum reagent R2AlXAlR2 with allyl 
phosphate. 
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Figure 1.28. Reaction between organophosphate and aluminum or gallium amides. 
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Figure 1.29. Reaction between trialkyl phosphates and aluminum and gallium alkyls. 
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Figure 1.30. Reaction between phosphate adduct and dimethylamine. 
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Figure 1.31. Formation of bicyclic intermediate from phosphate adduct of alumazene. 
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Chapter 2 
Synthesis of Mononuclear Boron Schiff Base Halides 
 
2.1. Background 
 Boron halides have been used over the years in various organic syntheses, for 
example, ester ring closing 167 and Friedel-Crafts alkylations. 168 However, boron 
trihalides are very reactive and difficult to handle. The use of chelated boron compounds 
could help overcome this problem. Also, chelated boron compounds provide the option of 
tuning their properties by changing the size of the chelate rings and substituents on them. 
Schiff base boron compounds have been studied recently for their possible applications in 
catalysis. For example, binuclear Schiff base boron halides have been shown to be 
effective for dealkylation of organophosphates.33-35 Unlike Schiff base aluminum 
compounds the boron chelates, e.g., chelated boron alkyls, cannot be prepared by an 
alcohol elimination reaction between the ligand LH2 and BR3 because of the low polarity 
of the B-C bond. The common methods for creating boron-ligand compounds are water 
elimination using a boronic acid and alcohol elimination using a borate (represented in 
the equations below).169  
LH2 + RB(OH)2 LBR + 2 H2O
LH2 + B(OR)3 LBOR + 2 ROH  
The boron alkyls arising from the boronic acid reaction are generally stable whereas the 
boron alkoxides formed from the reaction using a borate could be further derivatized, for 
example, to boron siloxides.148 
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 Binuclear boron halides of the type LB[BX2]2 (X = Cl, Br) (L = Salen ligands) can be 
prepared by the exchange reaction of the binuclear alkoxides LB[B(OMe)2]2 with BX3.33-
35 In this chapter the synthesis and full characterization of a series of mononuclear boron 
halides of the type LBX and LBX2 (L = various Schiff base N,O and N,O,O ligands; X = 
Cl, Br) made in this way will be described. The halides were prepared from their borate 
precursors LBOMe and LB(OMe)2. The compounds will be shown to be of utility in the 
dealkylation of organophosphates in the following chapter. 
2.2. Synthesis  
 The Schiff base boron halide compounds were prepared from their borate precursors. 
The borate precursors were prepared in good yield by alcohol elimination reaction 
between the Schiff base salicylidenimine ligand and excess trimethylborate under reflux. 
The byproduct MeOH could be removed under vacuum to drive the reaction to 
completion. The salicylidenimine ligands could be easily prepared by the condensation 
reaction between 3,5-di-t-butylsalicylaldehyde and the corresponding amines according 
to the literature procedures.170 The synthetic route used for the preparation of compounds 
1-12 is depicted in Figure 2.1. Thus the halides 2, 3 and 7-12 were prepared from the 
corresponding borate precursors 1 and 4-6. The borate precursors, in turn, were prepared 
by refluxing Schiff base ligands and excess trimethyl borate in toluene. The borates were 
converted to the boron halides by reaction with BCl3 or BBr3 at room temperature. All the 
compounds were isolated by removing the solvent under vacuum or by precipitation after 
concentration and cooling to -30 ºC. The by-product B(OMe)3 was removed under 
vacuum. The compounds were pale white to orange in color. 
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2.3. Spectroscopy 
 Compounds 1-12 were characterized by 1H, 13C and 11B NMR, MP, MS and EA. The 
1H NMR data for all the compounds showed two singlets for the tBu-Ph groups in the 
range δ 1.24-1.54 ppm. The imine peaks appeared at δ 8.63, 8.52, 8.30 and 7.99 ppm for 
the borates 1, 4, 5 and 6, δ 8.29, 8.58, 8.11 and 7.93 ppm for the chlorides 2, 7, 9 and 11 
and δ 9.38, 8.81, 8.25 and 8.97 ppm for the bromides 3, 8, 10 and 12, respectively. The 
imine peaks for the bromides appeared at higher chemical shift compared to the 
chlorides. The presence of only one set of tBu peaks and one imine peak for each 
compound suggested a symmetric solution-state structure. 
 The 11B NMR spectra showed single peaks at δ 2.33, 5.09, 2.38 and 2.00 ppm for the 
borates 1, 4, 5 and 6, δ 2.48, 7.28, 2.05 and 3.30 ppm for the chlorides 2, 7, 9 and 11, and 
δ 2.38, 6.47, 2.00 and 9.70 ppm for the bromides 3, 8, 10 and 12, respectively. These 
shifts indicate the presence of four-coordinate boron 33 in all of the compounds. The IR 
spectra have a νB-N stretch in the region 1000-1042 cm-1 for all of the compounds. The 
mass spectra (EI) of the borates 1, 4, 5 and 6 showed peaks corresponding to molecular 
ion minus methoxy group and for 4, 5 and 6 this was the most abundant peak. 
Compounds 4, 5 and 6 showed molecular ions in low abundance. The chloride 
compounds 2, 7, 9 and 11 showed molecular ions minus the chloride in high abundance. 
Compounds 2, 9 and 11 also showed molecular ion in low abundance. The bromide 
compounds 8, 10 and 12 had molecular ion as well as molecular ion minus bromide in 
their spectra. However, 3 showed molecular ion minus the BBr2 group (33 %) and also 
molecular ion minus BBr2 and CH3 (100 %). This indicated that the EI ionization process 
was sufficiently strong to break apart the compound. This was a rare occurrence for 
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Schiff base-group 13 compounds, which are usually not observed to release the group 13 
element from the ligand.  
2.4. Structures 
 The borate compounds 1 and 6 and the halide compounds 11 and 12 were structurally 
characterized by single-crystal X-ray diffraction studies. The X-ray crystal structures 
confirm the presence of four-coordinate boron atoms in these compounds (Figures 2.2, 
2.3, 2.4 and 2.5). The crystal data collection parameters are shown in Tables 2.1 and 2.3 
and selected bond lengths and angles are shown in Tables 2.2 and 2.4. The B─O bond 
lengths are in the range 1.414(4) - 1.485(4) Å for the borates 1 and 6 and 1.391(2)-
1.437(2) Å for the halides 11 and 12. These distances are slightly shorter than the B-N 
distances (1.537(2)-1.628(4)) Å, which is a reflection of the smaller covalent radius of 
oxygen. The B-Br bond length (2.201(2) Å in 12 is longer than the B-Cl bond length 
(1.965(2) Å) in 11, which is a reflection of the greater covalent radius of Br compared to 
Cl. These distances are slightly larger compared to the binuclear boron halides reported 
previously. For example, in the binuclear Schiff base boron bromide salben(tBu)[BBr2]2 
35 the B-Br lengths are 2.023(8) and 2.077(9) Å and in the binuclear Schiff base boron 
chloride salpen(tBu)[BCl2]2 34 the B-Cl bond lengths are 1.849(5) and 1.855(5) Å.  
 The geometry around the boron atom is slightly distorted tetrahedral in all four 
compounds. For compound 1 the largest deviations are shown by the angles O1-B1-N1 
(106.8(3) °), O1-B1-O2 (112.1(3) °) and O1-B1-O3 (112.1(3) °) whereas for 6 the largest 
deviation is shown by the angle O2-B1-O3 (115.3(2) °). The angle O1-B1-N1 is slightly 
larger for 6 (109.4(2) °) compared to 1. This could be due to the steric restriction arising 
from the boron being part of a second six-membered ring in 6. 
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 For the halide compounds 11 and 12 the largest deviation from the ideal tetrahedral 
angle is observed for the angle O2A-B1A-N1A, which is 113.18(16) ° for 11 and 
114.92(14) ° for 12. The angles O1A-B1A-Cl1A (108.04(13)) °, O2A-B1A-Cl1A 
(111.22(14) °) and N1A-B1A-Cl1A (103.83(13) °) in 11 are larger than the 
corresponding angles O1A-B1A-Br1A (106.87(11) °), O2A-B1A-Br1A (109.00(12) °) 
and N1A-B1A-Br1A (101.97(11) °) in 12. This is contrary to what would be expected 
from Bents Rule171 considering the higher electronegativity of chlorine compared to 
bromine and thus less s-character in the B-Cl bond. The angle O1A-B1A-N1A 
(111.22(15)) for 11 and 112.33(14) for 12) is close to that found in the bimetallic boron 
halides, salpen(tBu)[BCl2]2 (110.1(4)) 34 and salben(tBu)[BBr2]2 (112.8(6)). 35 A 
quantitative correlation called the THC value (Figure 2.6; THC = tetrahedral character) 
has been proposed to determine the deviation of the geometry around boron in 
compounds containing N→B bonds. 172 A THC value of 100 % refers to a perfectly 
tetrahedral and a value of 0 % refers to a trigonal planar geometry around the boron. 
Compounds 1, 6, 11 and 12 have THC values of 88, 83, 84 and 77 %, respectively. 
According to the previous observation the THC values should increase with increased N-
B interaction, i.e., decrease in N→B bond length. 172 However, the N→B bond lengths in 
1, 6, 11 and 12 (1.628(4), 1.585(4), 1.552(2) and 1.537(2) Å respectively) do not agree 
with this observation, possibly due to the restriction imposed by the ligand. 
 Interestingly, the mononuclear borates 1 and 6 do not show any hydrogen bonding as 
was observed for binuclear Salen[(BOMe)2]2 compounds.146  
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 2.5. Hydrolysis of the boron halide compounds 
 The boron halide compounds are moisture sensitive. They are hydrolyzed by trace 
amounts of moisture present in the reaction medium. Binuclear compound 13 containing 
a B-O-B linkage was obtained during the preparation of the halide 7 by adventitious 
exposure to moisture (Figure 2.7). Similar Schiff base compounds with B-O-B bridges 
can be prepared intentionally from the combination of various Salen ligands with 
phenylboronic acid (Figure 2.8). 150, 173 
 The 1H NMR of 13 contained four tBu peaks that indicated a non-symmetric solution 
state structure. The 11B NMR showed two boron peaks at δ 3.19 and δ 7.33 ppm 
corresponding to four-coordinate boron atoms. The non-symmetry could arise from the 
non-planarity of the two BOBNCCO rings although this could not explain the presence of 
only one singlet for the imine protons. The IR shows a peak at 1620 cm-1 attributed to 
νC═N stretching. The mass spectra (EI) showed molecular ion peak in 5 % relative 
abundance. 
 An X-ray structure (shown in Figure 2.9) confirmed the presence of two four-
coordinate boron atoms in 13. The crystal data collection parameters are shown in Table 
2.5, and selected bond distances and angles are contained in Table 2.6. The boron atoms 
are part of two seven-membered BOBNCCO heterocycles. There is a B-O-B bridge 
between the two boron atoms. The bridging B-O bond lengths are 1.406(6) and 1.390(6) 
Å whereas B-O(Ph) bond lengths range from 1.459(6) to 1.481(6) Å. The bridging B-O 
lengths are close to those observed in some previously reported binuclear Schiff base 
boron compounds containing B-O-B bridges although the B-O(Ph) lengths are slightly 
shorter. For example, in the compounds L[PhB)2(µ-O)] (L = salen(tBu), salpen(tBu) and 
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acpen) the bridging B-O bond length ranges from 1.416(5) to 1.419(3) Å and B-O(Ph) 
length ranges from 1.493(3) to 1.511(4) Å.173 The B-N bond lengths for 13 are 1.606(6) 
and 1.610(5) Å.173 Each boron atom is in a distorted tetrahedral environment. The THC 
values for B1A and B2A are 75 % and 76 % respectively. The most acute angle for B1A 
is O2AB1AN1A (101.3(3)) and for B2A is O3A-B2A-N2A (101.9(3) °). The most obtuse 
angle is O2A-B1A-O5A (115.1(4) °) for B1A and O5A-B2A-O3A (115.2(4) °) for B2A. 
The B-O-B angle is 117.2(3) °. This angle is significantly smaller compared to the B-O-B 
bridged compounds L[PhB)2(µ-O) (L = Salen(tBu) (131.4(3) °), salpen(tBu) (137.5(3) ° 
and acpen (128.6 °).173 
2.6. Conclusion 
 A series of mononuclear Schiff base borates based on N,O and N,O,O ligands have 
been prepared. The borates were further derivatized to mononuclear Schiff base boron 
halides. The boron halides are moisture sensitive and one of them, on reaction with trace 
water present in the reaction medium, gave a binuclear compound containing a B-O-B 
linkage and BOBNCCO heterocycles. The boron halides could be further derivatized and 
used for phosphate dealkylation since the halides could potentially be replaced by a donor 
molecule to form cationic compounds. 
2.7. Experimental 
 
General remarks. All air-sensitive manipulations were conducted using standard bench-
top Schlenk line techniques in conjunction with an inert atmosphere glove box. All 
solvents were rigorously dried prior to use. All glassware was cleaned with a base and an 
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acid wash and dried in an oven at 130 ºC overnight. The Schiff base ligands N-phenyl-
3,5-di-t-butylsalicylaldimine, N-(2-hydroxyphenyl)-3,5-di-t-butylsalicylaldimine, N-(2- 
 hydroxyethyl)-3,5-di-t-butylsalicylaldimine) and N-(3-hydroxpropyl)-3,5-di-t-
butylsalicylaldimine) were synthesized according to the literature procedure. 170 NMR 
data were obtained on Varian Gemini-200 and Varian VXR-400 instruments. Chemical 
shifts were reported relative to SiMe4 for 1H and 13C and BF3.Et2O for 11B and are 
reported in ppm. Infrared transmission spectra were recorded at room temperature in a 
potassium bromide pellet on a Fourier-transform Magna-IR ESP 560 spectrometer. 
Elemental analyses were performed on either a Perkin Elmer 2400 CHN Analyzer or a 
LECO CHN-2000 Analyzer. 
X-ray data were collected on a either a Nonius Kappa-CCD (compounds 1, 6, 11 and 
12; Mo-Kα radiation) or a Bruker-Nonius X8 Proteum (compounds 13; Cu-Kα radiation) 
diffractometer. All calculations were performed using the software package SHELXTL-
Plus.174-177 The structures were solved by direct methods and successive interpretation of 
difference Fourier maps followed by least-squares refinement. All non-hydrogen atoms 
were refined anisotropically. The hydrogen atoms were included using a riding model 
with isotropic parameters tied to the parent atom.  
 Synthesis of LB(OMe)2 (LH = N-phenyl-3,5-di-t-butylsalicylaldimine) (1). To a 
rapidly stirred solution of N-phenyl-3,5-di-t-butylsalicylaldimine (3.00 g, 9.71 mmol) in 
toluene, B(OMe)3(6.00 g, 57.7 mmol) was added and refluxed for 16 hours. The volatiles 
were removed under vacuum and a yellow solid was obtained which was washed with 20 
mL of hexane and dried under vacuum. Yield: (3.4 g (92 %). X-ray quality crystals were 
grown from a concentrated toluene solution after slow cooling to -30 °C. Mp: 98 ºC 
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(dec.). 1H NMR (CDCl3): δ 1.33 (s, 9H, C(CH3)3), 1.48 (s, 9H, C(CH3)3), 3.22 (s, 6H, 
OCH3),7.25 (m, 1H, Ph-H), 7.27 (m, 2H, Ph-H), 7.44 (m, 3H, Ph-H), 7.62 (m, 1H, Ph-H), 
7.78 (m, 1H, Ph-H), 8.63 (s, 1H, N=CH); 13C NMR (CDCl3): δ 29.7 (C(CH3)3), 31.7 
(C(CH3)3), 34.4 (C(CH3)3), 35.3 (C(CH3)3), 49.9 (OCH3) 118.5 (Ph), 121.4 (Ph), 123.9 
(Ph), 126.1 (Ph), 126.7 (Ph), 128.5 (Ph), 129.5 (Ph), 133.5(Ph), 137.2 (Ph), 140.8 (Ph), 
148.9 (Ph), 158.5 (Ph), 164.0 (NCH). 11B NMR (CDCl3): δ 2.33 (W1/2 = 58 Hz). IR (KBr) 
ν/ cm-1: 3064w, 2962s, 2903m, 2860m, 1614s, 1575s, 1555w, 1478m, 1464m, 1437m, 
1390w, 1360m, 1319w, 1273w, 1248m, 1196m, 1171s, 1130w, 1074w, 1025w, 973w, 
903w, 878m, 865s, 823w, 801w, 759s, 728w, 688m. MS (EI, positive): 321 (M+, 5%), 
350 (M+ - OCH3, 45), 319 (M+ -2 OCH3, 10), 264 (M+ - OCH3 - tBu, 100%). Anal. Calcd. 
for C23H32O3NB: C 72.44, H 8.46, N 3.67. found: C 73.61, H 8.72, N 3.51. 
 Synthesis of LBCl2 (LH = N-phenyl-3,5-di-t-butylsalicylaldimine) (2). To a rapidly 
stirred solution of 1 (0.71 g, 1.9 mmol) in toluene, 1 M BCl3 in heptane (0.68 mL, 0.68 
mmol) was added. The yellow cloudy mixture was stirred for 13 hours. The volatiles 
were removed under vacuum. The yellow solid was washed with hexane and dried under 
vacuum. Yield: 0.45 g (62 %). Mp: 255-257 ºC (dec.). 1H NMR (CDCl3): δ 1.32 (s, 9H, 
C(CH3)3), 1.48 (s, 9H, C(CH3)3), 7.27 (m, 1H, Ph-H), 7.36 (m, 1H, Ph-H), 7.47 (m, 2H, 
Ph-H), 7.66 (m, 2H, Ph-H), 7.78 (m, 1H, Ph-H), 8.29 (s, 1H, N=CH); 13C NMR (CDCl3): 
δ 29.6 (C(CH3)3), 31.3 (C(CH3)3), 34.6 (C(CH3)3), 35.4 (C(CH3)3), 125.2 (Ph),.126.5 
(Ph), 129.5 (Ph), 129.7 (Ph), 136.0 (Ph), 144.2 (Ph), 164.2 (NCH). 11B NMR (CDCl3): δ 
2.48 (W1/2 = 57 Hz). IR (KBr) ν/ cm-1: 2961s, 2905w, 2869w, 1619s, 1566s, 1555m, 
1492w, 1468w, 1392w, 1380w, 1363w, 1254m, 1200m, 1132w, 1015m, 1005m, 918w, 
904w, 849m, 762w, 720w, 692m. MS (EI, positive): 390 (M+, 0.5%), 355 (M+ - Cl, 2%), 
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320 (M+- 2 Cl, 5%), 309 (M+- BCl2, 45%), 294 (M+- BCl2  CH3, 100%). Anal. Calcd. for 
C21H26ONBCl2: C 64.65, H 6.72, N 3.59. found: C 66.11, H 8.44, N 3.51. 
 Synthesis of LBBr2 (LH = N-phenyl-3,5-di-t-butylsalicylaldimine) (3). To a rapidly 
stirred solution of 1 (0.48 g, 1.3 mmol) in toluene, 1 M BBr3 in heptane (0.42 mL, 0.42 
mmol) was added with a syringe. The yellow reaction mixture was stirred for 20 hours. 
The volatiles were removed under vacuum and the yellow residue was washed with 
hexane and dried under vacuum. Yield: 0.45 g (75 %). Mp: 284-288 ºC (dec.). 1H NMR 
(CDCl3): δ 1.30 (s, 9H, C(CH3)3), 1.38 (s, 9H, C(CH3)3), 6.95 (d, 2H, Ph-H), 7.17-7.30 
(m, 3H, Ph-H), 7.85 (d, 1H, Ph-H), 7.98 (d, 1H, Ph-H), 9.38 (s, 1H, N=CH); 13C NMR 
(CDCl3): δ 29.7 (C(CH3)3), 31.4 (C(CH3)3), 34.9 (C(CH3)3), 35.3 (C(CH3)3), 123.4 
(Ph),.125.5 (Ph), 128.4 (Ph), 129.3 (Ph), 129.8 (Ph), 130.2 (Ph), 132.8 (Ph), 137.0 (Ph), 
138.9 (Ph), 141.6 (Ph), 145.0 (Ph), 153.6 (Ph), 167.7 (NCH). 11B NMR (CDCl3): δ 2.38 
(W1/2 = 60 Hz). IR (KBr) ν/ cm-1: 2959s, 2901w, 2870w, 1625m, 1594w, 1563s, 1493w, 
1469m, 1442w, 1414w, 1381m, 1363w, 1255m, 1203m, 1134w, 1067w, 1030m, 774w, 
757w, 690w. MS (EI, positive): 309 (M+ - BBr2, 33%), 294 (M+- BBr2  CH3, 100%). 
Anal. Calcd. for C21H26ONBBr2: C 52.65, H 5.47, N 2.92. found: C 53.00, H 5.15, N 
2.85. 
 Synthesis of L[B(OMe)] (LH2 = N-(2-hydroxyphenyl)-3,5-di-t-
butylsalicylaldimine) (4). To a rapidly stirred solution of N-(2-hydroxyphenyl)-3,5-di-t-
butylsalicylaldimine) (3.31g, 10.2 mmol) in toluene, excess B(OMe)3(6.50 g, 62.5 mmol) 
was added and refluxed for 8 hours. The volatiles were removed under vacuum to yield 
an orange solid. Yield: 3.1 g (82 %). Mp: 210 ºC (dec.). 1H NMR (CDCl3): δ 1.30 (s,9H, 
C(CH3)3), 1.49 (s,9H, C(CH3)3), 3.15 (s, 3H, OCH3), 6.86-7.66 (m, 6H, Ph-H), 8.52 (s, 
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1H, N=CH); 13C NMR (CDCl3): δ 29.5 (C(CH3)3), 31.2 (C(CH3)3), 34.2 (C(CH3)3), 35.4 
(C(CH3)3), 49.7 (OCH3), 114.3 (Ph), 114.7 (Ph), 119.1 (Ph),125.3 (Ph), 128.2 (Ph), 129.0 
(Ph), 131.3 (Ph),133.0(Ph),139.8 (Ph),142.2 (Ph), 150.5 (Ph), 154.6 (Ph),157.3 (NCH). 
11B NMR (CDCl3): δ 5.09. IR (KBr) ν/ cm-1: 2959s, 2905w, 2868w, 1628s, 1556m, 
1545m, 1480s, 1419m, 1390m, 1380m, 1362m, 1324s, 1259m, 1202m, 1181s, 1108s, 
1039w, 1018m, 1007m, 987m, 886w, 752s. MS (EI, positive): MS (EI, positive): 365 
(M+, 11 %), 334 (M+ - OCH3, 100%). Anal. Calcd. for C22H28O3NB: C 72.34, H 7.73, N 
3.83. found: C 73.20, H 8.33, N 3.60. 
 Synthesis of L[B(OMe)] (LH2 = N-(2-hydroxyethyl)-3,5-di-t-butylsalicylaldimine) 
(5). To a rapidly stirred solution of N-(2-hydroxyethyl)-3,5-di-t-butylsalicylaldimine 
(3.50 g, 12.6 mmol) in toluene, B(OMe)3(4.20 g, 40.8 mmol) was added and refluxed for 
18 hours. The volatiles were removed under vacuum and the yellow residue was washed 
with hexane. Yield: 3.2 g (81 %). Mp: 302-306 ºC (dec.). 1H NMR (CDCl3): δ 1.27 (s, 
9H, C(CH3)3), 1.42 (s, 9H, C(CH3)3), 3.17 (s, 3H, OCH3), 3.30-3.48  (m, 2H, NCH2), 
3.63-3.86 (m, 2H, OCH2);7.04 (d,1H, Ph-H), 7.52 (d, 1H, Ph-H), 8.30 (s, 1H, N=CH). 
13C NMR (CDCl3): δ 29.3 (C(CH3)3), 31.2 (C(CH3)3), 34.1 (C(CH3)3), 35.0 (C(CH3)3), 
49.5 (OCH3), 58.9 (NCH2), 59.8 (OCH2) 114.7 (Ph), 125.3 (Ph), 131.9 (Ph), 138.2 (Ph), 
140.4, (Ph),157.8(Ph), 166.8 (NCH). 11B NMR (CDCl3): δ 2.38. IR (KBr) ν/ cm-1: 2954s, 
2905w, 2863w, 1644s, 1567w, 1479w, 1462w, 1444w, 1384w, 1360w, 1309w, 1254m, 
1210m, 1149s, 1132m, 1017s, 989m, 805w, 774w. MS (EI, positive): 286 (M+ - OCH3, 
100%). Anal. Calcd. for C18H28O3NB: C 68.15, H 8.90, N 4.42. found: C 68.25, H 9.18, 
N 4.23. 
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 Synthesis of L[B(OMe)] (LH2 = N-(3-hydroxypropyl)-3,5-di-t-
butylsalicylaldimine) (6). To a rapidly stirred solution of N-(3-hydroxypropyl)-3,5-di-t-
butylsalicylaldimine (4.28 g, 14.7 mmol) in toluene, B(OMe)3 (2.00 g, 19.2 mmol) was 
added and refluxed for 16 hours. The volatiles were removed under vacuum and a pale 
yellow solid was obtained which was dried under vacuum. Yield: 4.5 g (92%). Mp: 190-
192 ºC (dec.). 1H NMR (CDCl3): δ 1.26 (s, 9H, C(CH3)3), 1.43 (s, 9H, C(CH3)3), 1.68-
1.86 (m, 1H, CH2), 2.00-2.24 (m, 1H, CH2), 3.23 (s, 3H, OCH3), 3.56-3.66 (m, 1H, 
NCH2), 3.92-3.99 (m, 1H, NCH2), 4.09- 4.31 (m, 2H, OCH2);7.03 (d, 1H, Ph-H), 7.53 (d, 
1H, Ph-H), 7.99 (s, 1H, N=CH). 13C NMR (CDCl3): δ 29.4 (C(CH3)3), 30.4 (CH2), 31.2 
(C(CH3)3), 34.0 (C(CH3)3), 35.1 (C(CH3)3), 49.7 (OCH3), 54.5 (NCH2), 61.2 (OCH2) 
114.8 (Ph), 125.0 (Ph), 132.1 (Ph), 138.7 (Ph), 140.5, (Ph),157.2(Ph), 160.7 (NCH). 11B 
NMR (CDCl3): δ 2.00 (W1/2 = 140 Hz). IR (KBR) ν/ cm-1: 2955s, 2901m, 2867m, 1661s, 
1567m, 1478m, 1448m, 1452m, 1429m, 1392w, 1361m, 1344m, 1307m, 1283w, 1265m, 
1244m, 1202m, 1186m, 1153m, 1105s, 1082m, 1039m, 989m, 970m, 923m, 884m, 
776w.MS (EI, positive): 331 (M+, 1%), 300 (M+  - OCH3, 100)%. Anal. Calcd. for 
C19H30O3NB: C 68.89, H 9.13, N 4.23. found:C 69.55, H 9.28, N 4.31. 
 Synthesis of L[BCl] (LH2 = N-(2-hydroxyphenyl)-3,5-di-t-butylsalicylaldimine) 
(7). To a rapidly stirred solution of 4 (1.00g, 2.74 mmol) in toluene, excess 1 M BCl3 in 
heptane (2.75 mL, 2.75 mmol) was added. The reaction mixture was stirred for 13 hours. 
The golden yellow solution was cannula filtered and the volatiles were removed from the 
filtrate under vacuum to give a yellow solid. Yield: 0.96 g (95 %). Mp: 298 ºC (dec.). 1H 
NMR (CDCl3): δ 1.36 (s, 9H, C(CH3)3), 1.54 (s, 9H, C(CH3)3), 6.97-7.81 (m, 6H, Ph-H), 
8.58 (s, 1H, N=CH); 13C NMR (CDCl3): δ 29.6 (C(CH3)3), 31.2 (C(CH3)3), 34.4 
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(C(CH3)3), 35.4 (C(CH3)3), 115.0 (Ph), 115.3 (Ph), 120.6 (Ph),125.8 (Ph), 128.2 (Ph), 
129.0 (Ph), 132.0 (Ph),134.1(Ph),140.6 (Ph),144.1 (Ph), 150.3 (Ph), 153.2 (Ph),156.3 
(NCH). 11B NMR (CDCl3): δ 7.28. IR (KBr) ν/ cm-1: 2960s, 2901w, 2869w, 1631s, 
1563m, 1549w, 1479s, 1467m, 1424m, 1392m, 1382m, 1363m, 1327m, 1254m, 1202m, 
1190s, 1111w, 1031w, 747m. MS (EI, positive): 286 (M+-Cl, 100%, 319 (M+- Cl - O, 
15%). Anal. Calcd. for C21H25O2NBCl: C 68.23, H 6.82, N 3.79. found: C 68.75, H 7.65, 
N 4.04. 
 Synthesis of L[BBr] (LH2 = N-(2-hydroxyphenyl)-3,5-di-t-butylsalicylaldimine) 
(8). To a rapidly stirred solution of 4 (1.00 g, 2.74 mmol) in toluene, excess 1 M BBr3 in 
heptane (2.78 mL, 2.78 mmol) was added. The reaction mixture was stirred for 13 hours. 
The solution was concentrated to about one third of its volume. The yellow precipitate 
was cannula filtered and dried under vacuum. Yield: 0.73 g (65 %). Mp: 234-238 ºC 
(dec.). 1H NMR (CDCl3): δ 1.34 (s, 9H, C(CH3)3), 1.52 (s, 9H, C(CH3)3), 7.00-7.83 (m, 
6H, Ph-H), 8.81 (s, 1H, N=CH); 13C NMR (CDCl3): δ 29.6 (C(CH3)3), 31.2 (C(CH3)3), 
34.4 (C(CH3)3), 35.4 (C(CH3)3), 115.3 (Ph), 118.3 (Ph), 121.3 (Ph),.126.3 (Ph), 128.6 
(Ph), 129.0 (Ph), 132.1 (Ph), 134.8(Ph),140.7 (Ph), 144.9 (Ph), 150.9 (Ph), 152.8 
(Ph),155.4 (NCH). 11B NMR (CDCl3): δ 6.47 (4-coordinate boron). IR (KBr) ν/ cm-1: 
2960s, 2905w, 2869w, 1629s, 1564m, 1549m, 1479s, 1424m, 1392m, 1380m, 1363m, 
1328s, 1253m, 1203w, 1189w, 1103w, 1014w, 864w, 769w, 747m, 694w, 664w. MS (EI, 
positive): 414 (M+, 3%) 334 (M+ - Br, 100%, 318 (M+- Br - O, 20%). Anal. Calcd. for 
C21H25O2NBBr: C 60.90, H 6.08, N 3.38. found: C 61.58, H 6.07, N 3.16. 
 Synthesis of L[BCl] (LH2 = N-(2-hydroxyethyl)-3,5-di-t-butylsalicylaldimine) (9). 
 68
To a rapidly stirred solution of 5 (0.97g, 3.1 mmol) in toluene, 1 M BCl3 in heptane (1.1 
mL, 1.1 mmol) was added. The reaction mixture was stirred for 24 hours. Then it was 
cannula filtered and the pale yellow residue was dried under vacuum. Yield: 0.78 g (80 
%). Mp: > 320 ºC (dec.). 1H NMR (CDCl3): δ 1.24 (s, 9H, C(CH3)3), 1.42 (s, 9H, 
C(CH3)3), 3.44-3.55 (m, 2H, NCH2), 3.33-3.44 (m, 2H, OCH2); 7.07 (d, 1H, Ph-H), 7.56 
(d, 1H, Ph-H), 8.11 (s, 1H, N=CH). 13C NMR (CDCl3): δ 29.86 (C(CH3)3), 31.4 
(C(CH3)3), 34.3 (C(CH3)3), 35.2 (C(CH3)3), 60.5 (NCH2) 61.2 (OCH2), 115.0 (Ph), 125.8 
(Ph), 133.7 (Ph), 139.0 (Ph), 141.4, (Ph),157.2(Ph), 164.9 (NCH). 11B NMR (CDCl3): δ 
2.05 (W1/2 = 360 Hz). IR (KBr) ν/ cm-1: 2960s, 2905w, 2870w, 1640s, 1573m, 1479s, 
1444s, 1395m, 1378s, 1363s, 1334m, 1302m, 1283m, 1261m, 1243m, 1214m, 1202m, 
1190m, 1138m, 1085m, 1027m, 913w, 879w, 851w, 818w, 802w, 774w.MS (EI, 
positive): 322 (M+, 1 %), (M+ - Cl, 90%). Anal. Calcd. for C17H25O2NBCl: C 63.48, H 
7.83, N 4.36. found: C 63.37, H 8.78, N 4.15. 
 Synthesis of L[BBr] (LH2 = N-(2-hydroxyethyl)-3,5-di-t-butylsalicylaldimine) 
(10). To a rapidly stirred solution of 5 (0.54 g, 1.7 mmol) in toluene, 1 M BBr3 in heptane 
(0.60 mL, 0.60 mmol) was added with a syringe. The clear yellow solution was stirred for 
17 hours. The volatiles were removed under vacuum and the off white residue was 
washed with hexane and dried under vacuum. Yield: 0.47 g (75 %). Mp: 228-232 °C 
(dec.). 1H NMR (CDCl3): δ 1.32 (s, 9H, C(CH3)3), 1.47 (s, 9H, C(CH3)3), 3.94 (m, 4H, 
NCH2 and OCH2); 7.17 (d, 1H, Ph-H), 7.59 (d, 1H, Ph-H), 8.25 (s, 1H, N=CH). 13C 
NMR (CDCl3): δ 29.4 (C(CH3)3), 31.2 (C(CH3)3), 33.2 (C(CH3)3), 35.0 (C(CH3)3), 50.8 
(NCH2), 55.0 (OCH2), 115.4 (Ph), 125.6 (Ph), 132.2 (Ph), 138.3 (Ph), 140.6, 
(Ph),157.8(Ph), 164.9 (NCH). 11B NMR (CDCl3): δ 2.00 (W1/2 = 122 Hz). IR (KBr) ν/ 
 69
cm-1: 2958s, 2901w, 2869w, 1644s, 1566m, 1479m, 1469m, 1441m, 1391m, 1378s, 
1360m, 1336m, 1304m, 1259m, 1240w, 1203w, 1188m, 1135s, 1042m, 975m, 931w, 
877w, 827w, 811w, 775w, 762w. MS (EI, positive): 366 (M+, 30%), 286 (M+ - Br, 55%, 
270 (M+- Br-O, 45%). Anal. Calcd. for C17H25O2NBBr: C 55.77, H 6.88, N 3.83. found: 
C 54.98, H 7.36, N 3.96. 
 Synthesis of L[BCl] (LH2 = N-(3-hydroxypropyl)-3,5-di-t-butylsalicylaldimine) 
(11). To a rapidly stirred solution of 6 (1.1 g, 3.2 mmol) in toluene, 1 M BBr3 in heptane 
(1.1 mL, 1.1 mmol) was added. The clear golden yellow solution was stirred for 14 hours. 
The volatiles were removed under vacuum and the yellow residue was washed with 
hexane and dried under vacuum Yield: 0.88 g (81 %). X-ray quality crystals were isolated 
after cooling a concentrated toluene solution to -30 °C. Mp: 192-194 ºC (dec.). 1H NMR 
(CDCl3): δ 1.29 (s, 9H, C(CH3)3), 1.45 (s, 9H, C(CH3)3), 2.02 (q, 2H, CH2), 4.06 (t, 2H, 
NCH2), 4.24 (t, 2H, OCH2) 7.13 (d, 1H, Ph-H), 7.66 (d, 1H, Ph-H), 7.93 (s, 1H, N=CH). 
13C NMR (CDCl3): δ 28.8 (CH2), 29.4 (C(CH3)3), 31.2 (C(CH3)3), 34.1 (C(CH3)3), 35.1 
(C(CH3)3), 53.8 (NCH2), 61.3 (OCH2) 115.4 (Ph), 125.4 (Ph), 133.1 (Ph), 139.2 (Ph), 
142.0 (Ph),155.9 (Ph), 161.3 (NCH). 11B NMR (CDCl3): δ 3.3 (W1/2 = 166 Hz). IR (KBr) 
ν/ cm-1: 2960s, 2866w, 1649s, 1572m, 1479m, 1461m, 1441m, 1432w, 1384m, 1365m, 
1345m, 1285w, 1265m, 1246w, 1193m, 1164m, 1125w, 1093w, 1024w, 959w, 930w, 
872w, 831w, 773w, 758w. MS (EI, positive): 336 (M+, 1%), 300 (M+ - Cl, 100%). Anal. 
Calcd. for C18H27O2NBCl: C 64.41, H 8.11, N 4.17. found: C 65.72, H 6.86, N 4.06. 
 Synthesis of L[BBr] (LH2 = N-(3-hydroxypropyl)-3,5-di-t-butylsalicylaldimine) 
(12). To a rapidly stirred solution of 6 (0.69 g, 2.1 mmol) in toluene, 1 M BBr3 in heptane 
(0.75 mL, 0.75 mmol) was added. The clear yellow solution was stirred for 6 hours. Then 
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it was concentrated to about one-third of its volume and yellow crystals were obtained 
after cooling at -30ºC overnight. The crystals were isolated by cannula filtration and dried 
under vacuum. Yield: (0.50 g (63 %). Mp: softens at 174 ºC and melts at 178-181 ºC 
(dec.). 1H NMR (CDCl3): δ 1.27 (s, 9H, C(CH3)3), 1.42 (s, 9H, C(CH3)3), 2.11 (m, 2H, 
CH2), 4.31 (s, br, 4H, NCH2 and OCH2), 7.48 (d, 1H, Ph-H), 7.78 (s, br, 1H, Ph-H), 8.97 
(s, 1H, N=CH). 13C NMR (CDCl3): δ 26.3 (CH2), 29.8 (C(CH3)3), 31.4 (C(CH3)3), 34.8 
(C(CH3)3), 35.4 (C(CH3)3), 52.3 (NCH2), 63.0 (OCH2) 116.9 (Ph), 127.2 (Ph), 135.9 (Ph), 
140.0 (Ph), 145.5 (Ph),154.5 (Ph), 166.6 (NCH). 11B NMR (CDCl3): δ 9.7 (W1/2 = 383 
Hz). IR (KBr) ν/ cm-1: 2962s, 2869w, 1638s, 1573s, 1471m, 1459m, 1452m, 1437w, 
1386w, 1365m, 1347m, 1285m, 1265m, 1247s, 1196s, 1180m, 1135m, 1097m, 1084m, 
1046w, 1000w, 961w, 931w, 874w, 831m, 772m, 755w, 661m, 623m, 607m, 545m. MS 
(EI, positive): 380 (M+, 5%), 300 (M+ - Br, 100). Anal. Calcd. for C18H27O2NBBr: C 
56.87, H 7.16, N 3.69. found: C 56.04, H 5.91, 3.36. 
 Hydrolyzed product (13): To a rapidly stirred solution of 4 (1.00 g, 2.74 mmol) in 
toluene 1 M BCl3 in heptane (1.00 mL, 1.00 mmol) was added. The deep brown solution 
was stirred for 18 hours. The volatiles were removed under vacuum to obtain a yellow 
solid. The solid was recrystallized from dichloromethane to give yellow X-ray quality 
crystals of 13. Yield: 0.61 g (33 %). Mp: 303 - 305 ºC (dec.). 1H NMR (CDCl3): δ 1.24 
(s, 9H, C(CH3)3), 1.29 (s, 9H, C(CH3)3), 1.31 (s, 9H, C(CH3)3), 1.45 (s, 9H, C(CH3)3), 
6.52-7.73 (m, 12H, Ph-H), 8.51 (s, 2H, N=CH); 13C NMR (CDCl3): δ 29.5 
(C(CH3)3),29.8 (C(CH3)3), 31.2 (C(CH3)3), 31.3 (C(CH3)3), 34.3 (C(CH3)3), 35.2 
(C(CH3)3), 38.1 (C(CH3)3), 114.9 (Ph), 120.6 (Ph), 121.8 (Ph), 122.0 (Ph), 125.6 (Ph), 
126.2 (Ph), 129.6 (Ph), 132.0 (Ph), 133.0 (Ph), 134.2 (Ph), 139.4 (Ph), 141.3 (Ph),144.9 
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(Ph), 151.6 (Ph), 159.4 (NCH). 11B NMR (CDCl3): δ 3.19 (W1/2 = 720 Hz), 7.33 (W1/2 = 
320 Hz). IR (KBr) ν/ cm-1: 2959s, 2909w, 2869w, 1620m, 1586m, 1563m, 1548m, 
1486m, 1468m, 1441m, 1414m, 1391m, 1378w, 1362m, 1324w, 1293m, 1263s, 1255s, 
1204s, 1187m, 1155m, 1110w, 1016w, 944m, 905m, 749m. MS (EI, positive): 684 (M+, 
5 %), 334 (M+ - C21H25O3NB, 100%). Anal. Calcd. for C42H50O5NB2: C 73.70, H 7.36, N 
4.09. found: C 73.77, H 7.11, N 3.62. 
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Table 2.1. Crystallographic data and refinement details for compounds 1 and 6 
 1 6 
Empirical formula C23H32BNO3 C19H30BNO3 
M/ g mol-1  381.31 331.25 
Color  Yellow Yellow 
Crystal size/mm 0.90 x 0.15 x 0.03 0.20 x 0.10 x 0.08 
Crystal system, space group Monoclinic Monoclinic 
Space group C c P 21/c 
a/ Å 11.5730(4) 16.2045(3) 
b/ Å 26.0370(11) 11.2564(3) 
c/ Å c = 8.5110(3) 10.4662(5) 
α/ û 90.00 90.00 
β/ û 120.9071(19) 94.7290(11) 
γ/ û 90.00 90.00 
V/ Å3 2200.42(14) 1902.58(11) 
ρ calc/ g cm-3 1.151 1.156 
Z 4 4 
F(000) 824 720 
Radiation used Mo-Kα Mo-Kα 
µ /mm -1 0.074 0.076 
T/ K 90.0(2) 90.0(2) K 
hkl range -13 ≤ h ≤ 13, -30 ≤ k ≤ 30, -
10 ≤ l ≤ 10 
-19 ≤ h ≤ 19, -13 ≤ k ≤ 13, 
-12 ≤ l ≤ 12 
Θ range/ û 1.56 - 25.00 1.26 - 25.00 
Reflections measured  3820  6477 
Unique reflections (Rint) 3808 (0.0241) 3359 (0.0748) 
Obsd reflections, n [I ≥ 2σ 2648 1647  
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(I)] 
Refinement method Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
Refined 
parameters/restraints 
261/2 224/0 
R1 [I > 2σ] R1 = 0.0512, wR2 = 0.0950 0.0556, wR2 = 0.1277 
R1 (all data) R1 = 0.0980, wR2 = 0.1108 0.1418, wR2 = 0.1583 
Goodness-of-fit on F2 1.134  0.924 
Largest diff. peak and hole/ 
e. Å -3 
0.238 and -0.177 0.190 and -0.234 
 74
Table 2.2. Selected bond distances (Å) and angles (º) for the borate compounds 1 and 6. 
1     
B1-O1 1.485(4)  O3-C23 1.412(4) 
B1-O2 1.414(4)  N1-C15 1.302(4) 
B1-O3 1.426(4)  N1-C16 1.442(4) 
B1-N1 1.628(4)    
     
O1-B1-N1 106.8(3)  O1-B1-O2 112.1(3) 
O2-B1-N1 108.5(3)  O1-B1-O3 112.1(3) 
O3-B1-N1 108.9(3)  O2-B1-O3 108.4(3) 
     
6     
B1-O1 1.473(3)  O3-C19 1.428(3) 
B1-O2 1.431(3)  N1-C15 1.286(3) 
B1-O3 1.444(3)  N1-C16 1.466(3) 
B1-N1 1.585(4)    
     
O1-B1-N1 109.4(2)  O1-B1-O2 107.6(2) 
O2-B1-N1 108.2(2)  O1-B1-O3 111.2(2) 
O3-B1-N1 105.0(2)  O2-B1-O3 115.3(2) 
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Table 2.3. Crystallographic data and refinement details for compounds 11 and 12 
 11 12 
Empirical formula C18.15H27.46BCl0.85NO2.15 C18H27BBrNO2 
M/ g mol-1  335.00  380.13 
Color   Pale yellow 
Crystal size/mm 0.45 x 0.35 x 0.25 0.30 x 0.20 x 0.08 
Crystal system Triclinic Triclinic 
Space group P -1 P -1 
a/ Å 11.63150(10) 11.5811(1) 
b/ Å 11.82500(10)  11.9058(1) 
c/ Å 16.5808(2)  16.5674(1) 
α/ û 100.1133(4)  101.1731(3) 
β/ û 102.1617(5) 101.3603(4) 
γ/ û 115.9115(5)  115.8035(3) 
V/ Å3 1910.10(3)  1912.52(3) 
ρ calc/ g cm-3 1.165  1.320 
Z 4  4 
F(000) 720  792 
Radiation used Mo-Kα Mo-Kα 
µ /mm -1 0.188  2.157 
T/ K 90.0(2)  90.0(2) 
hkl range -15≤ h ≤ 15, -15≤ k ≤ 15, -21≤ 
l ≤ 21 
-15 ≤ h ≤ 15, -15≤ k ≤ 15, 
-21≤ l ≤ 21 
Θ range/ û 1.32 - 27.49  1.32 - 27.50 
Reflections measured  17406  47040 
Unique reflections (Rint) 8762 (0.0334)  8775 (0.0410) 
Obsd reflections, n [I ≥ 2σ 6064 7220  
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(I)] 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares 
on F2 
Refined 
parameters/restraints 
453/85 261/2 
R1 [I > 2σ] 0.0523, wR2 = 0.1419  0.0267, wR2 = 0.0598 
R1 (all data) 0.0834, wR2 = 0.1599 0.0388, wR2 = 0.0641 
Goodness-of-fit on F2 1.076 1.017 
Largest diff. peak and hole/ 
e. Å -3 
0.496 and -0.367  0.408 and -0.409 
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Table 2.4. Selected bond distances (Å) and angles (º) for the boron halide compounds 11 
and 12  
11     
B1A-O1A 1.437(2)  B1A-N1A 1.552(2) 
B1A-O2A 1.400(2)  B1A-Cl1A 1.965(2) 
     
O1A-B1A-N1A 111.22(15)  O1A-B1A-Cl1A 108.04(13) 
O1A-B1A-O2A 109.16(16)  O2A-B1A-Cl1A 111.22(14) 
O2A-B1A-N1A 113.18(16)  N1A-B1A-Cl1A 103.83(13) 
     
12     
B1A-O1A 1.426(2)  B1A-N1A 1.537(2) 
B1A-O2A 1.391(2)  B1A-Br1A 2.201(2) 
     
O1A-B1A-N1A 112.33(14)  O1A-B1A-Br1A 106.87(11) 
O1A-B1A-O2A 111.01(15)  O2A-B1A-Br1A 109.00(12) 
O2A-B1A-N1A 114.92(14)  N1A-B1A-Br1A 101.97(11) 
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Table 2.5. Crystallographic data and refinement details for compound 13 
 13 
Empirical formula C44H54B2Cl4N2O5 
M/ g mol-1  854.31 
Color  Yellow 
Crystal size/mm 0.12 x 0.08 x 0.05 
Crystal system Orthorhombic 
Space group P212121 
a/ Å 12.9606(2) 
b/ Å 19.6141(3) 
c/ Å 51.9064(7) 
α/ û 90.00 
β/ û 90.00 
γ/ û 90.00 
V/ Å3 13195.2(3) 
ρ calc/ g cm-3 1.290 
Z 12 
F(000) 5400 
Radiation used Cu-Kα 
µ /mm -1 2.810 
T/ K 90.0(2) 
hkl range -9 ≤ h ≤ 15, -22 ≤ k ≤ 23, -46 ≤ l ≤ 62 
Θ range/ û 2.41 to 67.99 
Reflections measured  93693 
Unique reflections (Rint) 23333 (0.0767) 
Obsd reflections, n [I ≥ 2σ (I)] 16374  
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Refinement method Full-matrix least-squares on F2 
Refined parameters/restraints 1658/ 1678 
R1 [I > 2σ] 0.0686, wR2 = 0.1648 
R1 (all data) 0.1032, wR2 = 0.1867 
Goodness-of-fit on F2 1.026 
Largest diff. peak and hole/ e. Å -3 0.609 and -2.022 
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Table 2.6. Selected bond distances (Å) and angles (º) for compound 13  
B1A-O1A 1.459(6)  B2A-O3A 1.481(6) 
B1A-O2A 1.480(5)  B2A-O4A 1.463(5) 
B1A-O5A 1.406(6)  B2A-O5A 1.390(6) 
B1A-N1A 1.606(6)  B2A-N2A 1.610(5) 
     
O1A-B1A-N1A 106.2(3)  O5A-B2A-N2A 112.1(3) 
O1A-B1A-O2A 111.3(3)  O5A-B2A-O3A 115.2(4) 
O1A-B1A-O5A 109.4(4)  O5A-B2A-O4A 110.1(4) 
O2A-B1A-N1A 101.3(3)  O3A-B2A-N2A 101.9(3) 
O2A-B1A-O5A 115.1(4)  O3A-B2A-O4A 110.9(3) 
O5A-B1A-N1A 113.0(3)  O4A-B2A-N2A 106.1(3) 
B1A-O5A-B2A 117.2(3)    
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Figure 2.1. Preparation of compounds 1-12. 
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Figure 2.2. Structure of 1. 
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Figure 2.3. Structure of 6. 
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Figure 2.4. Structure of 11. 
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Figure 2.5. Structure of 12. 
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Figure 2.6. THC diagram. (a) Equation for calculating THC % (θn (n = 1-6) are the 
angles around the boron atom). (b) Weak interaction between boron and the donor 
leading to three-coordinate trigonal boron. (c) Strong interaction between boron and the 
donor leading to tetrahedral four-coordinate boron. 
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Figure 2.7. Formation of hydrolyzed product 13 from the halide compound 7. 
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Figure 2.8. Formation of binuclear oxo-bridged boron compounds from Salen ligands. 
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Figure 2.9. Structure of the hydrolyzed product 13. 
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Chapter 3 
Dealkylation of Organophosphates with Mononuclear Boron Chelates 
3.1. Background 
 In Chapter 1 the effectiveness of binuclear boron halides for the dealkylation of a 
series of organophosphates under mild conditions was discussed.33-35 For example, 
salpen(tBu)[BBr2]2 dealkylates trimethyl phosphate up to 89 % conversion in 30 
minutes.33 The binuclear compounds catalyzed the reactions between phosphate esters 
and boron tribromide. To determine the full utility of the chelated boron compounds it is 
necessary to try similar mononuclear boron compounds for phosphate dealkylation. This 
would allow a comparison with the binuclear system to both understand how the reaction 
proceeds and to determine the optimal system. Although a mononuclear boron compound 
tBuSal(tBu)[BBr2]2 was previously found to dealkylate trimethylphosphate at 92% 
conversion in 30 minutes a systematic study was not conducted. A series of mononuclear 
Schiff base boron halides for the dealkylation of trimethyl phosphate will be presented in 
this chapter. The mononuclear boron mono- and dihalide compounds of the type LBX 
and LBX2 reported in chapter 2 will be used for this study. 
3.2. Dealkylation of trimethylphosphate with various mononuclear compounds 
 The mononuclear Schiff base boron halide compounds 2, 3, 7-12 (see Figure 2.1) 
dealkylated trimethyl phosphate at room temperature in stoichiometric reaction to 
produce methyl bromide and an unidentified phosphate material which remained in 
solution (Figure 3.1 and Table 3.1). The dealkylation reaction was conducted in NMR 
tubes in CDCl3 and the percent conversion was determined from the integration of the 1H 
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NMR peaks for the methyl bromide produced and the unchanged methoxy groups of the 
phosphate. The reaction mixture stayed clear throughout. The possible dealkylation 
pathway for the LBX compounds is shown in Figure 3.2. The best results were obtained 
from the monobromide compounds 8 (90 % after 30 min) and 12 (64 % after 30 min, 74 
% after 2 h and 100 % after 24 h). These results are comparable to the binuclear boron 
halides studied before. In compounds 8 and 12 with an ONO environment either an o-
phenylene or a propylene backbone connects the N and O atoms. These compounds were 
far more active than the chloride analogues, 7 and 11. This could be expected from the 
lower B-Br bond strength (396 kJ mol-1) compared to B-Cl bond strength (511 kJ mol-1) 
and the consequent ease of formation of the phosphate coordinated cations. Interestingly, 
the LBX (X = Cl, Br) compounds, 9 and 10, with an ethylene backbone between the N 
and O atoms, were almost inactive towards phosphate dealkylation. Compound 3, the 
dibromide LBBr2, also showed negligible activity. However, the dichloride compound (2) 
showed moderate activity (17 % in 30 minutes, 61 % in 2 h and 85 % in 24 h). The higher 
activity of chloride compared to bromide for LBX2 could not be explained by the B-X 
bond strength. Thus, a correlation of higher reactivity vs. B-X bond strength occurs only 
for the monohalide compounds. That the LBCl2 compounds are more reactive can be 
explained by the fact that the inductive effect of the second halide makes the formation of 
LBCl+ easier to achieve. 
3.3. Preparation of a chelated monomeric boron phosphinate through dealkylation 
 Although it was not possible to get the structure of the fully dealkylated phosphate 
triester, the dealkylated product, 14 (Figure 3.4), produced from tert-butyl-
diphenylphosphinate, Ph2P(O)OtBu and the boron bromide compound 8 was fully 
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characterized. Molecular phosphates and phosphonates have been of interest due to their 
possible use as precursors to solid-state materials. 178-181 Monomeric main group or 
transition metal chelate compounds with terminal phosphinates are rare. Previously 
reported metal phosphinate compounds of Ti, 182, 183 Zr 184, Ta, 183 Sn, 185, 186 Pb 185 Al, 187, 
188 Ga,189, 190 and In 189 contained bridging phosphinate groups and almost all of the 
compounds were di- or polynuclear. A unique example of a mononuclear metal chelate 
phosphinate compound is Sn(CH2Ph)2[O2P(C6H11)2]2[HO2P(C6H11)2]2 (Figure 3.3). 186 In 
this compound the phosphinate groups participate in intramolecular hydrogen bonding. 
The aluminum phosphinate Salen chelate compounds contained six-coordinate aluminum 
and some of them showed unique coupling reactions with THF.188 Compound 14 is a rare 
example of a monomeric chelated compound with a terminal phosphinate group. 
 Compound 14 was prepared by refluxing 8 and Ph2P(O)OtBu in toluene (Figure 3.4). 
The byproduct tBuBr was removed under vacuum. Compound 14 is soluble in organic 
solvents. The 1H NMR showed tBu peaks at δ 1.31 and δ 1.50 ppm, and an imine peak at 
δ 8.57 ppm. The 11B NMR showed a single peak at δ 3.57 ppm which is in the 
appropriate region for a four-coordinate boron atom. Interestingly, the 31P NMR showed 
two peaks at δ 28.90 and δ 33.97 ppm in the intensity ratio of 4:3. The presence of two 
peaks suggests that there might be some type of rearrangement in the solution state. 
Alternatively, the peak at 28.90 ppm could be due to the presence of some 
diphenylphosphinic acid (for which the literature value of 31P shift is 25.50 ppm 191) 
produced from the hydrolysis of the starting phosphinate material by the adventitious HCl 
present in the NMR solvent CDCl3. The 31P chemical shift in 14 is close to some other 
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phosphinate compounds, for example, in [(η5-Cp)TiCl2(µ-Ph2PO2)}2] the 31P shift is 34.5 
ppm.183 
 The IR showed strong νB-N absorption at 1014 cm-1, νC═N at 1640 cm-1 and νP═O at 
1212 cm-1. The mass spectrum (EI, positive) showed a molecular ion peak in 15 % 
abundance and a M+-PhPO2 peak in 45 % abundance. The base peak (100 %) was due to 
M+  − PhPO2  H. 
3.3.1. Structure of 14 
 The crystal structure of the boron phosphinate, compound 14, was determined by 
single-crystal X-ray diffraction. The crystal data collection parameters are shown in 
Table 3.2 and selected bond lengths and angles are contained in Table 3.3. The 
compound contains a four-coordinate boron and a four-coordinate phosphorus atom. The 
B-O bond lengths (1.432(2), 1.463(2) and 1.476(2) Å) are shorter than the B-N bond 
length (1.568(3) Å). The P1-O3 bond length (1.5633(13) Å) is in a single bond range 
(1.59-1.60 Å) and the P1-O4 bond (1.4811(13) Å) is close to the double bond range 
(1.45-1.46 Å).192 It may be mentioned that in a previously reported molecular 
borophosphonate cage compound [tBuPO3BEt]4 the average P-O bond length was 1.50 Å, 
intermediate between P-O and P═O.193 
 The geometry around the boron is distorted tetrahedral. The THC value (defined in 
chapter 2) 172 for 14 is 81 %. The largest deviation from a perfect tetrahedral angle is 
shown by O2-B1-N1 (102.22(15) °), and is caused by the constraints imposed by the 
chelate.  
 The phosphorus atom is in a distorted tetrahedral environment. The angle O3-P1-O4 
(116.50(7)) °) is the most obtuse angle whereas the angle C22-P1-C28 (106.26(9) °) is 
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the most acute. The angle P1-O3-B1 is 132.43(12) ° is significantly smaller than the Al-
O-P angle (138.8(3) °) in the dimeric aluminum phosphinate compound 
[salophen(thf)(tBu)AlO2P(H)Ph]2.188 
3.4. Conclusion 
 Compounds 2, 3, 7-12 dealkylated trimethyl phosphate to various extents at room 
temperature. The monobromide compounds 8 and 12 were the most effective and their 
activity was comparable to the results obtained from binuclear Salen boron bromide 
compounds. However, mononuclear compounds are less stable to air and moisture 
compared to their binuclear counterparts. For any useful application this problem has to 
be addressed. Although the structure of the fully dealkylated product could not be 
determined, a monodealkylated product (compound 14) was fully characterized. 
Compound 14 is the first example of a chelated boron phosphinate. Interestingly the 
compound has a terminal phosphinate group in contrast to bridging phosphinate groups 
found in many other metal chelates. The dealkylation reaction has the potential to 
produce novel structures when used with phosphate di- and triesters, i.e., phosphonates 
and phosphates.  
3.5. Experimental 
General remarks. All air-sensitive manipulations were conducted using standard bench-
top Schlenk line technique in conjunction with an inert atmosphere glove box. All 
solvents were rigorously dried prior to use. All glassware was cleaned with a base and an 
acid wash and dried in an oven at 130 ºC overnight. NMR data were obtained on Varian 
Gemini-200 and Varian VXR-400 instruments. Chemical shifts were reported relative to 
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SiMe4 for 1H and 13C, BF3·Et2O for 11B and 85 % H3PO4 for 31P and are reported in ppm. 
Infrared transmission spectra were recorded at room temperature in a potassium bromide 
pellet on a Fourier-transform Magna-IR ESP 560 spectrometer. Elemental analyses were 
performed on either a Perkin Elmer 2400 CHN Analyzer or a LECO CHN-2000 
Analyzer. 
X-ray data for compound 14 were collected on a Nonius Kappa-CCD diffractometer 
using Mo-Kα radiation. All calculations were performed using the software package 
SHELXTL-Plus.174-177 The structures were solved by direct methods and successive 
interpretation of difference Fourier maps followed by least-squares refinement. All non-
hydrogen atoms were refined anisotropically. The hydrogen atoms were included using a 
riding model with isotropic parameters tied to the parent atom. 
Dealkylation of phosphates. In a typical experiment the chelate compound (for 8, 30 
mg, 0.070 mmol) was dissolved in 1 mL CDCl3 in a glass vial. The solution was 
transferred to an NMR tube and trimethylphosphate (2.8 µL, 0.024 mmol, density 1.197 
g/mL) was added with a syringe. The mixture was shaken and monitored by 1H NMR. 
The % dealkylation was calculated from the peak integrations of  methyl halide produced 
and unchanged phosphate. 
Synthesis of LBOP(O)Ph2 (LH2 = N-(2-hydroxyphenyl)-3,5-di-t-
butylsalicylaldimine) (14). To a rapidly stirred solution of 8 (0.57 g, 1.6 mmol) in 
toluene tert-butyl-diphenylphosphinate (0.41 g, 1.6 mmol) was added. The golden yellow 
reaction mixture was refluxed for 7 hours. The volatiles were removed under vacuum and 
a yellow solid was obtained, which was dried under vacuum and washed with hexane. 
Yield: 0.59 g (68 %). Mp: 239-240 ºC (dec.). δ 1.31 (s, 9H, C(CH3)3), 1.50 (s, 9H, 
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C(CH3)3), 6.64 (m, 1H, Ph-H), 6.86 (m, 1H, Ph-H), 7.14-7.23 (m, 4H, Ph-H), 7.25-7.39 
(m, 4H, Ph-H), 7.44-7.54 (m, 4H, Ph-H), 7.66-7.79 (m, 2H, Ph-H), 8.57 (s, 1H, N=CH); 
13C NMR (CDCl3): δ 29.7 (C(CH3)3), 31.5 (C(CH3)3), 35.7 (C(CH3)3), 38.0 (C(CH3)3), 
120.2 (Ph), 128.0 (Ph), 128.2 (Ph), 129.2 (Ph), 131.4 (Ph), 132.8 (Ph), 143.3 (Ph), 157.6 
(NCH) 11B NMR (CDCl3): δ 3.57 (W1/2 = 47 Hz). 31P{H} NMR (CDCl3): δ 28.90 (s), δ 
33.97 (s). IR (KBR) ν/ cm-1: 2959m, 2909w, 2867w, 1640s, 1564w, 1548w, 1482m, 
1440m, 1391m, 1384m, 1365w, 1327m, 1259m, 1212s, 1184m, 1127m, 1082m, 1014s, 
994s, 966m, 888w, 750m, 725m, 694m, 544m. MS (EI, positive): 331 (M+, 15 %), 334 
(M+  - Ph2PO2, 45)%), 333 (M+  - Ph2PO2 - H, 100 %). Anal. Calcd. for C33H35O4NBP: C 
71.88, H 6.40, N: 2.54. found: C 70.78, H 6.73, N 1.84. 
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Table 3.1. Percent dealkylation a of trimethylphosphate with Schiff base boron halides 
 
Compound 2 3 7 8 9 10 11 12 
         
30 min 17 10 9 90 2 4 3 64 
2 h 61 13 24 90 6 4 8 74 
4 h   40 92 7    
6 h   52 94 7    
8 h   62 94 9    
10 h   68 94 11    
12 h   73 94 11    
24 h 85 18 84 94 13 4 57 100
a Calculated from the integration of 1H NMR spectra of methyl halide produced and 
unchanged trimethyl phosphate at room temperature in CDCl3. 
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Table 3.2. Crystallographic data and refinement details for compound 14. 
 14 
Empirical formula C36.50H39BNO4P 
M/ g mol-1  597.47 
Color  Yellow 
Crystal size/mm 0.15 x 0.15 x 0.05 
Crystal system  Triclinic 
Space group P -1 
a/ Å 12.1241(2) 
b/ Å 12.3740(2) 
c/ Å 12.4470(2) 
α/ û 73.7525(6) 
β/ û 89.0625(7) 
γ/ û 62.5102(6) 
V/ Å3 1576.34(4) 
ρ calc/ g cm-3 1.259 
Z 2 
F(000) 634 
Radiation used Mo-Kα 
µ /mm -1 0.128 
T/ K 90.0(2) 
hkl range -15 ≤ h ≤ 15, -16 ≤ k ≤ 15, -16 ≤ l ≤ 16 
Θ range/ û 1.72  27.45 
Reflections measured  13929 
Unique reflections (Rint) 7183 (0.0532) 
Obsd reflections, n [I ≥ 2σ (I)] 4399 
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Refinement method Full-matrix least-squares on F2 
Refined parameters/restraints 431/0 
R1 [I > 2σ] R1 = 0.0501, wR2 = 0.1109 
R1 (all data) R1 = 0.1036, wR2 = 0.1318 
Goodness-of-fit on F2 1.005 
Largest diff. peak and hole/ e. Å -3 .326 and -0.416 
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Table 3.3. Selected bond distances (Å) and angles (º) for the borate compound 14.  
B1-O1 1.432(2)  P1-O3 1.5633(13) 
B1-O2 1.463(2)  P1-O4 1.4811(13) 
B1-O3 1.476(2)  P1-C22 1.799(2) 
B1-N1 1.568(3)  P1-C28 1.8004(19) 
N1-C15 1.293(2)    
N1-C16 1.413(2)    
     
O1-B1-N1 109.97(16)  O3-P1-O4 116.50(7) 
O2-B1-N1 102.22(15)  O3-P1-C22 107.33(8) 
O3-B1-N1 110.45(16)  O3-P1-C28 112.93(8) 
O1-B1-O2 114.49(16)  O4-P1-C22 111.30(8) 
O1-B1-O3 107.91(15)  O4-P1-C28 112.93(8) 
O2-B1-O3 111.71(16)  C22-P1-C28 106.26(9) 
   P1-O3-B1 132.43(12) 
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3 MeX x "(LB)y(PO4)z"+(MeO)3P(O) + mLBXn
m = 3, n = 1, x = 1, y = 3, z = 1
m = 3/2, n = 2, x = 1/2, y = 3, z = 2
X = Br, Cl  
 
 
 
Figure 3.1. Reaction between trimethylphosphate and mononuclear Schiff base boron 
halides. 
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Figure 3.2. Possible dealkylation pathway for the boron compound LBX. 
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Figure 3.3. Monomeric tin phosphinate. 
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Figure 3.4. Synthesis of 14. 
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Figure 3.5. Crystal structure of compound 14. 
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Chapter 4 
Salen Aluminum Bromides: Synthesis, Structure and Cation Formation 
4.1. Introduction 
Examples of five-coordinate group 13 bromide compounds reported so far have been 
limited to indium. 194 This is despite the fact that the chloride compounds have been quite 
popular for synthetic and catalytic applications. 17, 195-198 Specifically, Salen aluminum 
chloride (Salen = N,N'- alkylene(or arylene)bis(salicylideneimine)) compounds have been 
the subject of interest recently for their ease of synthesis and cation formation, and 
subsequent use in catalysis. The compounds contain five-coordinate aluminum with a 
single 27Al NMR peak in the range δ 43-57 ppm. The coordination environment around 
the central aluminum is either trigonal bipyramidal (tbp) or square pyramidal (sqp) 
depending on the backbone (the connection between the nitrogens) of the ligand. With 
three or more methylene units in the backbone (e.g., salpen) a tbp geometry is obtained 
whereas for two methylene units (e.g., salen) or 1,2 arylene (e.g., salophen) a sqp 
geometry is observed.199 
 SalenAlCl compounds have been used in oxirane polymerization,17 phospho-transfer 
reactions (Figure 4.1),195 conjugate addition of nucleophiles to unsaturated imides196-198 
and an inverse electron demand Diels-Alder reaction.200 The chloride group in 
Salen(tBu)AlCl can be displaced by strong donors, such as, H2O, MeOH, THF, or HMPA 
to give cationic aluminum compounds (Figure 4.2).19, 20, 201 Also, solvent-free cations can 
be achieved by removing the chloride of SalenAlCl with GaCl3 (Figure 4.2).202 In 
general, the utility of the SalenAlCl compounds has relied on their ability to produce the 
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cation [SalenAl(base)2]+. It is likely that the bromide derivatives will have greater utility 
based upon the weaker Al─Br bond strength. Thus it is anticipated that cation formation 
may occur for the bromide derivatives with less strong Lewis bases, thereby broadening 
the potential applicability of the compounds.  
This chapter will detail the synthesis of five-coordinate Salen aluminum bromides and 
the formation of six-coordinate aluminum cations on combination with a Lewis base. 203 
4.2. Synthesis   
 Salen(tBu)H2 ligands were prepared by the condensation reaction between 3,5-di-t-
butylsalicylaldehyde and appropriate diamine following the literature procedure (Figure 
4.3) .204 The Salen aluminum bromide compounds 15-18 were prepared by alkane 
elimination between diethylaluminum bromide (prepared in situ by the redistribution of 
triethylaluminum and aluminum(III) bromide) and Salen(tBu)H2 under reflux (Figure 
4.4). The compounds were isolated by removing the solvent under vacuum or by 
precipitation after concentration and cooling to -30 ºC. The compounds were yellow and 
soluble in chloroform.  
4.3. Characterization 
4.3.1. Spectroscopy 
Compounds 15-18 were characterized by NMR, IR and MS. The 1H NMR data were 
very close to the corresponding chloride analogues reported in the literature.17, 205 For 
example, the 1H NMR data for all four compounds show two singlets for the tBu-Ph 
groups in the range δ 1.30-1.63 ppm. For 15, 16 and 17 there are multiple CH2 peaks 
corresponding to the alkylene backbone protons from the ligand ranging from δ 1.80 to 
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3.97 ppm. There is only one imine singlet for each compound at δ 8.40, 8.29, 8.23 and 
8.94 ppm, respectively. Like their chloride analogues, these values decrease slightly with 
increasing backbone length from 15 to 17, and increases in 18 because of the greater 
electronegativity and deshielding effect of the aryl backbone compared to an alkyl 
backbone. The presence of only one set of tBu peaks and one imine peak for each 
compound suggests a symmetric solution-state structure. 
 The 27Al NMR showed broad single peaks centered at δ 38, 36, 36 and 32 ppm, 
respectively, for 15-18 which indicate the presence of five-coordinate aluminum. 
However, these are shifted upfield from the related chloride analogues salen(tBu)AlCl (δ 
57 ppm), salpen(tBu)AlCl (δ 43 ppm and salophen(tBu)AlCl (δ 52 ppm).205 This is in 
accordance with the lower electronegativity of Br compared to Cl and hence more 
shielding of the Al center. 
 The IR spectra showed strong absorptions due to νC═N at 1648, 1642, 1643 and 1621 
cm-1 for 15-18, respectively. The mass spectra (EI) of 15 and 17 contained molecular ion 
peaks in low abundance. All four compounds had a peak corresponding to the molecular 
ion minus bromide, and for 15, 16 and 17 this was the most abundant peak. Compounds 
15 and 18 also had peaks corresponding to molecular ion minus bromide and one oxygen, 
and for 18 this was the most abundant peak. It was interesting to note that the loss of 
bromide occurred and not the loss of tBu from the ligand. This might provide some 
indication of the relative weakness of the Al―Br bond in the compounds. 
4.3.2. Structures 
The solid-state structures of compounds 15-18 were determined by single-crystal X-
ray diffraction. Compounds 15 and 17 crystallized in orthorhombic space group Pbca 
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while 16 and 18 crystallized in triclinic space group P
_
1 . The X-ray crystal structures 
confirmed the presence of five-coordinate aluminum atoms in 15-18 (Figures 4.5, 4.6, 4.7 
and 4.8). The crystal data collection parameters are listed in Table 4.1 and selected bond 
lengths and angles in Table 4.2. The Al─Br bond lengths fall in the range 2.35-2.38 Å 
which are longer than the Al─Cl bond length (~ 2.18 Å) in Salen(tBu)AlCl 
compounds.199 The Al─N bond lengths (~ 1.96-2.02 Å) are marginally longer than the 
Al─O bond length (~1.75-1.81 Å). The geometries of these compounds are close to either 
square pyramidal (sqp) or trigonal bipyramidal (tbp) depending on the ligand backbone. 
Salen and salophen have rigid backbones and favor square pyramidal geometry while 
salpen and salben with longer, flexible, propylene and butylene backbones, respectively, 
favor tbp geometry around the aluminum. A similar trend was observed previously in the 
case of salen aluminum alkyl, chloride and siloxide compounds. 199, 206, 207  
 A quantitative measure, expressed as the τ value, can be used to describe the 
distortion from perfectly sqp or tbp geometry in these compounds (Figure 4.9). 208 A 
perfectly sqp geometry has a τ value equal to zero whereas a perfectly tbp geometry has a 
τ value equal to 1. In Table 4.3 the calculated τ values for compounds 15- 18, along with 
some previously described five-coordinate Salen aluminum chloride compounds, are 
listed. Compounds 15 and 18 have τ values close to 0 indicative of a distorted sqp 
geometry whereas 16 and 17 have τ values close to 1 indicating a distorted tbp geometry. 
This value may be important in determining the accessibility of a sixth coordination site 
on aluminum. 209 Attempts have been made to relate the τ value to the hyperfine splitting 
in the EPR spectra for five-coordinate copper (II) complexes.210 The hyperfine splitting 
constant AII is sensitive to the type of ligand coordinating to the metal center. This 
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constant for a series of five-coordinate copper complexes of pyridine-2,6-dicarboxamide 
ligands were determined and a linear correlation was found between τ and AII values. 
However, for some of the complexes this correlation breaks down due to structural 
features such as out-of-plane distortions and ligand strain. 
4.4. Six-coordinate aluminum cations 
4.4.1 Synthesis 
Four cationic compounds, [salen(tBu)Al(Ph3PO)2]Br (19), [salpen(tBu)Al(Ph3PO)2]Br 
(20), [salophen(tBu)Al(Ph3PO)2]Br (21) and [salophen(tBu)Al{(PhO)3PO)}2]Br (22) were 
formed by displacement of the bromide from compounds 15, 16 and 18 with either 
triphenylphosphine oxide or triphenyl phosphate (Figure 4.10). Similar cationic 
compounds were formed previously from Salen(tBu)AlCl with H2O, THF or MeOH.17, 18 
Salen aluminum chlorides do not form cations with triphenylphosphine oxide, which 
confirms the value of the SalenAlBr compounds in making new cations. 
Triphenylphosphine oxide was also found to form [Me2Al(OPPh3)2]Br from Me2AlBr.211 
However, it was not a strong enough base to displace chloride from Me2AlCl even under 
reflux. Instead, the adduct Me2AlClOPPh3 formed (Figure 4.11). 
4.4.2. Spectroscopy 
 The 1H NMR spectra of 19, 21 and 22 show two peaks for the tBu groups of the ligand 
with each peak corresponding to 18 protons. Interestingly, for 20, there is only one tBu 
peak with 36 protons. This could be attributed to the shielding of the ortho- tBu group of 
the ligand due to the ring current of the phenyl groups of triphenylphosphine oxide. This 
shielding causes an upfield shift of the tBu group thus superimposing it on the peak of the 
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other. 212 In the aromatic regions there are overlapping peaks due to the phenyl groups 
from both the ligands and triphenylphosphine oxide or triphenylphosphate. The 27Al 
NMR shows very broad peaks at δ -6, 0, and 12 ppm for 19, 20, and 22, respectively. 
These correspond to the presence of six-coordinate aluminum.188 However, for 21 this 
value is δ 42 ppm which is more likely to be the shift of a five-coordinate aluminum 
atom.205 Thus the solution product for 21 appears to be different from the solid-state 
structure found in the X-ray crystal studies where the aluminum atom is six-coordinate 
(see next paragraph). One possible explanation could be that one of the two loosely 
bound triphenylphosphine oxide ligands dissociates in the polar NMR solvent (CDCl3) 
making the aluminum five-coordinate. The 31P NMR spectra of 19, 20 and 21 show peaks 
at δ 34, 35 and 33 ppm, respectively. These are downfield from the NMR shift of δ 29 
ppm of free triphenylphosphine oxide 213 because of the deshielding of the phosphorus 
due to coordination to aluminum. However, for 22 this shift is δ -21 ppm which is 
slightly upfield from the shift of -18 ppm of free triphenylphosphate.213 The IR spectrum 
shows strong P═O absorption at 1173, 1162, 1172 and 1278 cm-1 for 19, 20, 21, and 22, 
respectively. For 22, the stretching of the P─O bond of the P─O─C linkage of the 
phosphate gives rise to a strong band at 1029 cm-1. In the mass spectra (EI) of the six- 
coordinate aluminum compounds no parent ion or parent ion minus bromide ion was 
observed. However, all the compounds show peaks corresponding to parent ion minus the 
bromide and two triphenylphosphine oxide or triphenylphosphate moieties in high 
abundance. This indicates the weak coordination between the Lewis base and the 
aluminum. 
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4.4.3. Structure 
 Compounds 20, 21 and 22 were structurally characterized by single crystal X-ray 
diffraction. The data collection parameters are contained in Table 4.4 while Table 4.5 
lists selected bond lengths and angles. Compounds 20 and 21 crystallize in orthorhombic 
space group Pbca whereas 22 crystallizes in monoclinic space group P21/n. Their 
structures consist of a central six-coordinate aluminum atom in a distorted octahedral 
geometry (Figures 4.12, 4.13 and 4.14). The ligand occupies four equatorial positions and 
two phosphine oxide or the phosphate molecules occupy the two axial positions. The 
equatorial bond angle is larger for O-Al-O (~89.38 - 96.1º) compared to N-Al-N (~80.7 - 
90.85 º). This is a reflection of the steric restrictions of the ligand creating a more open 
front for the compound. The axial O-Al-O bond angles are distorted (~ 169.1 - 174.6º) 
from ideal linearity. The amount of distortion is more for the phosphine oxide compounds 
20 and 21 compared to the phosphate compound 22. This is probably due to the fact that 
the P-O-Ar linkage in 22 allows the bulky phenyl group to move away from the 
equatorial ligand atoms and thus avoid steric congestion. The axial Al-O distances (~ 
1.92  1.97 Å) are longer than the equatorial Al-O distances (~1.79  1.84 Å) due to the 
greater steric requirements of the axial groups. Interesting observations were made in 
terms of Al-O-P bond angles in the three cationic compounds. The two Al-O-P angles 
were widely different in each of the phosphineoxide compound 20 (~170 and ~153 º) and 
the phosphate compound 22 (~157 and 166 º). But in the phosphineoxide compound 21 
these angles are much closer (~164 and 161 º). These variations in bond angles could 
arise from different degrees of interactions involving the phenyl rings and the tBu groups. 
These values also show that all the three compounds are characterized by rather linear Al-
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O-P linkages. A similarly large Al-O-P angle (~166 º) was observed in the compound 
(Me2N)3Al·OPPh3.157 
4.5. Conclusion 
Four new five-coordinate aluminum bromides salen(tBu)AlBr (15), salpen(tBu)AlBr 
(16), salben(tBu)AlBr (17) and salophen(tBu)AlBr (18) have been synthesized and fully 
characterized. The compounds have distorted trigonal bipyramidal or square pyramidal 
geometries. Compounds 15 and 18 are closer to sqp whereas 16 and 17 are closer to tbp. 
These compounds readily formed six coordinate aluminum cations when combined with 
triphenylphosphine oxide or triphenyl phosphate. The six-coordinate cations have 
distorted octahedral geometries. The ready cation formation with Salen aluminum 
bromide compounds could be useful for their application in organic synthesis and 
catalysis.  
4.6. Experimental 
General remarks. All air-sensitive manipulations were conducted using standard bench-
top Schlenk line techniques in conjunction with an inert atmosphere glove box. All 
solvents were rigorously dried prior to use. All glassware was cleaned with a base and an 
acid wash and dried in an oven at 130 ºC overnight. The ligands salen(tBu)H2, 
salpen(tBu)H2, salben(tBu)H2 and salophen(tBu)H2 were synthesized according to the 
literature procedure.204 NMR data were obtained on Varian Gemini-200 and Varian 
VXR-400 instruments. Chemical shifts were reported relative to SiMe4 for 1H and 13C, 
AlCl3 in D2O for 27Al and 85 % H3PO4 for 31P, and are reported in ppm. Infrared 
transmission spectra were recorded at room temperature in a potassium bromide pellet on 
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a Fourier-transform Magna-IR ESP 560 spectrometer. Elemental analyses were 
performed on a Perkin Elmer 2400 CHN Analyzer. 
 X-ray data were collected on a either a Nonius Kappa-CCD (compounds 16, 17, 20, 21 
and 22; Mo-Kα radiation) or a Bruker-Nonius X8 Proteum (compounds 15 and 18; Cu-Kα 
radiation) diffractometer. All calculations were performed using the software package 
SHELXTL-Plus.174-177 The structures were solved by direct methods and successive 
interpretation of difference Fourier maps followed by least-squares refinement. All non-
hydrogen atoms were refined anisotropically. The hydrogen atoms were included using a 
riding model with isotropic parameters tied to the parent atom. 
 Synthesis of salen(tBu)AlBr (15). A rapidly stirred solution of Et2AlBr in toluene, 
prepared in situ by the redistribution of triethylaluminum (0.42 g, 3.6 mmol) and 
aluminum(III) bromide (1 M solution in dibromomethane, 1.8 mL, 1.8 mmol), was 
combined with a solution of salen(tBu)H2 (2.69 g, 5.46 mmol) in toluene by cannula. The 
reaction mixture was refluxed for 8 hours and filtered. The volatiles were removed under 
vacuum from the clear yellow filtrate to give a yellow microcrystalline solid which was 
purified by recrystallization from toluene. Single crystals suitable for X-ray analysis were 
grown from slow diffusion of hexane vapor into a concentrated CH2Cl2 solution. Yield: 
2.7 g (74%). Mp: 330-332ºC (dec.).1H NMR (CDCl3): δ 1.33 (s, 18H, C(CH3)3), 1.57 (s, 
18H, C(CH3)3), 3.97 (m, 4H, NCH2), 7.08 (d, 2H, PhH), 7.60 (d, 2H, PhH), 8.40 (s, 2H, 
N=CH); 13C NMR (CDCl3): δ 29.7 (C(CH3)3), 31.3 (C(CH3)3), 34.0 (CCH3)3), 35.5 
(CCH3)3), 54.5 (NCH2), 118.2 (Ph), 127.3 (Ph), 131.6 (Ph), 139.1 (Ph), 141.3 (Ph), 162.7 
(Ph), 170.4 (NCH); 27Al NMR (CDCl3): δ 38 (W1/2 = 5183 Hz). IR (KBr) ν in cm-1: 
2962m, 2905w, 2866w, 1648s, 1628s, 1544m, 1475m, 1444m, 1421w, 1390w, 1361w, 
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1310w, 1257w, 1180w, 867w, 845m, 816w, 786w, 756w, 608m, 586w. MS (EI, 
positive): 597 (M+, 8%), 517 (M+ - Br, 100%), 501 (M+ - Br - O, 44%). Anal. Calcd. for 
C32H46O2N2AlBr: C 64.31, H 7.76, N 4.69. found: C 62.13, H 7.93, N 4.43. 
 Synthesis of salpen(tBu)AlBr (16). A rapidly stirred solution of Et2AlBr in toluene, 
prepared in situ by the redistribution of triethylaluminum (0.24 g, 2.1 mmol) and 
aluminum(III) bromide (1 M solution in dibromomethane, 1.0 mL, 1.0 mmol), was 
combined with a solution of salpen(tBu)H2 (1.57 g, 3.10 mmol) in toluene by cannula. 
The reaction mixture was refluxed for 17 hours. The cloudy yellow solution was 
concentrated under vacuum to about one third of its volume. The yellow precipitate was 
isolated by cannula filtration, washed with ~15 mL of hexane, dried under vacuum and 
recrystallized from toluene. X-ray quality crystals were grown from slow diffusion of 
hexane vapor into a concentrated CH2Cl2 solution. Yield: 1.0 g (55%). Mp: 333-334ºC 
(dec.). 1H NMR (CDCl3): δ 1.30 (s, 18H, C(CH3)3), 1.50 (s, 18H, C(CH3)3), 2.23 (m, 2H, 
CH2CH2CH2), 3.85 (m, 4H, NCH2), 7.07 (d, 2H, Ph-H), 7.56 (d, 2H, Ph-H), 8.29 (s, 2H, 
N=CH); 13C NMR (CDCl3): δ 27.2 (CH2), 29.7 (C(CH3)3), 31.3 (C(CH3)3), 33.9 
(CCH3)3), 35.4 (CCH3)3), 55.1 (NCH2), 118.1 (Ph), 127.2 (Ph), 131.4 (Ph),138.9 (Ph), 
141.0 (Ph), 162.5 (Ph), 172.0 (N=CH); 27Al NMR (CDCl3): δ 36 (W1/2 = 3339 Hz). IR 
(KBr) ν in cm-1: 2956m, 2906w, 2866w, 1642s, 1624s, 1548m, 1463s, 1418m, 1390w, 
1361m,1312m,, 1259m, 1180m, 1097w, 863m, 847m, 784w,755w, 601m. MS (EI, 
positive): 531 (M+ - Br, 100%). Anal. Calcd. for C33H48O2N2AlBr: C 64.80, H 7.91, N 
4.58. found: C 62.12, H 7.78, N 4.36. 
 Synthesis of salben(tBu)AlBr (17). To a rapidly stirred solution of Et2AlBr in 
toluene, prepared in situ by the redistribution of triethylaluminum (0.35 g, 3.1 mmol) and 
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aluminum(III) bromide (1 M solution in dibromomethane, 1.31 mL, 1.31 mmol), a 
solution of salben(tBu)H2 (2.05 g, 3.93 mmol) in toluene was cannula transferred. The 
cloudy yellow reaction mixture was refluxed for 14 hours. The cloudy yellow solution 
was concentrated under vacuum to about one third of its volume. The yellow precipitate 
was isolated by cannula filtration, washed with two portions of 15 mL of hexane and 
dried under vacuum. X-ray quality crystals were grown from slow diffusion of hexane 
vapor into a concentrated CH2Cl2 solution of salben(tBu)AlBr. Yield: 1.8 g (73 %). Mp: 
314-316ºC (dec.). 1H NMR (CDCl3): δ 1.30 (s,18H, C(CH3)3), 1.49 (s,18H, C(CH3)3), 
1.80 (m, 4H, CH2CH2CH2CH2), 3.62 (m, 4H, NCH2), 7.08 (d, 2H, Ph-H), 7.57 (d,2H, Ph-
H), 8.23 (s, 2H, N=CH); 13C NMR (CDCl3): δ 27.7 (CH2), 29.9 (C(CH3)3), 31.5 
(C(CH3)3), 34.2 (CCH3)3), 35.6 (CCH3)3), 57.7 (NCH2), 118.6 (Ph), 126.1 (Ph), 127.4 
(Ph), 128.5 (Ph), 129.2 (Ph), 132.4 (Ph), 134.4 (Ph), 141.1 (Ph), 170.8 (N=CH); 27Al 
NMR (CDCl3): δ 36 (W1/2 = 2485 Hz). IR (KBr) ν/ cm-1: 2959 s, 2909 m, 2866 w, 1643 s, 
1566 m, 1468 m, 1429 w, 1390 w, 1359 w,1309w, 1261 m, 1205 s, 1132 s, 1014 w, 986 
m, 847 m,800 w. MS (EI, positive): 545 (M+ - Br, 100%). Anal. Calcd. for 
C34H50O2N2AlBr: C 65.28, H 8.06, N 4.48. found: C 63.08, H 7.88, N 4.64. 
 Synthesis of salophen(tBu)AlBr (18). A rapidly stirred solution of Et2AlBr in 
toluene, prepared in situ by the redistribution of triethylaluminum (0.21 g, 1.8 mmol) and 
aluminum(III) bromide (1 M solution in dibromomethane 0.90 mL, 0.90 mmol), was 
combined with a solution of salophen(tBu)H2 (1.46 g, 2.70 mmol) in toluene by cannula. 
The golden yellow solution was refluxed for 15 hours. Then it was concentrated under 
vacuum to about one third of its volume. Yellow crystals precipitated after cooling at -30 
ºC for 24 hours. The crystals were isolated by cannula filtration, washed with hexane and 
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dried under vacuum. Yield: 1.5 g (88 %). Mp: 320 ºC (dec.). 1H NMR (CDCl3): δ 1.37 (s, 
18H, C(CH3)3), 1.63 (s, 18H, C(CH3)3), 7.24 (d, 2H, Ph-H), 7.35 (m, 2H, Ph-H), 7.66 (m, 
2H, Ph-H), 7.71 (d, 2H, Ph-H), 8.94 (s, 2H, N=CH); 13C NMR (CDCl3): δ 29.8 
(C(CH3)3), 31.2 (C(CH3)3), 34.1 (C(CH3)3), 35.6 (C(CH3)3), 115.4 (Ph), 115.7 (Ph), 118.5 
(Ph), 126.7 (Ph), 127.5 (Ph), 128.2 (Ph), 129.1 (Ph), 133.2 (Ph), 137.5 (Ph), 139.8 (Ph), 
141.6 (Ph), 161.2 (Ph), 162.4 (Ph), 164.1 (N=CH); 27Al NMR (CDCl3): δ 32 (W1/2 = 5183 
Hz). IR (KBR) ν in cm-1: 2961s, 2905w, 2868w, 1621s, 1554m, 1542s, 1469s, 1474m, 
1445m, 1420m, 1391m,, 1361s, 1311m, 1255m, 1202w, 1179w, 865w, 847m, 786w, 
757w, 610m. MS (EI, positive): 646 (M+, 13%), 565 (M+ - Br, 95%), 549 (M+ - Br- O, 
100%). Anal. Calcd. for C36H46O2N2AlBr: C 66.97, H 7.18, N 4.34. found: C 67.23, H 
7.35, N 4.14. 
 Synthesis of [salen(tBu)Al(Ph3PO)2]Br (19). A rapidly stirred solution of 
salen(tBu)AlBr (0.41 g, 0.69 mmol) in toluene was combined with triphenylphosphine 
oxide (0.38 g, 1.4 mmol). The cloudy yellow slurry became clear greenish yellow with 
heating. The solution was refluxed for 16 hours. A pale yellow precipitate formed after 
cooling to room temperature. The precipitate was isolated by cannula filtration and dried 
under vacuum. Yield: 0.77 g (97 %). Mp: 260 ºC. 1H NMR (CDCl3): δ 1.31 (s, 18H, 
C(CH3)3), 1.42 (s, 18H, C(CH3)3), 3.67 (s, br, 4H, NCH2), 6.86 (d, 2H, Ph-H), 7.29-7.54 
(m, 32H, Ph-H), 8.04 (s, 2H, N=CH); 13C NMR (CDCl3): δ 29.8 (C(CH3)3), 31.4 
(C(CH3)3), 33.9 (C(CH3)3), 35.5 (C(CH3)3), 53.3 (NCH2), 118.6 (Ph), 127.3 (Ph), 128.1 
(Ph), 128.6 (Ph), 128.9 (Ph), 128.1 (Ph), 129.5 (Ph), 128.1 (Ph), 130.4 (Ph), 132.0 (Ph), 
132.3 (Ph), 132.8 (Ph), 132.9 (Ph), 137.5 (Ph), 139.9 (Ph), 162.7 (Ph), 168.7 (NCH); 27Al 
NMR (CDCl3): δ -6 (W1/2 = 7859 Hz). 31P{1H} NMR (CDCl3): δ 34 (s) IR (KBr) ν in cm-
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1: 2951s, 2901w, 2862w, 1621s, 1547w, 1439m, 1422w, 1391w, 1358w, 1258w, 1173s 
(νP═O), 1121m, 856w, 787w, 757w, 724s, 694m, 610m, 539s. MS (MALDI-TOF): 795 
(M+ - Br - Ph3PO, 100%), 517 (M+ - Br  2 Ph3PO, 36%). Anal. Calcd. for 
C68H76O4N2P2AlBr: C 70.76, H 6.64, N 2.43. found: C 70.43, H 7.01, N 2.22. 
 Synthesis of [salpen(tBu)Al(Ph3PO)2]Br (20). A rapidly stirred solution of 
salpen(tBu)AlBr (0.32 g, 0.53 mmol) in toluene was combined with triphenylphosphine 
oxide (0.29 g, 1.1 mmol). The cloudy yellow slurry became clear yellow with heating. 
The solution was refluxed for 10 hours. A yellow precipitate formed after cooling down 
to room temperature and concentrating the solution. The precipitate was isolated by 
cannula filtration and dried under vacuum. Yield: 0.42g (69 %). Mp: 246 ºC. 1H NMR 
(CDCl3): δ 1.31 (s, 36H, C(CH3)3), 2.08 (m, 2H, CH2CH2CH2), 3.56 (m, 4H, NCH2),7.05 
(d, 2H, Ph-H), 7.27-7.59 (m, 32H, Ph-H), 8.29 (s, 2H, N=CH); 13C NMR (CDCl3): δ 27.2 
(CH2), 29.9 (C(CH3)3), 31.6 (C(CH3)3), 34.2 (C(CH3)3), 35.5 (C(CH3)3), 56.6 (NCH2), 
118.8 (Ph), 128.1 (Ph), 128.4 (Ph), 129.0 (Ph), 129.2 (Ph), 130.3 (Ph), 131.3 (Ph), 132.4 
(Ph), 132.6 (Ph), 133.1 (Ph), 133.2 (Ph), 139.2 (Ph), 140.2 (Ph), 162.6 (Ph), 172.8 
(N=CH); 27Al NMR (CDCl3): δ 0 (W1/2 = 4835 Hz). 31P{1H} NMR(CDCl3): δ 35 (s) IR 
(KBr) ν in cm-1: 2950s, 2905w, 2866w, 1632s, 1620s, 1548m, 1478m 1461m, 1439s, 
1426s, 1391w, 1358m, 1316m, 1279w, 1255m, 1200w, 1162s (νP═O), 1120s, 1094w, 
999w, 841m, 786w, 753m, 726s, 693s, 537s. MS (MALDI-TOF): 809, (M+ - Br - Ph3PO, 
11%), 531 (M+ - Br - 2 Ph3PO, 100%). Anal. Calcd. for C69H78O4N2P2AlBr: C 70.94, H 
6.73, N 2.40. found: C 68.86, H 6.84, N 2.13. 
 Synthesis of [salophen(tBu)Al(Ph3PO)2]Br (21). A rapidly stirred solution of 
salophen(tBu)AlBr (0.51 g, 0.79 mmol) in toluene was combined with 
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triphenylphosphine oxide (0.44 g, 1.6 mmol). The yellow slurry was refluxed for 14 
hours and then cooled down to room temperature and concentrated. Yellow crystals 
precipitated which were isolated by cannula filtration and dried under vacuum. Yield: 
0.58 g (61 %). Mp: 304-305 ºC (dec.). 1H NMR (CDCl3): δ 1.34 (s, 18H, C(CH3)3), 1.50 
(s, 18H, C(CH3)3), 6.92 (d, 2H, Ph-H), 7.06-7.40 (m, 34H, Ph-H), 7.62 (d, 2H, Ph-H), 
8.11 (s, 2H, N=CH); 13C NMR (CDCl3): δ 30.1 (C(CH3)3), 31.6 (C(CH3)3), 34.3 
(C(CH3)3), 35.9 (C(CH3)3), 116.2 (Ph), 119.1 (Ph), 125.6 (Ph), 126.7 (Ph), 128.5 (Ph), 
128.6 (Ph), 128.8 (Ph), 128.9 (Ph), 129.3 (Ph), 129.8 (Ph), 132.2 (Ph), 132.4 (Ph), 133.0 
(Ph), 133.1 (Ph), 137.6 (Ph), 138.2 (Ph), 140.8 (Ph), 159.9 (Ph), 164.9 (N=CH); 27Al 
NMR (CDCl3): δ 42 (W1/2 = 5078 Hz); 31P{1H} NMR(CDCl3): δ 33 (s). IR (KBr) ν in cm-
1: 2954s, 2901w, 2862w, 1614s, 1586s, 1547m, 1536s, 1469m, 1440m, 1413 w, 1391m, 
1357w, 1266w, 1199m, 1172s (νP═O), 1121s, 847w, 787w, 757w, 756w, 726s, 693m, 
602w, 538s. MS (MALDI-TOF): 843 (M+ - Br - Ph3PO, 100%). Anal. Calcd. for 
C72H76O4N2P2AlBr: C 71.93, H 6.37, N 2.33. found: C 69.03, H 7.80, N 3.64. 
 Synthesis of [salophen(tBu)Al{(PhO)3PO)}2]Br (22). To a rapidly stirred solution of 
salophen(tBu)AlBr (0.68 g, 1.1 mmol) in toluene, triphenylphosphate (0.69 g, 2.1 mmol) 
was added. The clear golden yellow solution was stirred at room temperature for 17 
hours. Concentration followed by slow evaporation at room temperature gave yellow 
crystals which were cannula filtered, washed with hexane and dried under vacuum. Yield: 
1.1 g (79 %). Mp: 120-122 ºC (dec.). 1H NMR (CDCl3): δ 140 (s, 18H, C(CH3)3), 6.81-
7.60 (m, 38H, Ph-H), 7.62 (d, 2H, Ph-H), 8.43 (s, 2H, N=CH); 13C NMR (CDCl3): δ 30.0 
(C(CH3)3), 31.6 (C(CH3)3), 34.4 (C(CH3)3), 35.9 (C(CH3)3), 116.0 (Ph), 118.6 (Ph), 119.7 
(Ph), 119.8 (Ph), 125.5 (Ph), 126.2 (Ph), 128.4 (Ph), 128.6 (Ph), 129.2 (Ph), 130.1 (Ph), 
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132.8 (Ph), 137.5 (Ph), 139.0 (Ph), 141.3 (Ph), 149.9 (Ph), 150.0 (Ph), 161.5 (Ph), 164.3 
(N=CH); 27Al NMR (CDCl3): δ 12 (W1/2 = 15053 Hz). 31P{1H} NMR(CDCl3): δ -21 (s) 
IR (KBR) ν in cm-1: 2953m, 2901w, 2866w, 1614s, 1587s, 1547m, 1536m, 1487s, 
1392w, 1359w, 1278s (νP═O), 1266m, 1220w, 1184vs, 1163s, 1029s ((νP─O), 1078m, 
983s, 848w, 783w, 753m, 726s, 686w, 610w, 523w. MS (MALDI-TOF): 843 (M+ - Br - 
2 (PhO)3PO, 100%). Anal. Calcd. for C72H76O10N2P2AlBr: C 66.61, H 5.90, N 2.16. 
found: C 66.90, H 6.17, N 2.02. 
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Table 4.1. Crystallographic data and refinement details for compounds 15-18 
  15 16 17 18 
Empirical 
formula 
C32.25H46AlBrCl.50
N2O2 
C33.50H49AlBrCl
N2O2 
C34H50AlBrN2
O2 
C36H46AlBr
N2O2 
M/ g mol-1  618.33 654.09 625.65 645.64  
Color  Yellow Yellow Pale yellow Yellow 
Crystal 
size/mm 
0.32 x 0.25 x 0.03 0.30 x 0.30 x 
0.10 
0.20 x 0.15 x 
0.15 
0.30 x 0.30 
x 0.01 
Crystal 
system 
Orthorhombic Triclinic Orthorhombic Triclinic 
Space 
group 
Pbca P 1  Pbca P 1  
a/ Å 18.9792(4 14.4180(2) 9.8704(3) 10.7690(3) 
b/ Å 9.7445(2) 14.8094(2) 25.0262(7) 12.4573(5) 
c/ Å 35.3217(7)  17.2404(3) 26.8713(9) 13.6139(5)  
α/ û 90.00 76.0377(6) 90.00 92.427(2) 
β/ û 90.00 69.8258(6) 90.00 95.630(2) 
γ/ û 90.00 85.9439(6) 90.00 110.941(2)  
V/ Å3 6532.5(2) 3352.95(9) 6637.7(4) 1691.58(10) 
ρcalc /g cm-3 1.257  1.296 1.252 1.268 
Z 8 4 8 2 
F(000) 2608 1380 2656 680 
Radiation 
used 
Cu-Kα Mo-Kα Mo-Kα Cu-Kα 
µ /mm -1 2.575 1.363 1.296 2.157  
T/ K 90.0(2) 90.0(2) K 90.0(2) 90.0(2)  
hkl range -22 ≤h ≤6, -9 ≤ k 
11, -41 ≤ l ≤ 41 
-16 ≤ h ≤ 17, -17 
≤ k ≤ 17, -20 ≤ l 
≤ 20 
-11 ≤ h ≤ 11, -
29 ≤ k ≤ 29, -
31 ≤ l ≤ 31 
-11 ≤h ≤12, 
-13 ≤ k ≤ 4, 
-15 ≤l ≤15 
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Θ range/ û 2.50 -68.01 1.29-25.00 1.52 -25.00 3.27 -59.99 
Reflections 
measured  
31154  76859 10083 16067 
Unique 
reflections 
(Rint) 
5672 (0.0617) 11822 (0.0000) 5695 (0.0531) 4987 
(0.0730)  
Obsd 
reflections, 
n [I ≥ 2σ 
(I)] 
4849 7985 3718 4157 
Refinemen
t method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix 
least-squares 
on F2 
Full-matrix 
least-
squares on 
F2 
Refined 
parameters
/restraints 
368/0 755/0 373/0 391/0 
R1 [I > 2σ] 0.0631, wR2 = 
0.1671 
0.0706, wR2 = 
0.1880 
0.0481, wR2 = 
0.0940 
0.052, wR2 
= 0.1470 
R1 (all 
data) 
0.0724, wR2 = 
0.1725 
0.1153, wR2 = 
0.2193 
0.0972, wR2 = 
0.1094 
0.0700, 
wR2 = 
0.1553 
Goodness-
of-fit on F2 
1.134  1.020 1.026 1.037  
Largest 
diff. peak 
and hole/ 
e. Å -3 
1.444 and -0.622 1.350 and -0.758 0.471 and -
.512 
1.934 and -
0.609  
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Table 4.2. Selected bond distances (Å) and angles (º) for compounds 15-18  
Salen(tBu)AlBr (15)     
Al1-N1 2.002(4)  Al1-O2 1.777(3) 
Al1-N2 2.001(4)  Al1-Br1 2.3580(14 
Al-O1 1.794(3)    
     
O1-Al1-O2 92.18(15)  O1-Al1-Br1 102.80(12) 
O1-Al1-N1 88.38(15)  O2-Al1-Br1 109.17(12) 
O1-Al1-N2 158.47(17)  O2-Al1-N1 146.44(16) 
O2-Al1-N2 88.84(15)  N1-Al1-Br1 103.37(12) 
N1-Al1-N2 79.10(15)  N2-Al1-Br1 97.14(12) 
     
Salpen(tBu)AlBr (16)     
Al1A-N1A 1.958(5)  Al1A-O2A 1.755(4) 
Al1A-N2A 2.023(5)  Al1A-Br1A 2.3640(19) 
AlA-O1A 1.814(4)    
     
O1A-Al1A-O2A 90.4(2)  O1A-Al1A-Br1A 94.13(15) 
O1A-Al1A-N1A 89.6(2)  O2A-Al1A-Br1A 120.05(17) 
O1A-Al1A-N2A 173.5(2)  O2A-Al1A-N1A 127.3(2) 
O2A-Al1A-N2A 90.0(2)  N1A-Al1A-Br1A 112.51(16) 
N1A-Al1A-N2A 85.0(2)  N2A-Al1A-Br1A 91.26(15) 
     
Salben(tBu)AlBr (17)     
Al1-N1 1.963(3)  Al1-O2 1.754(2) 
Al1-N2 2.001(3)  Al1-Br1 2.3804(11) 
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Al1-O1 1.808(2)    
     
O1-Al1-O2 91.70(11)  O1-Al1-Br1 92.90(8) 
O1-Al1-N1 89.25(11)  O2-Al1-Br1 116.97(9) 
O1-Al1-N2 176.32(12)  O2-Al1-N1 119.87(12) 
O2-Al1-N2 91.16(11)  N1-Al1-Br1 123.01(9) 
N1-Al1-N2 87.32(12)  N2-Al1-Br1 87.86(9) 
     
Salophen(tBu)AlBr (18)     
Al1-N1 1.998(4)  Al1-O2 1.783(3) 
Al1-N2 1.992(4)  Al1-Br1 2.3508(12) 
Al-O1 1.776(3)    
     
O1-Al1-O2 90.51(14)  O1-Al1-Br1 109.79(11) 
O1-Al1-N1 88.53(15)  O2-Al1-Br1 101.01(11) 
O1-Al1-N2 142.22(15)  O2-Al1-N1 161.65(15) 
O2-Al1-N2 90.26(15)  N1-Al1-Br1 96.55(11) 
N1-Al1-N2 79.44(15)  N2-Al1-Br1 107.11(11) 
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Table 4.3. Tau (τ) values of some Salen aluminum halide compounds. 
 
 
 
 
 
Compound τ value Reference 
Salpen(tBu)AlCl 0.77 199 
Salomphen(tBu)AlCl 0.18 199 
Salen(tBu)AlBr (15) 0.20 This work 
Salpen(tBu)AlBr (16) 0.77 This work 
Salben(tBu)AlBr (17) 0.89 This work 
Salophen(tBu)AlBr (18) 0.32 This work 
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Table 4.4. Crystallographic data and refinement details for compounds 20-22 
 20 21 22 
Empirical 
formula 
C76H86AlBrN2O4P2 C76.99H81.70AlBrN2O4P2 C75.50H79AlBrN2O10P2 
M/ g mol-1 1260.30 1267.84 1343.24 
Color pale yellow Yellow Yellow-brown 
Crystal 
size/ mm 
0.50 x 0.20 x 0.15 0.35 x 0.21 x 0.02  0.30 x 0.08 x 0.08 
Crystal 
system 
Orthorhombic Orthorhombic Monoclinic 
Space 
group 
Pbca Pbca P21/n 
a/ Å 22.3928(2) 22.6120(3) 19.3380(4) 
b/ Å 22.5503(2) 22.8580(3) 15.3855(3) 
c/ Å 25.8204(3)  26.7850(4) 23.7586(6)  
α/ û 90.00 90 90 
β/ û 90.00 90 103.8434(9) 
γ/ û 90.00 90 90 
V/ Å3 13038.4(2) 13844.2(3) 6863.4(3)  
ρcalc/g cm-3 1.284  1.217 1.300 
Z 8 8 4 
F(000) 5328 5341 2816 
µ (Mo-Kα) 
/mm -1 
0.745 0.702 0.719  
T/ K 90.0(2) 90.0(2) K 90.0(2)  
hkl range -28 ≤ h ≤ 28, -29 ≤ k 
≤ 29, -33 ≤ l ≤ 33 
-24 ≤ h ≤ 24, -24 ≤ k ≤ 
24, -28 ≤ l ≤ 28 
-20 ≤ h ≤ 20, -16 ≤ k 
≤ 16, -25 ≤ l ≤ 25 
Θ range/ û 1.50 - 27.49 1.48 to 22.50 1.55 - 22.50 
Reflections 28736 34655 17173 
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measured 
Unique 
reflections 
(Rint) 
14950 (0.0725) 9057 (0.1170) 8987 (0.1057) 
Obsd 
reflections, 
n [I≥ 2σ 
(I)] 
8931 5480  4508 
Refinemen
t method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Refined 
parameters
/restraints 
795/75 897/ 513 840/ 691 
R1 [I > 2σ] 0.0491, wR2 = 0.1011 0.0809, wR2 = 0.2129 0.0823, wR2 = 0.2024 
R1 (all 
data) 
0.1085, wR2 = 0.1172 0.1407, wR2 = 0.2431 0.1760, wR2 = 0.2464 
Goodness-
of-fit on F2 
1.036 1.072 1.061 
Largest 
diff. peak 
and hole/ 
e. Å -3 
.619 and 0.465 1.061 and 0.587 1.213 and 0.522  
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Table 4.5. Selected bond distances (Å) and angles (°) for compounds 20-22 
salpen(tBu)Al(Ph3PO)2Br (20) 
Al1-N1 2.092(2) Al1-N(2) 2.045(2) Al1-O1 1.8195(16) 
Al1-O2 1.8437(17) Al1-O(3) 1.9241(17) Al1-O4 1.9516(17) 
      
O1-Al1-O2 89.38(7)   O1-Al1-O4 94.36(7) 
O2-Al1-O4 94.14(7)   O1-Al1-O3 93.45(7) 
O2-Al1-O3 93.48(7)   O4-Al1-O3 169.14(8) 
O1-Al1-N2 179.60(9)   O2-Al1-N2 90.55(8) 
O4-Al1-N2 85.25(7)   O3-Al1-N2 86.95(8) 
O1-Al1-N1 89.23(8)   O2-Al1-N1 178.58(8) 
O4-Al1-N1 86.23(7)   O3-Al1-N1 86.35(7) 
N2-Al1-N1 90.85(8)   Al1-O3-P1 170.37(11) 
    Al1-O4-P2 153.04(10) 
salophen(tBu)Al(Ph3PO)2Br (21) 
Al-N1 1.989(6) Al-N(2) 1.986 (6) Al-O1 1.794 (5) 
Al-O2 1.804 (5) Al-O(3) 1.958 (5) Al-O4 1.950 (5) 
      
O1-Al-O2 93.8 (2)   O1-Al-O4 94.1 (2) 
O2-Al-O4 92.6 (2)   O1-Al-O3 93.2 (2) 
O2-Al-O3 94.2 (2)   O4-Al-O3 169.7 (2) 
O1-Al-N2 173.8 (2)   O2-Al-N2 92.3 (2) 
O4-Al-N2 84.9 (2)   O3-Al-N2 87.1 (2) 
O1-Al-N1 92.7 (2)   O2-Al-N1 173.4 (2) 
O4-Al-N1 87.4 (2)   O3-Al-N1 85.0 (2) 
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N2-Al-N1 81.2 (2)   Al1-O3-P1 164.0(3) 
    Al1-O4-P2 161.0(3) 
Salophen(tBu)Al[(PhO)3PO]2Br (22) 
Al1-N1 1.973(6) Al1-N(2) 1.984(7) Al1-O1 1.811(6) 
Al1-O2 1.798(6) Al1-O(3) 1.935(6) Al-O4 1.967(6) 
      
O1-Al1-O2 96.1(3)   O1-Al1-O4 91.0(2) 
O2-Al1-O4 91.1(3)   O1-Al1-O3 92.6(2) 
O2-Al1-O3 92.6(3)   O4-Al1-O3 174.6(3) 
O1-Al1-N2 172.3(3)   O2-Al1-N2 91.5(3) 
O4-Al1-N2 89.4(2)   O3-Al1-N2 86.5(2) 
O1-Al1-N1 91.6(3)   O2-Al1-N1 172.1(3) 
O4-Al1-N1 87.1(2)   O3-Al1-N1 88.7(2) 
N2-Al1-N1 80.7(3)   Al1-O3-P1 157.2(4) 
    Al1-O4-P2 165.5(4) 
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Figure 4.1. Phospho transfer reaction with SalenAlCl. 
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Figure 4.2. Formation of cationic aluminum compounds with Salen ligands. 
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Figure 4.3. Synthesis of Salen(tBu)H2 ligands. 
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Figure 4.4. Formation of Salen(tBu)AlBr compounds. 
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Figure 4.5. Crystal structure of salen(tBu)AlBr (15). 
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Figure 4.6. Crystal structure of salpen(tBu)AlBr (16). There are two molecules in the 
asymmetric unit; only one is shown. 
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Figure 4.7. Crystal structure of salben(tBu)AlBr (17). 
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Figure 4.8. Crystal structure of salophen(tBu)AlBr (18). 
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Figure 4.9. Tau (τ) diagram. τ = (β  α)/60. α (c ─ e) and and β (b ─ d) are the angles 
opposite to each other in the xy plane where a is along the z-axis. By convention β is the 
most obtuse angle. 
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Figure 4.10. Formation of six-coordinate aluminum cations from Salen(tBu)AlBr 
compounds. 
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Figure 4.11. Reaction of triphenylphosphine oxide with Me2AlX. 
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Figure 4.12. Crystal structure of [salpen(tBu)Al(Ph3PO)2]Br (20). 
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Figure 4.13. Crystal structure of [salophen(tBu)Al(Ph3PO)2]Br (21). 
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Figure 4.14. Crystal structure of [salophen(tBu)Al{(PhO)3PO}2]Br (22). 
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CHAPTER 5 
Dealkylation of Organophosphates with Salen Aluminum Bromides 
5.1. Background 
Although extensive research is being carried out on phosphate ester cleavage using 
various metal compounds in models of biological phosphate hydrolysis (see Chapter 1), 
66, 95, 96 the use of group 13 compounds in this field is limited. For example, some 
phosphate cleavage has been achieved with organoaluminum reagents,156 and aluminum 
or gallium amides.157-159 However, these reagents have not been considered as potential 
nerve agent or pesticide decontamination reagents, probably due to their limited scope or 
the high temperatures and the long reaction times required. Recently the use of boron-
Schiff base halides has shown promise for the catalytic cleavage of various 
organophosphates at room temperature, opening the possibility of finding a soft, 
chemical, catalytic means of destroying or decontamintating nerve gas agents and 
pesticides.33-35 In chapter 3 the application of mononuclear boron compounds in the 
dealkylation of trimethyl phosphate was described and some of them showed very good 
percent conversion. The Salen aluminum bromide compounds synthesized in chapter 4 
could also be promising candidates for phosphate dealkylation since the bromide group in 
these compounds was demonstrated to be easily displaced by the weak Lewis bases 
triphenylphosphine oxide and triphenyl phosphate. In this chapter the application of Salen 
aluminum bromide compounds 15, 16 and 18 for the dealkylation of various 
organophosphates will be examined.203 Also, attempts will be made to isolate and 
characterize some of the dealkylated compounds.214 
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5.2. Dealkylation of organophosphates with compounds 15, 16 and 18 
 The compounds salen(tBu)AlBr (15), salpen(tBu)AlBr (16) and salophen(tBu)AlBr 
(18) dealkylated a series of organophosphate compounds at room temperature to produce 
alkyl bromide and an unidentified aluminum phosphate compound that remained in 
solution (Figure 5.1). The dealkylation reaction was carried out in an NMR tube in CDCl3 
by using stoichiometric amounts of the Salen aluminum bromide compounds and the 
phosphate. The percent conversion was calculated from the integration of the remaining 
phosphate and the alkyl bromide produced (Table 5.1). The percent dealkylation was 
comparable to the binuclear boron Salen bromide compounds Salen(tBu)[BBr2]2 reported 
before.33-35 For trimethylphosphate, compound 15, having an ethylene backbone, showed 
greater dealkylation activity compared to 16 which has a propylene backbone, and 18 
which has an aromatic backbone. For example, with 1 the dealkylation was 89% 
complete in just 4 hours and 96% complete after 12 hours. However, the difference in 
Salen ligand backbone does not seem to affect the dealkylation of longer chain 
phosphates. Another interesting observation is that the percent dealkylation was greater 
for longer chain phosphates compared to those with shorter chains. For example, with 16, 
dealkylation was complete in 2 hours for triethylphosphate and in 30 minutes for tributyl 
phosphate, as opposed to only 30 % conversion for trimethylphosphate after 2 hours. This 
is probably due to increased nucleophilicity of the phosphate from the increased number 
of electron releasing carbon atoms in the alkoxy group.  
 Previously, it was shown that Salen(tBu)AlCl compounds readily formed cations 
through the replacement of chloride by a donor ligand like THF, MeOH or H2O.17-22 
Cation formation should be more favorable for the Salen bromide compounds because 
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bromide is a better leaving group. As noted previously in Chapter 4, cations are readily 
formed when SalenAlBr compounds are combined with triphenylphosphine oxide and 
triphenylphosphate. Cation formation was also observed for Salen boron bromide 
compounds with THF.35 Thus, it is likely that compounds 15, 16 and 18 form cations 
through coordination of the Lewis basic phosphate to the aluminum with displacement of 
the bromide anion. This activates the α-carbon of the phosphate for nucleophilic attack of 
the bromide (Figure 5.1). A similar activation of an ester carbon due to coordination of 
the phosphoryl oxygen to a cationic center was reported before in the combination of 
phosphinic esters with metal halides.215 The cation formation is followed by attack of the 
bromide on the α carbon and elimination of alkyl bromide. Ultimately, all three ester 
bonds are cleaved to produce an unidentified phosphate material [(SalenAlO)3PO]. 
This mechanism is supported by the following observations: 
(i) There is little dealkylation in CD3OD (Table 5.1). Methanol is a stronger Lewis base 
than trimethylphosphate and although a cation is formed18 the phosphate cannot replace 
the CD3OD to become activated.  
(ii) The dealkylation with Salen(tBu)AlCl (55% after 24 hours, Table 5.1) is much less 
compared to the bromide analogue. The Al―Cl bond is stronger than the Al―Br bond 
which impedes the replacement of chloride with the phosphate and hence the required 
cation formation. 
(iii) The triphenylphosphate coordinated cationic compound 22 was structurally 
characterized (Chapter 4). Salen aluminum halide compounds do not dealkylate 
triphenylphosphate. No dealkylation was also found with Salen boron bromide 
compounds.35 The reaction stops at the formation of the phosphate-coordinated cation.  
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(iv) The postulate that the bromide attacks the ester carbon instead of the phosphorus is 
in agreement with the previous findings that for cleavage of phosphate esters in solution 
nucleophiles with a high charge density, such as hydroxides and alkoxides, preferentially 
attack the phosphorus whereas more polarizable nucleophiles like bromides or iodides 
attack the carbon (Figure 5.2).215, 216 
 Salen(tBu)AlBr compounds, when added in catalytic amount, were found to accelerate 
the reaction between trimethylphosphate and stoichiometric amount of BBr3 (Table 5.2). 
With BBr3 only, the dealkylation of trimethyl phosphate is low. However, compounds 15 
16 and 18 in only 10 mol% with BBr3 increased the extent of dealkylation. For example, 
with 15 the reaction was 100% complete within only two hours. Although detailed 
mechanistic studies were not carried out, it is likely that BBr3 regenerates the catalytic 
species from the dealkylated phosphate material allowing the repetition of the catalytic 
cycle. However, the dealkylation was higher for the (Salen(tBu)AlBr + TMP + BBr3) 
system compared to either (Salen(tBu)AlBr+ TMP) system or (BBr3 + TMP) system. 
Thus it is likely that it is not the Salen(tBu)AlBr compound itself but a species which is 
formed from the reaction of Salen(tBu)AlBr and BBr3 that speeds up the reaction. 
 In an attempt to get a preliminary idea of the catalytic species, a series of NMR tube 
experiments involving multinuclear NMR were conducted. Based on this preliminary 
evidence a catalytic cycle shown in Figure 5.3 is proposed. In the NMR tube reaction 
system of BBr3 and salen(tBu)AlBr (15) (1:1) a narrow 27Al peak was observed at δ 79 
ppm (w1/2 = 507 Hz) which is a significant upfield shift from the broad five-coordinate 
aluminum peak observed at δ 38 ppm (w1/2 = 5183 Hz) for compound 15 and in the range 
of four-coordinate aluminum.217 This suggests a severe weakening of the B-Br bond in 15 
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by interaction with BBr3. BBr3 is known to form BBr4- (11B NMR: δ -21.60 ppm) by 
abstracting Br from L[BBr2]2 (L = salpen(tBu)) to form the cationic species 
L[BBr2(BBr)+].35 The 11B shift in the system (15 + BBr3) was observed at δ -0.79 ppm 
(w1/2 = 1038 Hz) which is significantly upfield from the shift observed for boron 
tribromide (δ 38 ppm), but this shift was not close to the shift of BBr4-. Hence, it is likely 
that instead of the formation of an ion pair, [SalenAl]+[BBr4]-, the bromide bridges 
both the aluminum and the boron centers and a complex (type A shown in figure 5.3) is 
formed. This would give the 11B shift observed. This gives a partially positive charge to 
the aluminum and a partially negative charge to the boron. The formation of this complex 
increases the electrophilicity of the aluminum, which is now a stronger Lewis acid than 
either neutral salen(tBu)AlBr (15) or BBr3. Attack of the phosphate on A causes cleavage 
of the Al·····Br bond to form the cationic complex B. This is followed by abstraction of 
the methyl group by the bromide to give the aluminophosphate C which on combination 
with BBr3 forms a boron phosphate material D with the regeneration of the active species 
A. The dealkylation results with salen(tBu)AlBr for trimethyl phosphate shown in Table 
5.2 indicate that the dealkylation reaction is 88 % in 30 minutes but it goes to 100 % 
conversion within 2 h. On the other hand Table 5.1 indicates that the dealkylation with 
only salen(tBu)AlBr (15) is only 79 % after 2 hours. Thus it can be assumed that in the 
presence of both 15 and BBr3, the reaction speeds up and goes to completion at some 
point between 30 minutes and 2 hours. This makes one think that there is probably an 
induction period during which the reaction is slow and during which the formation of the 
active species A is complete. To verify this, BBr3 was added to 15 in 1:1 ratio and 
allowed to stand for 1 h to allow the formation of A. To this mixture TMP was added and 
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the 1H NMR taken after 15 minutes showed complete conversion. Thus the formation of 
complex A appears to be responsible for accelerating and taking the dealkylation reaction 
to completion which is otherwise slower either with 15 or BBr3. To check if species A is 
being regenerated in the reaction system, BBr3 was added to a solution containing 
compound 15 and TMP (3:1) and a peak at 75 ppm (w1/2 = 238 Hz) appeared in the 27Al 
NMR spectra. Appearance of this peak indicates the formation of A from the 
aluminophosphate compound C by BBr3. A similar peak was observed on addition of 
BBr3 to the fully characterized aluminum phosphinate compound salen(tBu)AlOP(O)Ph2 
(23) (the synthesis and characterization of 23 is described in the next section). The 
regeneration of this cationic species is presumably accompanied by the formation of an 
insoluble boron phosphate material D which showed a 11B peak at δ -13.58 ppm (w1/2 = 
124 Hz), which matched closely to a 11B peak (-13.51 ppm, w1/2 = 3 Hz) found in the 
system (BBr3 + (MeO)3P(O)) (1:1). The 31P NMR shift (-5.11) present in the salen 
aluminum-TMP-boron bromide system was different from the 31P shift observed in salen 
aluminum-TMP system (-14.09 ppm) suggesting that a boron phosphate material and not 
an aluminum phosphate material is the final dealkylated product. Isolation of the catalytic 
species and either the boron or aluminum phosphate compound will be required to 
confirm this cycle. Also, low-temperature studies could tell if the three esters groups are 
getting dealkylated in a stepwise manner or at the same time. Based on current 
experiments it was not possible to tell the efficiency of the Salen aluminum bromide 
compounds as the catalyst. Detailed studies on catalyst loading and determination of 
turnover frequency will be required for this purpose. 
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5.3. Formation of aluminum phosphates and phosphinates by dealkylation 
Although attempts to isolate the fully dealkylated product [(SalenAlO)3PO] by 
running the dealkylation reaction on a larger scale (mmol) than the NMR tube 
experiments (0.05 mmol) were not successful, a unique aluminophosphinate and an 
aluminophosphate compound were isolated and fully characterized. Group 13 phosphates 
and phosphonates are of potential utility in areas such as catalysis, molecular sieves, ion-
exchange resins and adsorption media. 218-220 Aluminophosphate molecular sieves 221 
have traditionally been prepared by hydrothermal synthetic methods at temperatures 
between 100 and 200 ºC where a source of aluminum, e.g., Al(OiPr)3, is combined with 
aqueous H3PO4.222, 223 The non-aqueous syntheses of aluminum phosphate molecules and 
materials have recently been discovered.73, 157, 158, 224 Previously, the preparation of 
molecular aluminophosphates by a dealkylation reaction between aluminum amides and 
phosphoric acid triesters and also by a dealkylsilylation reaction between aluminum 
chloride and OP(OSiMe3)3 were reported.157 Also, aluminum trialkyls undergo adduct 
formation and subsequent dealkylsilylation to produce molecular aluminophosphates.158 
Most of the aluminophosphate molecules and materials contain four-coordinate 
aluminum.79 There are relatively few higher-coordinate aluminum compounds bound to 
either a phosphate, phosphonate, or phosphinate. One such example is 
[(AlOiPr)2O2P(OtBu)2]4 where the aluminum atom is five-coordinate (Figure 5.4).225  
Group 13 molecular phosphates and phosphinates are predominantly dimeric and 
almost all of them have four-coordinate aluminum. Previously, it was reported that six-
coordinate aluminum phosphinates may be readily obtained using the tetradentate Salen 
class of ligand (Figure 5.5).187, 226 In these chelated phosphinates, 
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[Salen(tBu)AlO2P(H)Ph]n, the degree of aggregation was manipulated by changing the 
length of the ligand backbone. Some of the compounds revealed unique coupling of the 
Salen ligand with THF. 
The work described in this section shows for the first time the use of Salen aluminum 
compounds for the dealkylation of phosphinates and phosphates at room temperature in 
an organic solvent to prepare soluble monomeric aluminum phosphates and phosphinates 
with five- and six-coordinate aluminum.  
5.3.1. Five-coordinate monomeric Salen aluminum phosphinate 
 Salen(tBu)AlOP(O)Ph2 (23) was prepared by dealkylation of 
methyldiphenylphosphinate by salen(tBu)AlBr at room temperature (Figure 5.6). 
Compound 23 was soluble in organic solvents (toluene and chloroform). It was fully 
characterized using 1H, 13C, 27Al and 31P NMR, IR and MS (EI, positive). The 1H NMR 
spectrum of 23 was very close to the corresponding chloride analogues reported in the 
literature 205 and also the bromide starting materials.203 There are two singlets for the tBu-
Ph groups at δ 1.29 and δ 1.58 ppm. Two methylene peaks corresponding to the ethylene 
backbone protons from the ligand appear at δ 3.64 and δ 4.40 ppm. There is only one 
imine singlet at δ 8.17 ppm. The 27Al NMR showed a broad peak centered at δ 30 ppm 
for five-coordinate aluminum which is similar to the shift observed in many other five-
coordinate aluminum Salen compounds, e.g., salen(tBu)AlOSiMe3 (δ 30.5 ppm) and 
salen(tBu)AlN3 (δ 31.9 ppm).199 However, this is upfield from the related chloride 
analogue (δ 57 ppm).205 The 31P{H} NMR of 23 contained a single peak at δ 35 ppm. 
Interestingly, this is considerably downfield compared to dimeric or polymeric Salen 
aluminum phosphinates (δ 7.08-9.16 ppm). 226 
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 Compound 23 was recrystallized by slow evaporation of a methanol solution at room 
temperature under atmospheric conditions to produce 23MeOH. The compound was 
stable in the atmosphere and no nucleophilic displacement of the phosphinate group by 
methanol or atmospheric moisture was observed. The compound crystallizes in the 
orthorhombic space group P212121. The molecular structure is shown in Figure 5.7. There 
are two molecules in the asymmetric unit; only one is shown in the figure. The crystal 
data collection parameters are shown in Table 5.3 and the important bond lengths and 
angles are shown in Table 5.4. Previously, the only structurally characterized examples of 
Salen aluminum phosphinate compounds, [Salen(tBu)Al{O2P(H)Ph}]n, were polymeric 
(n = ∞) for salen, salophen and salomphen and dimeric (n = 2) for salpen and salben. 187, 
188 In these compounds two phosphinate groups bridge between the Salen(tBu)Al units. 
They were synthesized by alkane elimination between Salen(tBu)AlMe and 
phenylphosphinic acid Ph(H)P(O)OH. Compound 23MeOH is the first example of a 
structurally characterized monomeric aluminum phosphinate compound bound by a Salen 
ligand. The aluminum atom has a six-coordinate distorted octahedral environment with 
MeOH and the phosphinate group at the axial positions. The O3-Al-O4 angle is nearly 
linear (~175º). The Al-O-P linkage is bent with a bond angle of 151º which is 
considerably narrower than the Al-O-P angle (~ 159º) in [salen(tBu)Al{O2P(H)Ph}] ∞. 188 
The Al-O (ligand) bond distances (~1.80-1.81 Å) are marginally shorter than the Al-O(P) 
bond distance (~1.87 Å).  
5.3.2. Salpen aluminum phosphate ring compound (24) 
The compound [salpen(tBu)AlO]2[(BuO)2PO]2 (24) resulted from the dealkylation 
reaction of salpen(tBu)AlBr with tributylphosphate in toluene at room temperature 
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(Figure 5.8). Only one of the three butoxy groups on each phosphate molecule underwent 
dealkylation. The compound is soluble in toluene and chloroform. It was characterized by 
IR, 1H NMR, 27Al NMR, 31P NMR, Mp and MS. The 1H NMR has peaks corresponding 
to the ligand and the alkoxy groups of the mono-dealkylated phosphate. The 27Al NMR 
shows two peaks. The peak at δ -5 ppm corresponds to six-coordinate aluminum. 
However the peak at δ 40 ppm falls in the region of five-coordinate aluminum. This does 
not correspond to the solid-state structure of the compound which shows the presence of 
six-coordinate aluminum only. It could be possible that in solution one phosphate linkage 
from one of the aluminum atoms dissociates, thus making it five-coordinate. The 31P 
NMR has a single peak at δ -18 ppm. The TGA curve (Figure 5.9) of 24 shows a weight 
loss of about 5 % around 100-120 ûC which is probably due to the entrapped solvent. 
There is a second weight loss of about further 85 % in the temperature range 300-600 ûC 
that is probably due to the thermal oxidation of the organic species leaving behind some 
inorganic aluminophosphate material. The remaining weight percentage (~ !0 %) is lower 
than the calculated percentage of AlPO4 (16 %). 
 Compound 24 crystallizes in the monoclinic space group P21/c. The molecular 
structure of 24 (Figure 5.10) contains an aluminum-phosphate ring formed by two salen 
aluminum units and two mono-dealkylated phosphate units. The crystal data collection 
parameters are shown in Table 5.3 and important bond lengths and angles are contained 
in Table 5.4. Two aluminum and two phosphorus atoms are part of an eight-membered 
Al-O-P ring. The ring P-O bond distances P1-O3 and P1-O4 (1.4827(18) and 1.4778(18) 
Å respectively) are essentially equal and have double bond character (Table 5.4). The 
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other P-O distances P1-O5 and P1-O6 are longer (1.5750(19) and 1.5836(18) Å 
respectively) and in the range of P-O single bonds. 
 Each phosphorus atom is in a distorted tetrahedral geometry. The biggest distortion is 
found in the O-P-O bond angle (118.52(11) º) inside the aluminophosphate ring. Each 
aluminum atom is six-coordinate with a distorted octahedral geometry. The phosphate 
oxygen atoms occupy two of the equatorial positions. The other two equatorial positions 
are occupied by one nitrogen atom and one oxygen atom from the ligand. Another pair of 
nitrogen and one oxygen from the ligand occupy the axial positions. The axial Al-O 
distance (1.8274(19) Å) is slightly shorter than the equatorial Al-O distances (1.8597(19), 
1.8816(19) and 1.8611(19) Å. However, the axial Al-N2 distance (2.001(2) Å) is almost 
equal to the equatorial Al-N1 distance (2.026(2) Å). The longer Al-N distances compared 
to Al-O distances are a reflection of larger atomic radius and lower electronegativity of 
nitrogen. The Al-O-P angles are not equal. Al1-O4-P1 (165.22(12) û) is larger than Al1-
O3-P1 (150.46(12) û. 
 The crystal packing diagram of 24 (Figure 5.11) shows that the aluminophosphate 
rings stack on top of each other with alkoxy chains on phosphorus and ligand groups on 
aluminum extending away from the ring. The distance between two aluminum atoms is 
5.108 Å (Figure 5.12) which is comparable to the pore diameter (6.6 Å) of a synthetic 
layered aluminphosphate templated by 2-methylpiperazine.227 This distance is also 
comparable to the pore size of the aluminophosphate material AlPO-5.218  
5.4. Conclusion  
The Salen(tBu)AlBr compounds 15, 16 and 18 dealkylate a series of trialkyl phosphates 
in high percent conversion. They also appeared to promote the reaction between 
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trimethylphosphate and boron tribromide. The phosphates used in this study could be 
envisioned as model compounds for organophosphate chemical warfare agents and 
pesticides. Thus these compounds could be developed into potential nerve gas and 
pesticide decontamination agents. A mechanism has been proposed for the dealkylation 
reaction based on literature precedents for similar reactions and initial experimental 
findings. Although the attempts to isolate and characterize the fully dealkylated 
phosphate triester of the type (LAlO)3PO did not succeed these efforts produced two new 
aluminum phosphinate and phosphate compounds. The dealkylation reaction between 
salen(tBu) aluminum bromide and methyldiphenylphosphinate gave the first structurally 
characterized monomeric Salen aluminum phosphinate. Furthermore the dealkylation 
reaction of salpen(tBu)AlBr with tri-butyl phosphate produced an aluminophosphate ring 
compound. This compound is the first example of an aluminum phosphate with Salen 
ligands. It contains six-coordinate aluminum which is rare for molecular 
aluminophosphate compounds. The reaction conditions for all these compounds are very 
mild. This method could be developed to prepare aluminophosphate ring, cage and chain 
structures for soluble models of aluminophosphate materials. This is the first example of 
the intentional use of an aluminum chelate-based dealkylation reaction in forming 
compounds containing an Al-O-P linkage. 
5.5. Experimental 
General remarks. All air-sensitive manipulations were conducted using standard bench-
top Schlenk line technique in conjunction with an inert atmosphere glove box. All 
solvents were rigorously dried prior to use. All glassware was rigorously cleaned and 
dried in an oven at 130ºC overnight prior to use. All other chemicals were purchased 
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from Sigma-Aldrich. NMR data were obtained on Varian Gemini-200 and Varian VXR-
400 instruments. Chemical shifts were reported relative to SiMe4 for 1H and 13C, 85% 
H3PO4 for 31P and AlCl3 in D2O for 27Al, and were reported in ppm. Infrared transmission 
spectra were recorded at room temperature in a potassium bromide pellet on a Fourier-
transform Magna-IR ESP 560 spectrometer. Thermogravimetric analyses were performed 
on a TA Instruments Hi-Res TGA 2950 Analyzer. Elemental analyses were performed on 
a LECO CHN-2000 Analyzer. 
 X-ray data were collected on either a Bruker-Nonius X8 Proteum diffractometer (23; 
CuKα radiation) or a Nonius Kappa-CCD (24; MoKα radiation). All calculations were 
performed using the software package SHELXTL-Plus.174, 176 The structures were solved 
by direct methods and successive interpretation of difference Fourier maps, followed by 
least-squares refinement. All non-hydrogen atoms were refined with anisotropic thermal 
parameters. The hydrogen atoms were included using a riding model with isotropic 
parameters tied to the parent atom.  
Dealkylation of phosphates. In a typical experiment salen(tBu)AlBr (15) (30 mg, 
0.050 mmol) was dissolved in about 1 mL CDCl3 in a glass vial. The solution was 
transferred to a NMR tube in which trimethylphosphate (1.96 µL, 0.0170 mmol, density 
1.197 g/mL) was added with a syringe. The mixture was shaken and monitored by 1H 
NMR. The % dealkylation was calculated from the peak integrations of methyl bromide 
produced and unchanged phosphate. 
 Catalytic dealkylation of phosphate. In a typical experiment in a glass vial 15 mg 
(0.025 mmol) salen(tBu)AlBr (15) was dissolved in about 1 mL CDCl3. The solution was 
transferred to a NMR tube in which trimethylphosphate (29 µL, 0.25 mmol, density 1.197 
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g/mL) and boron tribromide (0.25 mL, 0.25 mmol, 1 M solution in hexane) were added 
with syringe. The mixture was shaken and monitored by 1H NMR. The % dealkylation 
was calculated from the peak integrations of methyl bromide produced and unchanged 
phosphate. 
Attempts to identify the active species for the catalytic reaction: (a) In a glass vial 
60 mg (0.10 mmol) salen(tBu)AlBr (15) was dissolved in about 1 mL CDCl3. The 
solution was transferred to an NMR tube in which boron tribromide (0.10 mL, 0.10 
mmol, 1 M solution in heptane) was added with a syringe. The mixture was shaken, 
allowed to stand for 30 minutes and NMR was taken. 27Al NMR: δ 79 ppm (w1/2 = (507 
Hz).11B NMR: δ -0.79 ppm (( w1/2 = 1038 Hz).  
b) In a glass vial 60 mg (0.10 mmol) salen(tBu)AlBr (15) was dissolved in about 1 mL 
CDCl3. The solution was transferred to an NMR tube in which boron tribromide (0.10 
mL, 0.10 mmol, 1 M solution in heptane) was added with a syringe. The mixture was 
shaken, allowed to stand for 1 h. To this mixture trimethylphosphate (3.9 µL, 0.034 
mmol, density 1.197 g/mL) was added with a microsyringe. 1H NMR taken after 15 
minutes showed 100 % conversion of trimethyl phosphate. 
 Attempts to observe the regeneration of the catalytic species: (a) In a glass vial 30 
mg (0.05 mmol) salen(tBu)AlBr (15) was dissolved in about 1 mL CDCl3. The solution 
was transferred to an NMR tube in which trimethylphosphate (1.96 µL, 0.017 mmol, 
density 1.197 g/mL) was added with a microsyringe. The mixture was shaken, allowed to 
stand for 24 h. Boron tribromide (0.05 mL, 0.05 mmol, 1 M solution in heptane) was then 
added to the reaction mixture with syringe and NMR was taken after 20 minutes. 27Al: δ 
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75 ppm (w1/2 = 238 Hz). 31P{1H}: δ -5.11 ppm. 11B: δ 12.28 (w1/2 = 475 Hz), -0.56 (w1/2 = 
1894 Hz), -6.55 (w1/2 = 1100 Hz), -13.58 (w1/2 = 124 Hz) ppm. 
(b) In a glass vial 60 mg (0.080 mmol) salen(tBu)AlOP(O)Ph2 (23)was dissolved in 
about 1 mL CDCl3. The solution was transferred to an NMR tube in which boron 
tribromide (0.08 mL, 0.08 mmol, 1 M solution in heptane) was added with a syringe. The 
mixture was shaken, allowed to stand for 2 h and NMR was taken. 27Al NMR: δ 76 ppm 
(w1/2 = (290 Hz). Similar peak was observed when BBr3 was added in excess (23:BBr3 = 
1:10). 
(c) In an NMR tube trimethyl phosphate (29 µL, 0.25 mmol, density 1.197 g/mL) was 
dissolved in about 1 mL CDCl3. Boron tribromide (0.25 mL, 0.25 mmol, 1 M solution in 
hexane) was then added to the reaction mixture with syringe. The reaction mixture was 
shaken and allowed to stand for 2 h and NMR was taken. 11B: δ -13.51 ppm (w1/2 =3 Hz), 
37.39 ppm (w1/2 = 64 Hz). 31P{1H}: δ -9.08 ppm. 
(d) In a glass vial 30 mg (0.050 mmol) salen(tBu)AlBr (15) was dissolved in about 1 
mL CDCl3. The solution was transferred to an NMR tube in which trimethylphosphate 
(1.96 µL, 0.017 mmol, density 1.197 g/mL) was added with a microsyringe. The mixture 
was shaken, allowed to stand for 12 h and NMR was taken. 27Al: δ 24 ppm (w1/2 = 5900 
Hz). 31P{1H}: δ -14.09 ppm. 
 Synthesis of salen(tBu)AlOP(O)Ph2 (23). To a rapidly stirred solution of 
salen(tBu)AlBr (15) (0.50g, 1.8 mmol) in toluene, Ph2P(O)OMe (0.20 g, 0.85 mmol) was 
added. The reaction mixture was stirred for 24 hours and then refluxed for 17 hours. Then 
it was cannula filtered and the pale yellow residue was dried under vacuum. Yield: 0.40 g 
(65.0%). Mp: 302-304 ºC. 1H NMR (CDCl3): δ 1.29 (s, 18H, C(CH3)3), 1.59 (s, 18H, 
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C(CH3)3), 3.64 (m, 2H, NCH2), 4.40 (m, 2H, NCH2), 6.90 (d, 2H, Ph-H), 6.99 (m, 5H, 
Ph-H), 7.26 (d, 2H, Ph-H), 7.52 (m, 5H, Ph-H) 8.17 (s, 2H, N=CH); 13C NMR (CDCl3): δ 
29.7 (C(CH3)3), 31.3 (C(CH3)3), 33.9 (CCH3)3), 35.6 (CCH3)3), 54.7 (NCH2), 118.3 (Ph), 
127.2 (Ph), 127.4 (Ph), 127.5 (Ph), 129.9 (Ph), 130.8 (Ph), 130.9 (Ph), 131.1 (Ph), 138.4 
(Ph), 140.5 (Ph), 162.8 (Ph), 170.3 (N=CH); 27Al NMR (CDCl3): δ 30 (W1/2 = 1951 Hz). 
31P{1H} NMR (CDCl3): δ 35. IR ν/ cm-1: 3053 (w),2955s, 2905m, 2858w, 1643s, 1625s, 
1547w, 1536w, 1478m, 1468m, 1441m, 1390m, 1359m, 1259m, 1176s, 1131m, 1071w, 
1025, 857w, 847m,786w,753m, 726m, 700m, 605m, 555m. MS (EI, positive): 734(M+, 
17%), 677 (M+-tBu, 100%), 517 (M+ - Ph2P(O)O, 8%). Anal. Calc.for C44H56O4N2Al: C 
71.91, H 7.68, N 3.81. Found: C 71.40, H 8.18, N 3.57. 
 Synthesis of [salpen(tBu)AlO]2[(BuO)2PO]2 (24). To a rapidly stirred solution of 
salpen(tBu)AlBr (16) (0.81 g, 1.3 mmol) in toluene, (BuO)3PO (0.16 g, 0.44 mmol) was 
added. The yellow reaction mixture was stirred for 48 hours. After filtration and 
concentration to about one third of its volume and cooling for several days at -30 ºC 
yellow crystals precipitated which were filtered, washed with hexane (twice) and dried 
under vacuum. Yield: 0.17 g (52 %). Mp: softens at 196 ºC and melts at 236-238 ºC. 1H 
NMR (CDCl3): δ 0.65 (m, phosphate CH2CH2CH2CH3), 0.89 (m, phosphate 
CH2CH2CH2CH3), 1.30 (s, C(CH3)3), δ 1.32 (s, br, phosphate CH2CH2CH2CH3 and 
C(CH3)3), 1.41 (s, C(CH3)3), 1.46 (s, br, phosphate CH2CH2CH2CH3 and C(CH3)3), 2.1 
(m, CH2CH2CH2), 3.4 (m, phosphate CH2CH2CH2CH3), 3.72 (m, NCH2), 7.20-7.54 (m, 
Ph-H), 8.41 (s, br, N=CH), 8.50 (s, br, N=CH); 13C NMR (CDCl3, 200 MHz): δ 13.6 
(phosphate CH2CH2CH2CH3), 18.3 (phosphate CH2CH2CH2CH3), 27.2 (CH2), 29.6 
(C(CH3)3), (29.8 (C(CH3)3), 31.5 (C(CH3)3), 31.6(C(CH3)3), 31.9 (phosphate 
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CH2CH2CH2CH3), 34.2 (CCH3)3), 34.3 (CCH3)3), 35.5 (CCH3)3), 55.1 (NCH2), 67.8 
(CH2CH2CH2CH3), 118.4 (Ph), 125.6 (Ph), 126 (Ph), 128.1 (Ph), 128.5 (Ph), 129.3 (Ph), 
131.4 (Ph),139.4 (Ph), 140.6 (Ph), 166.9 (Ph), 172.0 (N=CH); 27Al NMR (CDCl3): δ -5 
(W1/2 = 997 Hz), 40 (W1/2 = 3704 Hz) . 31P{1H} NMR(CDCl3): δ -18 (s). IR ν/ cm-1: IR ν/ 
cm-1: 2957s, 2906s, 2870m, 1620s, 1547m, 1479s, 1467s, 1442s, 1418s, 1391m, 1361m, 
1342w, 1326w, 1312w, 1271s, 1259s, 1236m, 1201m, 1174s, 1091w, 1068w, 1028w, 
860w, 847m, 786w, 751w, 599w, 568w. MS (MALDI-TOF): 1272 (M+ - (BuO)2PO2, 
1.9%), 531 (M+  2 (BuO)2PO2, 100%). Anal. Calc. for C82H132O12N4Al2P2: C 66.46, H 
8.98, N 3.78. Found: C 65.85, H 9.66, N 4.15. 
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Table 5.1. Dealkylation (%)a of organophosphates with compounds 15, 16 and 18. 
 
 
 
 
 
 
Compound                15                  16                     18 
 TMP TEP TBP TMP TEP TBP TMP TEP TBP 
30 minutes 64 14 12 35 75 7 18 7 100 
2 hours 79 100 100 44 100 100 30 100  
4 hours 89   44   40   
6 hours 91   56   46   
8 hours 93   58   58   
10 hours 95   62   64   
12 hours 96   67   69   
24 hours 96   69   85   
a Calculated from the integration of 1H NMR spectra of alkyl bromide produced and 
unchanged trialkyl phosphate at room temperature in CDCl3. In CD3OD after 24 hours 15 
showed no dealkylation while 16 and 18 had 4% and 3% dealkylation, respectively. 
Salen(tBu)AlCl showed 55% dealkylation of TMP in CDCl3 after 24 hours. TMP = 
trimethylphosphate, TEP = triethylphosphate, TBP = tributylphosphate. 
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Table 5.2. Catalytic dealkylation (%) of trimethylphosphate (TMP) with Salen(tBu)AlBr 
compounds.a 
 
 
 
 
 
 
 
 
Compound 15 + TMP + 
BBr3 (1:10:10) 
16 + TMP + 
BBr3 (1:10:10) 
18 + TMP + 
BBr3 (1:10:10) 
TMP + BBr3 
(1:1) 
30 minutes 88 78 82 58 
2 hours 100 92 84 67 
6 hours 100 100 95 67 
24 hours 100 100 95 81 
a Calculated from the integration of 1H NMR spectra of methyl bromide produced and 
unchanged trimethyl phosphate at room temperature in CDCl3. 
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Table 5.3. Crystallographic data and refinement details for compounds 23·MeOH and 24 
 Compound 23 Compound 24 
Empirical formula C45H60AlN2O5P2 C96H148Al2N4O12P2 
M/ g mol-1   766.90 1666.08 
Color  Yellow Pale yellow 
Crystal size/mm 0.22 x 0.10 x 0.10 0.20 x 0.20 x 0.08 
Crystal system  Orthorhombic monoclinic 
Space group P 212121 P 21/c 
a/ Å 11.6850(2) 10.6546(2)  
b/ Å 26.1840(5) 17.6944(3)  
c/ Å 28.1148(5)  24.9473(5)  
α/ û 90.00 90.00  
β/ û 90.00 95.9921(7)  
γ/ û 90.00 90.00  
V/ Å3 8602.0(3) 4677.54(15)  
ρcalc/ g cm-3 1.184 1.183  
Z 8 2 
F(000) 3296 1808  
Radiation used Cu-Kα Mo-Kα 
µ /mm -1 1.121 0.126 
T/ K 90.0(2) 90.0(2) 
hkl range -14 ≤ h ≤ 13, -11 ≤ k ≤ 
31, -33 ≤l ≤ 32 
-12 ≤ h ≤12, -21 ≤ k ≤ 21, -
29 ≤ l ≤ 29 
Θ range/ û 2.31 - 68.22 1.41 - 25.00 
Reflections measured  48842 91792 
Unique reflections (Rint) 15283 [R(int) = 
0.0524] 
8238 (0.1476)  
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Obsd reflections, n [I≥ 2σ (I)] 14037  4803 
Refinement method Full-matrix least-
squares on F2 
Full-matrix least-squares on 
F2 
Refined parameters/restraints 1018/120 538/0 
R1 [I > 2σ] R1 = 0.0408, wR2 = 
0.0996 
R1 = 0.0566, wR2 = 0.1079 
R1 (all data) R1 = 0.0457, wR2 = 
0.1030 
R1 = 0.1236, wR2 = 0.1307 
Goodness-of-fit on F2 1.050 0.998 
Largest diff. peak and hole/ e. 
Å -3 
0.415 and -0.277 0.314 and -0.559 
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Table 5.4. Selected bond distances (Å) and angles (º) for compounds 23·MeOH and 24 
Salen(tBu)AlOP(O)Ph2 (23) 
Al1A-N1A 2.0023(19)  Al1A-O2A 1.8133(16) 
Al1A-N2A 1.9977(19)  Al1A-O3A 2.0255(17) 
Al1A-O1A 1.8033(16)  Al1A-O4A 1.8729(17) 
   O4A-P1A 1.5052(17) 
O1A-Al1-O2A 95.97(7)  O3A-Al1A-N1A 88.76(7) 
O1A-Al1-O3A 87.18(7)  O3A-Al1A-N2A 82.36(7) 
O1A-Al1A-N1A 91.34(7)  O3A-Al1A-O4A 175.39(7) 
O2A-Al1A-N2A 91.22(7)  N1A-Al1A-N2A 81.27(8) 
O2A-A1lA-O3A 89.79(7)  Al1A-O4A-P1A 151.12(11) 
     
[Salpen(tBu)AlO]2[(BuO)2PO]2 (24) 
Al1-N1 2.026(2)  P1-O3 1.4827(18) 
Al1-N2 2.001(2  P1-O4 1.4778(18) 
Al1-O1 1.8274(19)  P1-O5 1.5750(19) 
Al1-O2 1.8597(19)  P1-O6 1.5836(18) 
Al1-O3 1.8816(19)    
Al1-O4 1.8611(19)    
     
O1-Al1-N1 88.32(9)  O2-Al1-O4 91.34(8) 
O1-Al1-N2 176.15(10)  O3-Al1-N1 86.60(9) 
O1-Al1-O2 93.01(9)  O3-Al1-N2 87.23(9) 
O1-Al1-O3 93.64(8)  O3-Al1-O4 91.40(8) 
O1-Al1-O4 93.45(8)  N1-Al1-N2 87.98(9) 
O2-Al1-N1 90.45(9)  Al1-O3-P1 150.46(12) 
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O2-Al1-N2 85.94(9)  Al1-O4-P1 165.22(12) 
O2-A1l-O3 172.64(9)  O3-P1-O4 118.52(11) 
O3-P1-O5 111.59(10)  O4-P1-O6 110.32(10) 
O5-P1-O6 105.78(10)    
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Figure 5.1. Possible dealkylation pathway of organophosphates with Salen((tBu)AlBr 
compounds. 
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Figure 5.2. Dealkylation of a phosphinate with various iodide salts. 
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Figure 5.3. Proposed catalytic cycle for dealkylation of trimethylphosphate with excess 
boron tribromide in the presence of salen(tBu)AlBr (15). For the sake of simplicity only 
the dealkylation of one ester group is shown. 
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Figure 5.4. Compound [(AlOiPr)2O2P(OtBu)2]4 containing a rare five-coordinate 
aluminum phosphate. 
 171
 
 
 
 
 
 
 
N
O
Al
N
O
tBu
But
But
tBu
R
Al
O O
O
N N P
Ph H
O
n
Ph(H)P(O)OH
n = 2, ∞
R
R =  various alkylene or arylene 
groups forming the "backbone" of 
the ligand
Me
 
 
 
 
 
 
Figure 5.5. Salen aluminum phosphinate compounds formed by alkane elimination 
reaction. 
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Figure 5.6. Synthesis of salen aluminum phosphinate (23). 
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Figure 5.7. Crystal structure of 23MeOH.  
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Figure 5.8. Synthesis of compound 24. 
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Figure 5.9. TGA of compound 24.
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Figure 5.10. Molecular structure of 24. 
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Figure 5.11. Packing diagram of 24 viewed down the a-axis.  
 178
 
 
 
 
 
 
 
 
 
 
5.108 
Å
 
 
 
 
 
 
 
Figure 5.12. Al-O-P ring showing the Al-Al distance. 
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CHAPTER 6 
Conclusion and Future Research 
 In this dissertation research two group 13 systems, mononuclear boron Schiff base 
halide compounds based on salicylidenimine ligands, and mononuclear aluminum 
bromide compounds based on Salen ligands, have been investigated for the dealkylation 
of organophosphate esters. Some of the mononuclear boron compounds showed very 
good dealkylation activity. One of the dealkylated products from a phosphate monoester 
(t-butyl diphenylphosphinate) was characterized both spectroscopically and structurally. 
The Salen aluminum bromide compounds prepared could form cations easily with the 
weak bases, triphenylphosphine oxide and triphenylphosphate. These compounds were 
also found to be very active for the dealkylation of a series of phosphates. The good 
activity of both mononuclear boron and aluminum Schiff base compounds shows that a 
binuclear chelate compound is not necessary for the dealkylation of phosphate esters. 
However, the mononuclear boron compounds were prone to hydrolysis and thus 
comparatively more difficult to synthesize compared to the binuclear compounds. Both 
mono- and binuclear compounds had to be prepared in a two-step process through the 
borate precursor from the ligand. On the other hand the synthesis of mononuclear Salen 
aluminum compounds was a one-step process. These compounds are stable to hydrolysis 
in sealed containers and can be handled in air for short periods of time. The dealkylated 
product from both mononuclear boron and mononuclear aluminum systems remain 
soluble which makes them more suitable for spectroscopic and structural characterization 
compared to the binuclear system for which the end product is insoluble. The 
mononuclear Salen aluminum system having the advantage of producing soluble end 
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product and being fairly stable seems to be the most suitable system for further study. 
Although no fully dealkylated product from the phosphate triester P(O)(OR)3 could be 
isolated and characterized, two dealkylated products from the phosphinates, Ph2P(O)OtBu 
in case of mononuclear boron and Ph2P(O)OMe in case of Salen aluminum compounds, 
were fully characterized. Their structures represent rare examples of monomeric chelated 
compounds with terminal phosphinate groups. In another attempt, an aluminophosphate 
ring compound containing six-coordinate aluminum atoms was synthesized which 
indicates that dealkylation could be a useful tool to prepare soluble models for 
aluminophosphate materials. 
 Although the Schiff base boron and aluminum compounds described in this 
dissertation dealkylate organophosphates effectively in non-nucleophilic solvents, they 
might not be very effective in strong donor solvents like methanol or water. The solvent 
will be a stronger nucleophile compared to the phosphate and thus block the coordinating 
site of boron or aluminum. One potential way around this problem could be to carry out 
the reactions in ionic liquids that will be non-coordinating and also help dissolve the 
boron or aluminum Schiff base halides, which are poorly soluble in water. 
 Attempts have been made to examine the applicability of Salen(tBu)AlBr as a catalyst 
for the reaction between trimethyl phosphate and boron tribromide. It appears that  
Salen(tBu)AlBr combines with boron tribromide to form a more active partially cationic 
species. This partially cationic species seemed to regenerate in the system. However, a 
detailed mechanistic study and isolation of the catalytic species would be required for any 
confirmation of the catalytic cycle. 
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 The studies described in this dissertation could be the groundwork on which more 
expanded studies could be carried out in the future. Future work should be directed 
towards the isolation and characterization of fully dealkylated products from the 
phosphate triesters. Also kinetic studies should be undertaken which will help determine 
the optimum reaction conditions for the system. However, it should be noted that the 
possible applications of this dealkylation, the destruction of nerve gas agents and 
pesticides, need to be conducted in water. Thus, the creation of a water stable 
dealkylation system needs to be achieved before embarking on a detailed mechanistic 
study. The dealkylation study could be expanded to develop other similar systems which 
could also prove to be useful for phosphate dealkylation. For example, Salen aluminum 
iodide could be more useful than the bromide since Al-I bond is weaker than Al-Br bond. 
Considering the easier removal of bromide compared to chloride by a nucleophile, Salen 
aluminum bromides have the potential to be better application prospect compared to the 
widely used Salen aluminum chloride compounds in various Lewis acidic applications. 
 Beside potential application in nerve agents and pesticide decontamination the 
dealkylation reaction using boron and aluminum compounds could be used for various 
organic syntheses. One example is in oligonucleotide synthesis where the phosphate 
protecting group has to be removed in the last step by breaking a C-O bond. Also, chiral 
Salen aluminum bromide could be prepared and used for various enantioselective 
syntheses in which chiral Salen aluminum chlorides are already in use. Some other useful 
applications might be in ring opening polymerization of oxiranes and cyclic carbonates, 
and ether cleavage. 
Copyright © Amitabha Mitra 2006 
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Appendix I: Crystal Packing Diagrams 
Figure A1. Crystal packing diagram of compound 5 viewed down the a axis. 
Figure A2. Crystal packing diagram of compound 6 viewed down the a axis. 
Figure A3. Crystal packing diagram of compound 11 viewed down the a axis. 
Figure A4. Crystal packing diagram of compound 12 viewed down the a axis. 
Figure A5. Crystal packing diagram of compound 13 viewed down the a axis. 
Figure A6. Crystal packing diagram of compound 14 viewed down the a axis. 
Figure A7. Crystal packing diagram of compound 15 viewed down the a axis. 
Figure A8. Crystal packing diagram of compound 16 viewed down the a axis. 
Figure A9. Crystal packing diagram of compound 17 viewed down the a axis. 
Figure A10. Crystal packing diagram of compound 18 viewed down the a axis. 
Figure A11. Crystal packing diagram of compound 20 viewed down the a axis. 
Figure A12. Crystal packing diagram of compound 21 viewed down the a axis. 
Figure A13. Crystal packing diagram of compound 22 viewed down the a axis 
Figure A14. Crystal packing diagram of compound 23·MeOH viewed down the a axis 
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Figure A1. Crystal packing diagram of compound 5 viewed down the a axis. 
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Figure A2. Crystal packing diagram of compound 6 viewed down the a axis. 
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Figure A3. Crystal packing diagram of compound 11 viewed down the a axis. 
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Figure A4. Crystal packing diagram of compound 12 viewed down the a axis. 
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Figure A5. Crystal packing diagram of compound 13 viewed down the a axis. 
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Figure A6. Crystal packing diagram of compound 14 viewed down the a axis. 
 189
 
Figure A7. Crystal packing diagram of compound 15 viewed down the a axis. 
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Figure A8. Crystal packing diagram of compound 16 viewed down the a axis. 
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Figure A9. Crystal packing diagram of compound 17 viewed down the a axis. 
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Figure A10. Crystal packing diagram of compound 18 viewed down the a axis. 
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Figure A11. Crystal packing diagram of compound 20 viewed down the a axis. 
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Figure A12. Crystal packing diagram of compound 21 viewed down the a axis. 
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Figure A13. Crystal packing diagram of compound 22 viewed down the a axis 
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Figure A14. Crystal packing diagram of compound 23.MeOH viewed down the a axis 
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Appendix II: List of Symbols and Abbreviations 
 
General: 
Å     angstrom, 10-10 m 
Ac    acetate 
ATP    adenosine triphosphate 
nBu    normal- butyl, CH2(CH2)2CH3 
tBu    tertiary-butyl, C(CH3)3 
Calcd   calculated 
Cy    cyclohexyl 
D     bond dissociation energy 
Dec    decomposed 
EI     Electron Impact 
Et     Ethyl, CH2CH3 
g     grams 
GOF    goodness of fit 
h     hours 
HMPA   hexamethylphosphoramide 
Hz    hertz, s-1 
K     Kelvin 
M     molar 
M+    molecular ion 
Me    methyl, CH3 
mg    milligrams 
min    minutes 
mL    milliliters 
mmol   millimoles 
mp    melting point 
Ph     phenyl 
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nPent    normal pentyl, CH2(CH2)3CH3 
ppm    parts per million 
iPr     isopropyl, CH(CH3)2 
R     R - factor 
Rw    weighted R - factor 
s     seconds 
Salen    common name for the entire ligand class. 
t     time 
T     temperature 
THF    tetrahydrofuran 
ptolyl    para- tolyl 
For nuclear magnetic resonance  spectra: 
δ     chemical shift (in parts per million) 
d     doublet 
m     multiplet 
NMR    nuclear magnetic resonance 
s     singlet 
w1/2    width at half height 
For infrared spectra: 
br     broad 
cm-1    wavenumbers 
FT IR   Fourier Transform Infrared Spectra 
m     medium 
s     strong 
ν     vibrational frequency (cm-1) 
w     weak 
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